"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_POLICLINICOBARI",2000,15,6.26666666666667,2.53333333333333,0.866666666666667,0.333333333333333,0.866666666666667,1.02702702702703,1,0.833333333333333,1,0.266666666666667,2,5,3,2,4,0.33,0.2,0.13,0.27,52.13,1.15005976199137,NA,0.2,0.6,0.394,0.119,0,0.119,"V. MARCO RANIERI;DARIO TROISE;TOMMASO DE PALO;LORETO GESUALDO;LORENA PISANELLO;LICIA PERUZZI;ALESSANDRO SGAMBATO;A BRIENZA;RITA MINGARELLI;FRANCESCO BRUNO;ALESSANDRO VIENNA;GIANDOMENICO PALKA;DOMENICO DEL PRINCIPE;MARCO CHIRICO;A. ARRIGHINI;C. DE GAETANI;FILOMENA CARIOLA;PIETRO LEOCATA;MARIO MIGALDI;ALDO GIANNOTTI","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DANIELE DIONISIO;V. MARCO RANIERI;V. MARCO RANIERI;G. GUANTI;NENAD BUKVIĆ;G D'EREDITÀ;GIUSEPPE RUBINI;SALVATORE GRASSO;DARIO TROISE;TOMMASO DE PALO;VITO DE PINTO;SIMONETTA SIMONETTI;ANGELA MESSINA;ROLAND BENZ;FRANCO A. CARNEVALE;ANGELA SCHMID;LORETO GESUALDO;FILOMENA CARIOLA;ANTONIA LOPEZ;R BELLANTUONO","1;1;0.62;0.5;0.5;0.5;0.5;0.5;0.27;0.23;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14","V. MARCO RANIERI;DARIO TROISE;TOMMASO DE PALO;LORETO GESUALDO;ALESSANDRO SGAMBATO;A BRIENZA;FRANCESCO BRUNO;ANTONIA LOPEZ;R BELLANTUONO;RITA FISCHETTO;G. GUANTI;ARTHUR S. SLUTSKY;GINEVRA GUANTI;VALENTINA CAPPIELLO;PETER M. SUTER;SIMONETTA SIMONETTI;CARLO MANNO;VINCENZO COLELLA;RENATO DE TULLIO;ROLAND BENZ","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DANIELE DIONISIO;V. MARCO RANIERI;V. MARCO RANIERI;G. GUANTI;G D'EREDITÀ;GIUSEPPE RUBINI;SALVATORE GRASSO;DARIO TROISE;TOMMASO DE PALO;SIMONETTA SIMONETTI;ROLAND BENZ;FRANCO A. CARNEVALE;ANGELA SCHMID;LORETO GESUALDO;ANTONIA LOPEZ;R BELLANTUONO;GINEVRA GUANTI;VALENTINA CAPPIELLO;CARLO MANNO;VINCENZO COLELLA","1;1;0.62;0.5;0.5;0.5;0.5;0.27;0.23;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.14","V. MARCO RANIERI;A BRIENZA;ARTHUR S. SLUTSKY;COSIMO TORTORELLA;FRANCESCO BRUNO;J.-M. DAYER;PETER M. SUTER;RENATO DE TULLIO;CRISTIANO SIMONE;FILOMENA CARIOLA;GINEVRA GUANTI;I. DEMMA;MATTIA GENTILE;NICOLETTA RESTA;P. FIORENTE;TOMMASO DE PALO;ALBERTO EDEFONTI;ALESSANDRO VIENNA;ANTONIO PICCOLI;BIAGIO DI IORIO","273;266;266;266;266;266;266;266;124;124;124;124;124;124;124;119;106;106;106;106","A BRIENZA;ARTHUR S. SLUTSKY;COSIMO TORTORELLA;FRANCESCO BRUNO;J.-M. DAYER;PETER M. SUTER;RENATO DE TULLIO;V. MARCO RANIERI;GINEVRA GUANTI;TOMMASO DE PALO;GIOVANNI MESSINA;G. GUANTI;DOMENICO DE MATTIA;ALESSANDRO SGAMBATO;ANTONIA LOPEZ;CARLO MANNO;FRANCESCO PAOLO SCHENA;LORETO GESUALDO;RAFFAELLA MONNO;VALENTINA CAPPIELLO","266;266;266;266;266;266;266;266;124;119;106;80;54;44;34;34;34;34;34;34","TOMMASO DE PALO;A BRIENZA;ALESSANDRO SGAMBATO;ANGELA SCHMID;ANTONIA LOPEZ;ANTONIO RINALDI;ARTHUR S. SLUTSKY;CARLO MANNO;COSIMO TORTORELLA;D.A. CARINGELLA;DANIELE DIONISIO;DARIO TROISE;DOMENICO DE MATTIA;FRANCESCO BRUNO;FRANCESCO PAOLO SCHENA;FRANCO A. CARNEVALE;G D'EREDITÀ;G. GUANTI;GINEVRA GUANTI;GIOVANNI MESSINA","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;ENGINEERING;COMPUTER SCIENCE;CHEMISTRY;ECONOMICS;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","14;5;3;2;1;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;ANESTHESIA;INTENSIVE CARE MEDICINE;MECHANICAL ENGINEERING;CANCER RESEARCH;ENDOCRINOLOGY;ONCOLOGY;SURGERY;ANATOMY;BIOCHEMISTRY;BIOPHYSICS;CARDIOLOGY;CELL BIOLOGY;CHROMATOGRAPHY;DEMOGRAPHY;ECOLOGY;ECONOMIC GROWTH;ENVIRONMENTAL HEALTH;EPISTEMOLOGY;FAMILY MEDICINE;IMMUNOLOGY;LAW;MEDICAL EMERGENCY;PEDIATRICS;STATISTICS;TELECOMMUNICATIONS;THEOLOGY;UROLOGY;VIROLOGY;WORLD WIDE WEB;ZOOLOGY","11;6;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENE;MECHANICAL VENTILATION;VENTILATION (ARCHITECTURE);CARCINOMA;IMMUNOHISTOCHEMISTRY;LUNG;LYMPH NODE;PLATELET;RESPIRATORY FAILURE;ADENOMA;ALBUMIN;ANTIBODY;BIVARIATE ANALYSIS;BODY MASS INDEX;CHRISTIAN MINISTRY;CONFIDENCE INTERVAL;COUPLING (PIPING);CREATININE;DIABETES MELLITUS;DIALYSIS;DUODENUM;EPITHELIUM;EXCRETION;FRACTION (CHEMISTRY);HEALTH CARE;HELMINTHS;HEMATOLOGY;HEMODIALYSIS;HEMODYNAMICS;HEPARIN;HORMONE;INTEGRATED SERVICES DIGITAL NETWORK;INTESTINAL MUCOSA;KIDNEY;LARVA;LUMEN (ANATOMY);MALIGNANT TRANSFORMATION;MEDLINE;MEMBRANE;MYOPATHY;NEUROENDOCRINE TUMORS;PARASITE HOSTING;PERCENTILE;POPULATION;QUALITY (PHILOSOPHY);RANDOMIZED CONTROLLED TRIAL;RECEPTOR;RENAL FUNCTION;RESPIRATORY DISTRESS;RESPIRATORY SYSTEM;SCINTIGRAPHY;SHORT STATURE;SIGNAL TRANSDUCTION;SOMATOSTATIN;TURNER SYNDROME;ULTRASTRUCTURE;URINARY SYSTEM;VIRAL TEGUMENT;WEAKNESS","4;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE RESPIRATORY FAILURE;COLORECTAL CANCER;MUTATION;ACUTE RESPIRATORY DISTRESS;APHERESIS;BIOELECTRICAL IMPEDANCE ANALYSIS;BLOT;BREAST CANCER;CARCINOGENESIS;ENOLASE;ESCHERICHIA COLI;FRESH FROZEN PLASMA;GERMLINE;GLOMERULONEPHRITIS;GROWTH HORMONE;IMMUNOADSORPTION;ION CHANNEL;LIPID BILAYER;NEPHROPATHY;NEUROENDOCRINE CARCINOMA;NONINVASIVE VENTILATION;OCTREOTIDE;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;PROTEINURIA;RENAL BIOPSY;RESPIRATORY DISEASE;SOMATIC CELL;STRONGYLOIDES STERCORALIS;TELEMEDICINE;THROMBOCYTOPENIC PURPURA;X CHROMOSOME","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ARTIFICIAL VENTILATION;BACTERIAL OUTER MEMBRANE;BREAST CARCINOMA;GERMLINE MUTATION;HAPLOINSUFFICIENCY;IDIOPATHIC SHORT STATURE;LDL APHERESIS;MEMBRANOUS NEPHROPATHY;NEOPLASTIC TRANSFORMATION;PSEUDOAUTOSOMAL REGION;PTEN","1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;CHILD;CHILD, PRESCHOOL;VOLTAGE-DEPENDENT ANION CHANNEL 1;ADENOMATOUS POLYPOSIS COLI;ADOLESCENT;AGED;COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS;PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;STOMACH NEOPLASMS;AIDS-RELATED OPPORTUNISTIC INFECTIONS;BODY HEIGHT;BONE AND BONES;COLORECTAL NEOPLASMS;COMPLEMENT C3;GLOMERULONEPHRITIS, MEMBRANOUS;GLUCOCORTICOIDS","13;9;8;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3","MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;BODY COMPOSITION ASSESSMENT AND ANALYSIS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;GLOBAL IMPACT OF HELMINTH INFECTIONS AND CONTROL STRATEGIES;IMPROVING COMMUNICATION IN REFERRAL PROCESS;METASTATIC CARCINOMAS FROM LUNG AND BREAST;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;MTOR SIGNALING IN GROWTH AND DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;SEX DETERMINATION AND DIFFERENTIATION IN ORGANISMS","3;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE RESPIRATORY FAILURE;MECHANICAL VENTILATION;NONINVASIVE VENTILATION;ARTIFICIAL VENTILATION;BIOELECTRICAL IMPEDANCE ANALYSIS;BREAST CARCINOMA;CANCER;CANCER RISK;CANCER THERAPY;CARCASS CHARACTERISTICS;CHRISTIAN MINISTRY;COLORECTAL CANCER;COMMUNICATIONS;ELECTRICAL IMPEDANCE TOMOGRAPHY;ENOLASE;FETAL HYDROPS;FRACTION (CHEMISTRY);FRESH FROZEN PLASMA;HAPLOINSUFFICIENCY;HEMATOLOGY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE CHILDHOOD;ACUTE RESPIRATORY;AIEOP CONSENSUS;ARM REARRANGEMENTS;ARTIFICIAL VENTILATION;ASSIST VENTILATION;ASSOCIAZIONE ITALIANA;BIOELECTRICAL IMPEDANCE;BREAST CARCINOMA;CANCER SYNDROMES;CB- EXCRETION;CHANNEL-FORMING ACTIVITY;CHILDHOOD IDIOPATHIC;CHILDREN EXPERIENCE;COLORECTAL CANCER;COLORECTAL CANCEROGENESIS;CONSENSUS GUIDELINES;CONTROLLED TRIAL;DI EMATOLOGIA;DIALYSIS CENTER;DISTRESS SYNDROME;DTPA OCTREOTIDE;DUODENAL MUCOSA;GASTRIC CARCINOMAS;GENETIC PATHWAYS;HATCHED LARVAE;HEREDITARY COLORECTAL;HUMAN DUODENAL;HUMAN PATIENT;IDIOPATHIC MEMBRANOUS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE EXPRESSION;HATCHED LARVAE;IMN PATIENTS;PATHOGENETIC ROLE;URINARY CB-;URINARY EXCRETION;NEWLY HATCHED;PT CATEGORY;PTEN GENE;RELATIVE RISK;ACTIVATION PLAYS;BIOPSY TIME;CB- CORRELATES;CB- INDICES;CB- LEVELS;CELL LEVELS;CENTRAL PATHOGENETIC;COLORECTAL TUMOURS;COMPARTMENTS CORRELATED;CORTICAL TUBULAR;DISEASE RECENTLY;EPITHELIAL CELL;EXPRESSION IMN;GLOMERULAR PARIETAL;GLOMERULAR STAGE;HISTOPATHOLOGIC PATHOPHYSIOLOGIC;IDIOPATHIC MEMBRANOUS;IMMUNOLOGIC ACTIVITY;IMMUNOLOGIC URINARY;IMN URINARY","6;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2001,12,7.25,2.41666666666667,0.583333333333333,0.333333333333333,0.583333333333333,1,0.875,0.8,0.875,0.25,0,7,1,2,1,0.58,0.08,0.17,0.08,39.42,0.862652030331273,NA,0.166666666666667,0.666666666666667,0.264,0,0.15,0,"C GIARDINA;GABRIELLA SERIO;LUISA RONCALI;GIOACCHINO LEANDRO;ALESSANDRO SGAMBATO;MARGHERITA NERI;FIORELLA GURRIERI;PIERSANTE SESTINI;NATALINO BARBATO;ALESSANDRA MANGIA;MARGHERITA FANELLI;ALESSANDRA VACCA;ANGELO ANDRIULLI;L POLLICE;ANGELA GUERRIERI;MARCO MARINACCIO;C. DE GAETANI;F CAUSIO;VALERIA CONTI;ANTONIO PENNELLA","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","V. MARCO RANIERI;SALVATORE GRASSO;C GIARDINA;ANGELA GUERRIERI;VINCENZO LATTANZIO;GABRIELLA SERIO;ROBERTO DI PAOLA;EUSTACHIO NETTIS;A. TURSI;A. FERRANNINI;LUISA RONCALI;ALESSANDRA VACCA;BEATRICE NICO;DOMÉNICO RIBATTI;A. S. BELLONI;GASTONE G. NUSSDORFER;L POLLICE;MARCO MARINACCIO;ANTONIO PENNELLA;ANNA SCATTONE","0.5;0.5;0.48;0.33;0.33;0.27;0.25;0.25;0.25;0.25;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14","C GIARDINA;ALESSANDRO SGAMBATO;PIERSANTE SESTINI;VALERIA CONTI;ANNA SCATTONE;RITA FISCHETTO;A. GIANGASPERO;CHIARA NOVIELLI;GINEVRA GUANTI;NENAD BUKVIĆ;DOMÉNICO RIBATTI;PAOLA MUGGEO;ROBERTO DI PAOLA;SIMONETTA SIMONETTI;RENATO DE TULLIO;N RIGILLO;FRANCESCO SUSCA;ACHILLE CITTADINI;RAFFAELE ARDITO;EUSTACHIO NETTIS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SALVATORE GRASSO;C GIARDINA;ROBERTO DI PAOLA;EUSTACHIO NETTIS;A. TURSI;A. FERRANNINI;DOMÉNICO RIBATTI;ANNA SCATTONE;VALERIA CONTI;CHIARA NOVIELLI;GINEVRA GUANTI;NENAD BUKVIĆ;PAOLA MUGGEO;SIMONETTA SIMONETTI;N RIGILLO;FRANCESCO SUSCA;ANNUNZIATA LUCARELLI;FRANCESCO PAPADIA;ANTONIO CAPURSO;GIAMMARCO SURICO","0.5;0.48;0.25;0.25;0.25;0.25;0.17;0.14;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12","ACHILLE CITTADINI;ALESSANDRO SGAMBATO;BEATRICE FARAGLIA;C. DE GAETANI;GIAN PAOLO TRENTINI;GIOVANNI CAPELLI;GRAZIELLA DE ALOYSIO;MARIO MIGALDI;PAOLO FERRARI;RAFFAELE ARDITO;GABRIELLA SERIO;ANTONIO CAPURSO;FRANCESCO SUSCA;GINEVRA GUANTI;LUCIA BUONADONNA;MARGHERITA FANELLI;MATTIA GENTILE;NENAD BUKVIĆ;ANNAMARIA DE LUCA;ANTONELLA LIANTONIO","101;101;101;101;101;101;101;101;101;101;88;85;85;85;85;85;85;85;58;58","ACHILLE CITTADINI;ALESSANDRO SGAMBATO;BEATRICE FARAGLIA;GIOVANNI CAPELLI;RAFFAELE ARDITO;ANTONIO CAPURSO;FRANCESCO SUSCA;GINEVRA GUANTI;NENAD BUKVIĆ;FRANCESCO PAPADIA;SIMONETTA SIMONETTI;RITA FISCHETTO;DOMÉNICO RIBATTI;A. FERRANNINI;A. TURSI;EUSTACHIO NETTIS;ROBERTO DI PAOLA;A. GIANGASPERO;ANNUNZIATA LUCARELLI;CHIARA NOVIELLI","101;101;101;101;101;85;85;85;85;58;58;52;44;32;32;32;32;30;29;29","A. FERRANNINI;A. GIANGASPERO;A. TURSI;ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ANNA SCATTONE;ANNUNZIATA LUCARELLI;ANTONIO CAPURSO;BEATRICE FARAGLIA;C GIARDINA;CHIARA NOVIELLI;DOMÉNICO RIBATTI;EUSTACHIO NETTIS;FRANCESCO PAPADIA;FRANCESCO SUSCA;GIAMMARCO SURICO;GINEVRA GUANTI;GIOVANNI CAPELLI;N RIGILLO;NENAD BUKVIĆ","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY","12;5;1;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;ANATOMY;CANCER RESEARCH;ENDOCRINOLOGY;GASTROENTEROLOGY;ANESTHESIA;AUDIOLOGY;BIOCHEMISTRY;BIOPHYSICS;BIOTECHNOLOGY;CELL BIOLOGY;COMPUTER NETWORK;EMERGENCY MEDICINE;INTENSIVE CARE MEDICINE;LINGUISTICS;MECHANICAL ENGINEERING;PHYSICAL THERAPY;RADIOLOGY","9;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENE;IMMUNOHISTOCHEMISTRY;RESPIRATORY SYSTEM;ALLERGY;AMINO ACID;ANGIOGENESIS;ASYNCHRONOUS COMMUNICATION;COMBINATION THERAPY;CONTRACTION (GRAMMAR);DIFFERENTIAL DIAGNOSIS;DNA;DOSE;ECTODERMAL DYSPLASIA;ELECTROPHYSIOLOGY;EMBRYO;ENDOGENY;FOOT (PROSODY);FUNCTIONAL IMPAIRMENT;HEARING LOSS;HINDLIMB;HYGIENE;IN VIVO;INTERFERON;LUNG;MESOTHELIAL CELL;MESOTHELIOMA;MUSCLE CONTRACTION;NEBULIZER;OBESITY;OBSERVATIONAL STUDY;OVARY;PERITONEUM;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;RESPIRATION;SACCHARIN;SEROUS FLUID;SKELETAL MUSCLE;TOXICITY;VENTILATION (ARCHITECTURE);VIRUS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADENOMATOID TUMOR;ALPHA INTERFERON;ASYNCHRONY (COMPUTER PROGRAMMING);BREAST CANCER;CELL CYCLE;CHORIOALLANTOIC MEMBRANE;CHROMOSOME;CHRONIC HEPATITIS;CLINICAL IMMUNOLOGY;DYSTROPHIN;ECTRODACTYLY;EXTENSOR DIGITORUM LONGUS MUSCLE;FIBROBLAST GROWTH FACTOR;HEPATITIS C VIRUS;LATE EFFECT;LEPTIN;LOCUS (GENETICS);MESOTHELIN;MESOTHELIUM;MICRONUCLEUS TEST;MUCOCILIARY CLEARANCE;PERITONEAL MESOTHELIOMA;PHENOTYPE;RESPIRATORY PHYSIOLOGY;RHEOBASE;SARCOLEMMA;SENSORINEURAL HEARING LOSS;SISTER CHROMATID EXCHANGE;TAURINE;VARIABLE EXPRESSION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYCLIN;CYCLIN D1;MAMMOGRAPHY;MAMMOTOME;MDX MOUSE;PENETRANCE;RIBAVIRIN;SISTER CHROMATIDS","1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;ADOLESCENT;BIOMARKERS, TUMOR;BREAST NEOPLASMS;DRUG HYPERSENSITIVITY;FIBROBLAST GROWTH FACTOR 2;HEPATITIS C, CHRONIC;MESOTHELIOMA, CYSTIC;MUSCLE FIBERS, SKELETAL;MUSCLE, SKELETAL;PERITONEAL NEOPLASMS;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;TAURINE;ABNORMALITIES, MULTIPLE;AGED, 80 AND OVER","10;9;9;7;6;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3","BREAST PATHOLOGY AND IMAGING TECHNIQUES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEPATITIS C INFECTION AND TREATMENT;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;NEUROENDOCRINE REGULATION OF APPETITE AND BODY WEIGHT;PATHOBIOLOGY AND MANAGEMENT OF MUCOSITIS IN CANCER THERAPY;PULMONARY DRUG DELIVERY TECHNIQUES","1;1;1;1;1;1;1;1;1;1;1;1","ADENOMATOID TUMOR;ASYNCHRONY (COMPUTER PROGRAMMING);BLADDER CANCER;BREAST CANCER;BREAST IMAGING;BREAST TUMOURS;CHORIOALLANTOIC MEMBRANE;CLINICAL IMMUNOLOGY;COMBINATION THERAPY;CONTACT ALLERGY;DOSE;DRUG HYPERSENSITIVITY;ECTRODACTYLY;FOOT (PROSODY);FUNCTIONAL IMPAIRMENT;HINDLIMB;LATE EFFECT;LEPTIN;MALIGNANT PLEURAL MESOTHELIOMA;MAMMOGRAPHY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANGIOGENIC ACTIVITY;ASSIST VENTILATION;BLADDER CANCER;BREAST IMAGING;CELL CYCLEASSOCIATED;CELL PROLIFERATION;CHICK EMBRYO;CHILDHOOD HEAD;CHORIOALLANTOIC MEMBRANE;CHROMATID EXCHANGE;CHROMOSOME LOSS;CHRONIC HEPATITIS;CLINICAL OUTCOME;CONTROLLED TRIAL;COUPLING MECHANISM;CYCLEASSOCIATED PROTEINS;DIGITORUM LONGUS;DYSTROPHIC MDX;EMBRYO CHORIOALLANTOIC;ENDOGENOUS FIBROBLAST;EXCITATIONCONTRACTION COUPLING;EXTENSOR DIGITORUM;FAMILIES LINKED;FIBROBLAST GROWTH;FOOT MALFORMATION;GENEBU PROJECT;GROWTH FACTOR-;HANDSPLIT FOOT;HEAD CANCER;HEARING LOSS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EDL MUSCLE;MUSCLE FIBRES;AMINO ACID;DISEASEFREE SURVIVAL;EC COUPLING;HOME NEBULIZER;KI EXPRESSION;TUMOR STAGE;HIND LIMB;LIMB MUSCLES;LOW CYCLIN;MDX MICE;MDX MOUSE;PAPILLARY SUPERFICIAL;POSITIVE NUCLEI;PROTEIN EXPRESSION;TUMOR GRADE;ABSTRACT CYCLIN;ACID BRITISH;ACID LEVELS;ACTIVE REGENERATION;AGEMATCHED CONTROLS;AGES WEEKS;BLADDER CANCER;BLADDER CANCERS;BRITISH JOURNAL;BRONCHOPULMONARY SYMPTOMS;CALCIUM MOVEMENTS;CALCIUMDEPENDENT EXCITATIONCONTRACTION;CANCER PROGRESSION","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,633,3.45,0,0,142,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","1;1;1","CARDIOVASCULAR;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEART DISEASE;PREVENTION","1;1;1;1;1","CARDIOVASCULAR","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2002,24,7.54166666666667,2.20833333333333,0.708333333333333,0.25,0.666666666666667,1.06,1.0625,0.857142857142857,1,0.125,2,6,8,2,7,0.25,0.33,0.08,0.29,20.88,0.378384772900262,NA,0.125,0.625,0.405,0.248,0,0.248,"MATTIA GENTILE;PAOLO VOLPE;ALBERTO EDEFONTI;G CARUSO;M. MARASINI;NUNZIA MIGLIETTI;LUISA RONCALI;P MARCUCCIO;SARAH BIRINDELLI;GIANCARLO PARENTI;GIUSEPPINA RODORIGO;STEFANO ZOCCOLELLA;L. RAVIZZA;ALESSANDRO SGAMBATO;ANGELA FRADDOSIO;VIRGILIO GALLAI;AMELIA MORRONE;ADÉLAÏDE RUSSO;LUCIANA FUMAROLA;ANTONIO SCHENA","4;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NICOLA PANSINI;DANIELE DIONISIO;MATTIA GENTILE;PAOLO VOLPE;M. MARASINI;G CARUSO;GINEVRA GUANTI;DEBORAH A. ALTOMARE;GIACOMO DI;F CAUSIO;NICOLA LARICCHIUTA;DONATO DIMONTE;RITA FISCHETTO;A SILECCHIA;MASSIMO TARTAGNI;SIMONA GEUSA;ELENA SARCINA;MARIA PEPE;ROSA FIORE;ALFONSO TEMPESTA","1;1;0.87;0.87;0.58;0.39;0.33;0.33;0.33;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2","MATTIA GENTILE;PAOLO VOLPE;GIUSEPPINA RODORIGO;STEFANO ZOCCOLELLA;ALESSANDRO SGAMBATO;ANGELA FRADDOSIO;ANGIOLA ROCINO;ILARIO RUSSO;ANGELA PANSINI;LUIGI MORRONE;MIRKO PINOTTI;DONATO DIMONTE;R BELLANTUONO;DANIELA ETRO;LUIGI MARIA SPECCHIO;RITA FISCHETTO;GINEVRA GUANTI;DEBORAH A. ALTOMARE;DOMÉNICO RIBATTI;S. LAMBERTI","4;4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NICOLA PANSINI;DANIELE DIONISIO;MATTIA GENTILE;PAOLO VOLPE;GINEVRA GUANTI;DEBORAH A. ALTOMARE;GIACOMO DI;DONATO DIMONTE;RITA FISCHETTO;MARIA PEPE;ROSA FIORE;MARIO GIORDANO;IMMACOLATA SILLETTI;LUCIANO CAZZATO;A LORUSSO;ALESSANDRO SGAMBATO;ANGELA PANSINI;ANGELA BUONADONNA;GENNARO VOLPE;LUIGI MARIA SPECCHIO","1;1;0.87;0.87;0.33;0.33;0.33;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.14;0.14;0.14;0.14;0.12","MATTIA GENTILE;PAOLO VOLPE;G CARUSO;ALBERTO EDEFONTI;ANDREA MARZULLO;GENNARO VOLPE;MARIO LITUANIA;MAURIZIO MARASINI;ALBERTO BETTINELLI;ANNA ALÌ;DOMENICO COVIELLO;F SERENI;FABIO MALBERTI;GIACOMO COLUSSI;GIORGIO CASARI;LAILA CESAREO;MARIE‐LOUISE SYRÉN;MICHELE SACCO;MIRELLA PROCACCIO;MONICA SPROCATI","170;170;115;70;69;69;69;69;58;58;58;58;58;58;58;58;58;58;58;58","PAOLO VOLPE;GENNARO VOLPE;R BELLANTUONO;RITA FISCHETTO;ANGELA BUONADONNA;ANGELA PANSINI;FRANCOMICHELE PUCA;GIUSEPPE LIBRO;LUIGI MARIA SPECCHIO;MARCO GUIDO;MARINA DE TOMMASO;MATTIA GENTILE;VITTORIO SCIRUICCHIO;ANGELA FRADDOSIO;E. FERRANNINI;G. PALAGANO;GIOVANNI ILICETO;ILARIO RUSSO;S. LAMBERTI;STEFANO ZOCCOLELLA","170;69;58;51;45;45;45;45;45;45;45;45;45;29;29;29;29;29;29;29","PAOLO VOLPE;ALESSANDRO SGAMBATO;ANGELA BUONADONNA;ANGELA FRADDOSIO;ANGELA PANSINI;ANGIOLA ROCINO;DANIELA ETRO;DANIELE DIONISIO;DEBORA BINDINI;DEBORAH A. ALTOMARE;DOMÉNICO RIBATTI;DONATO DIMONTE;E. FERRANNINI;FRANCESCO BERNARDI;FRANCESCO PAPADIA;FRANCOMICHELE PUCA;G LOSITO;G. PALAGANO;GENNARO VOLPE;GIACOMO DI","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ECONOMICS;PHYSICS;BUSINESS;ENGINEERING;MATERIALS SCIENCE","20;13;3;3;2;2;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;SURGERY;ANATOMY;PSYCHIATRY;VIROLOGY;ANESTHESIA;CANCER RESEARCH;CARDIOLOGY;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;NEUROSCIENCE;ONCOLOGY;OPTICS;RADIOLOGY;ANDROLOGY;AUDIOLOGY;BOTANY;CELL BIOLOGY;DEVELOPMENTAL PSYCHOLOGY;ECONOMIC GROWTH;ENDOCRINOLOGY;GENERAL SURGERY;GYNECOLOGY;MACROECONOMICS;METALLURGY;MICROBIOLOGY;OBSTETRICS;OPERATING SYSTEM;OPERATIONS MANAGEMENT;PALEONTOLOGY;PHYSIOLOGY;PROGRAMMING LANGUAGE;PSYCHOTHERAPIST;UROLOGY","14;7;6;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;PREGNANCY;ADVERSE EFFECT;AMINO ACID;AORTA;CANCER;DISEASE;EMBRYO;IN VITRO;INCIDENCE (GEOMETRY);POPULATION;RECEPTOR;RESPIRATORY SYSTEM;VIRUS;AGENESIS;ALTERNATIVE MEDICINE;AMITRIPTYLINE;ANEMIA;ANGIOGENESIS;ANTIBIOTICS;ANTIBODY;ANTICHOLINERGIC;ATRIAL NATRIURETIC PEPTIDE;AUTOLOGOUS BLOOD;AUTOPSY;BIOPSY;BLOOD PRESSURE;BONE MARROW;CHEMOTHERAPY;CHLAMYDIA;CHOLERA;COAGULATION;CONCOMITANT;CORPUS CALLOSUM;CRANIOFACIAL;CRYPTOSPORIDIUM PARVUM;DEPRESSION (ECONOMICS);DIGEORGE SYNDROME;ENCODING (MEMORY);ENZYME;ERYTHROPOIETIN;ETIOLOGY;FERRITIN;GIRL;HABITUATION;HEALTH CARE;HEART DISEASE;HEART FAILURE;HEMOGLOBIN;HIPPOCAMPUS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IDENTIFICATION (BIOLOGY);IMMUNOSUPPRESSION;INFERIOR VENA CAVA;LAPAROSCOPY;LYMPHOMA;MAGNESIUM;MEDICAL LABORATORY;MERCURY (PROGRAMMING LANGUAGE);MIGRAINE;NEUROLOGY;NEUROSURGERY;OCCUPATIONAL EXPOSURE;OVARIAN TORSION;PATHOGENESIS;PHLEBOTOMY;PNEUMONIA;PROCESS (COMPUTING);RANDOMIZED CONTROLLED TRIAL;REFLEX;SIGNIFICANT DIFFERENCE;STAGE (STRATIGRAPHY);STIMULATION;STIMULUS (PSYCHOLOGY);SUBCLINICAL INFECTION;TORSION (GASTROPOD);TOXICITY;TRANSPLANTATION;TRIGEMINAL NERVE;TURNAROUND TIME;ULTRASOUND;VEGF RECEPTORS","9;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETUS;AORTIC ARCH;CHROMOSOME;MUTATION;RECOMBINANT DNA;TOLERABILITY;ALANINE;AMYOTROPHIC LATERAL SCLEROSIS;ANTIDEPRESSANT;ARGININE;AURA;BRAIN NATRIURETIC PEPTIDE;BREAST CANCER;CANCER CELL;CARCINOGENESIS;CHLAMYDIACEAE;CHORIOALLANTOIC MEMBRANE;COLORECTAL CANCER;COMMUNITY-ACQUIRED PNEUMONIA;COMPLEMENTARY DNA;CORNEAL REFLEX;CORPUS CALLOSUM AGENESIS;CORTICAL SPREADING DEPRESSION;DEMENTIA;EMBRYO TRANSFER;ENTEROVIRUS;ERYTHROPOIESIS;ESCHERICHIA COLI;ESSENTIAL HYPERTENSION;ETOPOSIDE;EXON;FACTOR VII;FIBROBLAST;FIBROBLAST GROWTH FACTOR;GENOMIC DNA;GROWTH FACTOR;HAMD;HEART DEFECT;HERPES SIMPLEX VIRUS;HYPOMAGNESEMIA;IN VITRO FERTILISATION;INTRON;IRON DEFICIENCY;LEVOFLOXACIN;LYMPHOPROLIFERATIVE DISORDERS;MESSENGER RNA;METASTASIS;NATRIURETIC PEPTIDE;NEURAL CREST;NEURORADIOLOGY;OCCULT;ORGAN TRANSPLANTATION;PARKINSONISM;PHENOTYPE;PROSTATE;PROSTATE CANCER;PROTEASES;RESPIRATORY TRACT;RESPIRATORY TRACT INFECTIONS;SERINE;SOCIOECONOMIC STATUS;STOP CODON;THROMBOPLASTIN;TISSUE FACTOR;TITER;TRYPSIN;UMBILICAL VEIN;VASCULAR ENDOTHELIAL GROWTH FACTOR;VIRAL DISEASE","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;INTERRUPTED AORTIC ARCH;KARYOTYPE;ANTIBODY TITER;BASIC FIBROBLAST GROWTH FACTOR;BREAKPOINT;CA15-3;CHLAMYDOPHILA PNEUMONIAE;CHYMOTRYPSIN;COMPOUND HETEROZYGOSITY;DUCTUS VENOSUS;ECHOVIRUS;FRAMESHIFT MUTATION;GITELMAN SYNDROME;HAMILTON DEPRESSION SCALE;HERPESVIRIDAE;IFOSFAMIDE;INTRACYTOPLASMIC SPERM INJECTION;IRON STATUS;MIGRAINE WITH AURA;NPR1;NPR2;PAROXETINE;PRIMARY TUMOR;PROSTATE BIOPSY;RETICULOCYTE;SINGLE UMBILICAL ARTERY;SPONTANEOUS CONCEPTION;UREA CYCLE;VTEC","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;ABNORMALITIES, MULTIPLE;FETAL DISEASES;ITALY;DELIVERY OF HEALTH CARE;DNA;LABORATORIES, HOSPITAL;ALKALOSIS;AORTA, THORACIC;BIOPSY;CLINICAL LABORATORY TECHNIQUES;HEMOLYTIC-UREMIC SYNDROME;HYPERTENSION;HYPOKALEMIA;LUNG NEOPLASMS;MAST CELLS;MIDDLE AGED","22;14;10;8;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF HYPONATREMIA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;LABORATORY MEDICINE AND TESTING PROCEDURES;MANAGEMENT AND TREATMENT OF HEMOPHILIA;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR MECHANISMS OF AQUAPORINS IN PHYSIOLOGY AND DISEASE;MOLECULAR MECHANISMS OF DEPRESSION TREATMENT STRATEGIES;PATHOGENESIS AND VIRULENCE OF ESCHERICHIA COLI;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;PROSTATE CANCER RESEARCH AND TREATMENT;REGULATION OF IRON METABOLISM AND ANEMIA","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INTERRUPTED AORTIC ARCH;MONOSOMY;TOLERABILITY;TRISOMY DETECTION;AGENESIS;ALANINE;ANGIOGENESIS;ANTIBODY TITER;ATRIAL NATRIURETIC PEPTIDE;AUTOLOGOUS BLOOD;B-TYPE NATRIURETIC PEPTIDE;BIOPSY;BRAIN ACTIVATION;BRAIN NATRIURETIC PEPTIDE;BREAKPOINT;CANCER METABOLISM;CANCER STEM CELLS;CHLAMYDOPHILA PNEUMONIAE;CHOLERA;CHORIOALLANTOIC MEMBRANE","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AORTIC ARCH;FACTOR VII;ITALIAN PATIENTS;PRENATAL DIAGNOSIS;ALPHA-A INTERFERON;AMYOTROPHIC LATERAL;ANGIOGENIC ACTIVITY;ARCH TYPE;ARTERIAL HYPERTENSION;AUTOLOGOUS BLOOD;BIOPSY BASED;BLINK REFLEX;BLOOD DONATION;CHICK EMBRYO;CHLAMYDIA PNEUMONIAE;CHORIOALLANTOIC MEMBRANE;CHROMOSOME ANALYSIS;CLINICAL LABORATORY;COLORECTAL CANCER;COMMUNITY-ACQUIRED PNEUMONIA;CONCOMITANT AMYOTROPHIC;CRM FACTOR;CYTOGENETIC CHARACTERIZATION;CYTOGENETICCONGENITAL ANOMALIES;DEFICIENCIES GLYSER;DEFICIENCY DETECTION;DELETION CLINICAL;DELETION PRENATAL;DIAGNOSTIC SETTING;DOUBLE-BLIND TRIAL","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TUMOR CELLS;CANCER CELLS;OCCULT DISSEMINATION;SLCA GENE;ACTIVATION DOMAIN;ADDITION ALA-FVII;AFFECTED GLYCINES;AG WILEY-LISS;ALKALOSIS HYPOCALCIURIA;APICAL MEMBRANE;ASYMPTOMATIC GLYSER;ASYMPTOMATIC SUBJECTS;AUTOSOMAL RECESSIVE;BEAR ALANINE;BIOCHEMICAL FEATURES;CAUSING SEVERE;CELLS REPRESENT;CHYMOTRYPSIN NUMBERING;CIRCULATING TUMOR;CO-TRANSPORTER NCCT;COAGULANT ACTIVITY;CODING REGIONS;COLORECTAL CANCER;COMMON MALIGNANCIES;CONCENTRATION SER-FVII;CONSERVED REGIONS;CONVOLUTED TUBULE;CRM DEFICIENCY;CRM FACTOR;CROSS-REACTING MATERIALPOSITIVE","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2003,30,10.3,2.46666666666667,0.466666666666667,0.3,0.466666666666667,1.27586206896552,1.27272727272727,1.125,1.27272727272727,0.366666666666667,1,14,9,1,3,0.47,0.3,0.03,0.1,76.2,1.43969433007954,NA,0.133333333333333,0.766666666666667,0.32,0.22,0.234,0.22,"FRANCESCO BOVENZI;NICOLA SIGNORE;ALBERTO EDEFONTI;NICOLA PANSINI;GIUSEPPE CAPOVILLA;GIOVANNI MONTINI;GRAZIELLA ZACCHELLO;ALFONSO FERRETTI;ALESSANDRO SGAMBATO;PAOLO COLONNA;SILVIO MARINGHINI;ALBERTO EUGENIO TOZZI;MAURIZIO GAIDO;LAURA DE PETRIS;R. GAGGERO;P ARCIPRETE;L. LA SELVA;ANDREA MARZULLO;ANGELA CARINGELLA;ALESSANDRA GIANVITI","3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","G. CIMINO;NICOLA PANSINI;FRANCESCO BOVENZI;NICOLA SIGNORE;MARILINA TAMPOIA;ALBERTO BENVEGNÙ;MAURO SPERA;NICOLA SANSONETTO;MICHELE DE MARI;PAOLO COLONNA;L DELUCA;I DELUCA;P ARCIPRETE;V. SABATO;GIUSEPPINA LACERRA;MARIA DE ANGIOLETTI;CLEMENTINA CARESTIA;GIOVANNI MONTINI;ANDREA MARZULLO;MATTIA GENTILE","1;0.54;0.47;0.47;0.34;0.33;0.33;0.33;0.29;0.27;0.27;0.27;0.25;0.25;0.25;0.25;0.25;0.21;0.21;0.21","FRANCESCO BOVENZI;NICOLA SIGNORE;NICOLA PANSINI;ALESSANDRO SGAMBATO;PAOLO COLONNA;P ARCIPRETE;L. LA SELVA;ANGELA CARINGELLA;ANDREA CAMERINI;MARILINA TAMPOIA;TOMMASO DE PALO;ACHILLE CITTADINI;PAOLO VOLPE;RODOLFO CANGIANO;MICHELE DE MARI;L DELUCA;I DELUCA;UMBERTO VITOLO;ANGELA FRADDOSIO;CLAUDIA DELL’AQUILA","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","G. CIMINO;NICOLA PANSINI;FRANCESCO BOVENZI;NICOLA SIGNORE;MARILINA TAMPOIA;ALBERTO BENVEGNÙ;MICHELE DE MARI;PAOLO COLONNA;L DELUCA;I DELUCA;P ARCIPRETE;V. SABATO;PAOLO VOLPE;ALESSANDRO SGAMBATO;ANDREA CAMERINI;ACHILLE CITTADINI;RODOLFO CANGIANO;ANTONIETTA FONTANA;PIERA MAGGIOLINI;FRANCESCA DI SERIO","1;0.54;0.47;0.47;0.34;0.33;0.29;0.27;0.27;0.27;0.25;0.25;0.21;0.2;0.2;0.2;0.2;0.2;0.2;0.2","GIUSEPPE CAPOVILLA;CAROL BROSGART;CHING‐LUNG LAI;CHRISTOPHER WESTLAND;CRAIG JAMES;DIDIER SAMUEL;EUGENE R. SCHIFF;GAVIN CHOY;HAMID NAMINI;HANS L. TILLMANN;JEAN‐PIERRE VILLENEUVE;JOHN FRY;LESLIE LILLY;MARIA RENDINA;MASSIMO COLOMBO;MICHAEL WULFSOHN;NICOLE LAMA;NORAH A. TERRAULT;P. NEUHAUS;SALLY VAN DOREN","500;377;377;377;377;377;377;377;377;377;377;377;377;377;377;377;377;377;377;377","MARIA RENDINA;L. LA SELVA;GIOVANNI LAPADULA;TOMMASO DE PALO;RITA FISCHETTO;PAOLO VOLPE;ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ANDREA CAMERINI;RODOLFO CANGIANO;MARILINA TAMPOIA;MICAELA MONTANARI;NICOLA PANSINI;L. NISI;PALMA SORINO;V. SABATO;GENNARO VOLPE;P ARCIPRETE;ANGELA CARINGELLA;U. JACOBELLIS","377;277;273;242;223;167;136;136;136;136;121;114;106;91;89;73;71;71;59;42","FRANCESCO BOVENZI;ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ANDREA CAMERINI;ANGELA CARINGELLA;FRANCESCA DI SERIO;L. LA SELVA;MARILINA TAMPOIA;NICOLA PANSINI;PAOLO VOLPE;RODOLFO CANGIANO;TOMMASO DE PALO;A VIVARELLI;ADELE NARDECCHIA;ALBERTO BENVEGNÙ;ANGELA FRADDOSIO;ANTONIETTA FONTANA;B. MENICHINI;BEATRICE FARAGLIA;BERARDINO DE BARI","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;HISTORY;MATHEMATICS;PSYCHOLOGY;GEOLOGY","24;15;3;3;2;2;2;2;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;CARDIOLOGY;GASTROENTEROLOGY;PEDIATRICS;PSYCHIATRY;VIROLOGY;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;RADIOLOGY;SURGERY;ANATOMY;CANCER RESEARCH;MICROBIOLOGY;PALEONTOLOGY;PATHOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;QUANTUM MECHANICS;UROLOGY","18;10;8;6;6;6;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","GENE;ANTIBODY;CANCER;DISEASE;NEPHROLOGY;POPULATION;CHEMOTHERAPY;DIALYSIS;EPILEPSY;MYOCARDIAL INFARCTION;NEUROLOGY;NEUROSURGERY;PREGNANCY;THROMBUS;VIRUS;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANTIGEN;ANTITHROMBOTIC;AORTA;APOPTOSIS;APPENDAGE;ARTERY;ASYMPTOMATIC;ATRIAL FIBRILLATION;CARBOXYLIC ACID;CARDIAC SURGERY;CELL ADHESION MOLECULE;COAGULOPATHY;COMPLICATION;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;DEPOT;DEPRESSION (ECONOMICS);DETECTION LIMIT;DIARRHEA;DNA TESTING;DRUG RESISTANCE;ECHO (COMMUNICATIONS PROTOCOL);ENZYME;EXTRACELLULAR MATRIX;HEALTH CARE;HEMODIALYSIS;HEPATITIS B;HEPATOLOGY;HOMOCYSTEINE;HORMONE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;IN VITRO;INCIDENCE (GEOMETRY);ISCHEMIA;KIDNEY;KIDNEY DISEASE;LIPOPHILICITY;LYMPHOMA;MEDICAL MICROBIOLOGY;NATURAL HISTORY;OUTFLOW;PATIENT CARE;PERITONEAL DIALYSIS;PIPERIDINE;POWER (PHYSICS);PRIMARY BILIARY CIRRHOSIS;PSYCHOMETRICS;QUANTUM;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;REFERENCE RANGE;REGIMEN;RENAL FUNCTION;REST (MUSIC);RETROSPECTIVE COHORT STUDY;SCINTIGRAPHY;SEROTYPE;SIGN (MATHEMATICS);SOFTWARE;STEM CELL;STENT;STRUCTURAL BASIN;SURVIVAL RATE;TEST (BIOLOGY);THROMBOSIS;TOXIN;TRANSPLANTATION;ULTRASOUND;VENTRICLE","7;5;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MUTATION;ALLELE;AUTOANTIBODY;BREAST CANCER;FETUS;MYOCLONIC EPILEPSY;NEURORADIOLOGY;ANGINA;AORTIC ARCH;AUTOIMMUNE DISEASE;BIOLOGICAL ACTIVITY;BREAKPOINT CLUSTER REGION;CASTRATION;CD34;CELL CYCLE;CHROMOSOMAL TRANSLOCATION;COELIAC DISEASE;COMPLEMENT SYSTEM;CONGENITAL MALFORMATIONS;CONSTRUCT VALIDITY;CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;CORONARY ARTERIES;CRONBACH'S ALPHA;CRYOGLOBULINS;DOXORUBICIN;DRAVET SYNDROME;EPILEPSY SYNDROMES;ESCHERICHIA COLI;ETOPOSIDE;FOLLICULAR LYMPHOMA;GESTATIONAL AGE;HAZARD RATIO;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HYPERHOMOCYSTEINEMIA;IMMUNE COMPLEX;IMMUNOASSAY;IMMUNOSTAINING;INFLAMMATORY BOWEL DISEASE;INTRACLASS CORRELATION;INVERSION (GEOLOGY);LAMININ;LEFT ATRIUM;LIVER TRANSPLANTATION;MESSENGER RNA;MULTICENTER STUDY;MUTANT;MYOCARDIAL ISCHEMIA;OSTEOARTHRITIS;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;PLASMAPHERESIS;PRIMARY SCLEROSING CHOLANGITIS;PROGRESSIVE SUPRANUCLEAR PALSY;PROSTATE CANCER;PULMONARY ATRESIA;QUANTUM STATISTICAL MECHANICS;RELIABILITY (SEMICONDUCTOR);RHEUMATOID FACTOR;RITUXIMAB;SEROLOGY;SINUS RHYTHM;STRESS ECHOCARDIOGRAPHY;TEST STRATEGY;THROMBOPHILIA;TISSUE TRANSGLUTAMINASE;TOLERABILITY;TROPONIN;TROPONIN I;TUMOR PROGRESSION;ULCERATIVE COLITIS;UNSTABLE ANGINA;VIRAL ENVELOPE;VIRAL LOAD;VIREMIA;WESTERN BLOT","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTHRACYCLINE;ABCIXIMAB;ANALYTICAL MECHANICS;ANTIANDROGEN;ANTIRETROVIRAL THERAPY;ATRIAL APPENDAGE;CD33;COMPOUND HETEROZYGOSITY;CONNECTIVE TISSUE DISEASE;CRYOGLOBULINEMIA;CYCLIN;CYCLIN-DEPENDENT KINASE;DYSTROGLYCAN;ENDOMYSIUM;GOSERELIN;HETEROZYGOTE ADVANTAGE;INTERNATIONAL PROGNOSTIC INDEX;LAMIVUDINE;MISSENSE MUTATION;PHILADELPHIA CHROMOSOME;PRENATAL DIAGNOSIS;PROSTATECTOMY;SHIGA TOXIN;SUPERSYMMETRIC QUANTUM MECHANICS;WOMAC","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ITALY;MIDDLE AGED;KIDNEY FAILURE, CHRONIC;ABNORMALITIES, MULTIPLE;ADULT;AGED;ESCHERICHIA COLI INFECTIONS;HEMOLYTIC-UREMIC SYNDROME;PLATELET AGGREGATION INHIBITORS;ADOLESCENT;CHILD;CHILD, PRESCHOOL;FETAL GROWTH RETARDATION;HEART DEFECTS, CONGENITAL;INFANT;RENAL DIALYSIS;RNA, VIRAL","26;19;19;13;10;8;7;7;7;7;6;6;5;5;5;5;5;5;5;5","EPILEPSY AND SEIZURES;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;FOUNDATIONS OF QUANTUM MECHANICS AND INTERPRETATIONS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEPATITIS B INFECTION AND TREATMENT;HEPATITIS C INFECTION AND TREATMENT;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;LYMPHOID NEOPLASMS;MANAGEMENT AND TREATMENT OF HEMOPHILIA;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEPHROLOGY;MYOCLONIC EPILEPSY;NEURORADIOLOGY;ABCIXIMAB;ADEFOVIR;ANTIBODY ENGINEERING;ANTIRETROVIRAL DRUG;ANTIRETROVIRAL THERAPY;AORTIC STIFFNESS;APPENDAGE;ATRIAL APPENDAGE;BREAKPOINT CLUSTER REGION;CANCER CELL METABOLISM;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CELL ADHESION;CELL CYCLE;CHROMOSOMAL REGION;CHROMOSOME 4;COMPOUND HETEROZYGOSITY","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CRITICAL REGION;HEMOLYTIC UREMIC;MYOCLONIC EPILEPSY;SEVERE MYOCLONIC;UREMIC SYNDROME;ACCEPTED WHS;ACETATE ZOLADEX;ACUTE INTRAMURAL;ACUTE THROMBOTIC;ADDITIONAL ULTRASOUND;ADEFOVIR DIPIVOXIL;ADULT PRO-B-ALL;ADVANCED PROSTATE;AGGREGATION INHIBITORY;ANALYTICAL EVALUATION;ANGIOGRAPHIC SIGN;ANOMALOUS CORONARY;ANTIBODY PREVALENCE;ANTIRETROVIRAL THERAPY;AORTIC ARCH;AORTIC CONTOUR;AORTIC HEMORRAGE;ARCH IMPACT;ARTERIAL TRUNK;ATRIAL APPENDAGE;AUTOANTIBODY TESTING;AUTOMATED IMMUNOASSAY;BCRABL FUSION;BILIARY CIRRHOSIS;BOWEL DISEASE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","WHS PHENOTYPE;HCV CORE;CORE PROTEIN;CRITICAL REGION;NON-ENVELOPED HCV;CHROMOSOMAL ANOMALIES;CLINICAL PHENOTYPE;CYCLIN E-OVEREXPRESSING;II MC;PRENATAL DIAGNOSIS;RF ACTIVITY;TYPE II;Β GC;Β GLOBIN;ACCEPTED WHS;ACCEPTED WHSCR;ALGOFUNCTIONAL INDEX;ALPHA-DG EXPRESSION;ANALYSIS DIVIDING;APPEARANCE MENTAL;BASIC PHENOTYPE;BCRABL CHIMERIC;CANDIDATE GENES;CELL LINES;CHROMOSOME REGION;CLINICAL ENTITIES;CLINICAL MANIFESTATIONS;CLONE INCLUDED;COMPLETE REMISSION;CONGENITAL HYPOTONIA","8;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",2,0.07,3,1.75,0,0,0,0,2,0,1,1.75,0,0,0,0,0,0,0,0,0,0,0,12.75,12.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2004,27,7.85185185185185,1.59259259259259,0.37037037037037,0.259259259259259,0.518518518518518,1.04878048780488,1,1,1.07692307692308,0.222222222222222,0,10,4,5,6,0.37,0.15,0.19,0.22,34.07,0.724154254323678,NA,0.259259259259259,0.592592592592593,0.369,0.141,0.208,0.172,"DOMÉNICO RIBATTI;ANGELO VACCA;FRANCESCO BOVENZI;R BELLANTUONO;LEONARDO DE LUCA;MARIO GIORDANO;TERESA CIRULLI;VALENTINO CONTER;ANNA GRAZIA RECCHIA;TERESA QUARTICELLI;ALESSANDRO SGAMBATO;FRANCESCA PAOLONI;ANTONIO SCHENA;FABRIZIO BARBETTI;LUCA MACARINI;DOMENICO PAPARELLA;P COMMEAU;B FAVOINO;MARIA GRAZIA FOSCHINO BARBARO;CATALDO MEMMOLA","4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","DOMÉNICO RIBATTI;FRANCESCO BOVENZI;LEONARDO DE LUCA;ANGELO VACCA;MATILDE LEONARDI;MARIO MUTO;C.F. ANDREULA;ITALO DE LUCA;TERESA CIRULLI;R BELLANTUONO;MARIO GIORDANO;MARIA MONTANARO;DANTE GALEONE;CLEMENTINA BONIVER;P. A. BATTISTELLA;LUCA MACARINI;DOMENICO PAPARELLA;CATALDO MEMMOLA;ANTONELLA GALEONE;MARIA PIA BOZZETTI","0.94;0.83;0.83;0.8;0.33;0.33;0.33;0.33;0.3;0.25;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2","DOMÉNICO RIBATTI;ANGELO VACCA;FRANCESCO BOVENZI;R BELLANTUONO;MARIO GIORDANO;TERESA QUARTICELLI;ALESSANDRO SGAMBATO;B FAVOINO;MARIA GRAZIA FOSCHINO BARBARO;ROBERTO RIA;GÁBOR BARI;MARIA TERESA NITTI;MARIA PIA BOZZETTI;ALMA BONINSEGNA;MARINA MICELLI;FRANCESCO CARNEVALE;P ARCIPRETE;L FRUGIS CAGGIANELLI;ALESSANDRO SANTO BORTONE;ANGELA CARINGELLA","4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DOMÉNICO RIBATTI;FRANCESCO BOVENZI;ANGELO VACCA;C.F. ANDREULA;R BELLANTUONO;MARIO GIORDANO;DANTE GALEONE;MARIA PIA BOZZETTI;MARINA MICELLI;M. DE SARIO;V. PETRUZZELLI;FRANCESCO PRUDENZANO;GIOVANNI FUSCO;A. D’ORAZIO;TERESA QUARTICELLI;FRANCO A. CARNEVALE;NICOLA BRIENZA;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;ANGELA CARINGELLA","0.94;0.83;0.8;0.33;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.14;0.14;0.14","C.F. ANDREULA;MARIO MUTO;MATILDE LEONARDI;GIOVANNI MESSINA;ANDREW T. HATTERSLEY;ANNA L. GLOYN;ANTONINO CRINÒ;B PASQUINO;DARIO IAFUSCO;ELENA D’AMATO;FABRIZIO BARBETTI;FRANCESCO DAMMACCO;FRANCO MESCHI;FRÁNCO CERUTTI;GIANFRANCO BOTTAZZO;GIORGIO ZANETTE;GIUSEPPE TONINI;MAURIZIO VANELLI;ORNELLA MASSA;OTTAVIA PORZIO","157;157;157;152;151;151;151;151;151;151;151;151;151;151;151;151;151;151;151;151","C.F. ANDREULA;GIOVANNI MESSINA;FRANCESCO DAMMACCO;FP SELVAGGI;P ARCIPRETE;GIORGINA SPECCHIA;ROBERTO RIA;ANGELA CARINGELLA;MARIO GIORDANO;R BELLANTUONO;TOMMASO DE PALO;VINCENZO COLELLA;DOMÉNICO RIBATTI;DANTE GALEONE;FRANCESCO CARNEVALE;GÁBOR BARI;ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;BEATRICE FARAGLIA","157;152;151;83;81;74;67;55;55;55;55;55;46;30;18;13;11;11;11;11","ANGELO VACCA;FRANCESCO BOVENZI;GIOVANNI MESSINA;ACHILLE CITTADINI;ALESSANDRO SANTO BORTONE;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;ANGELA CARINGELLA;B FAVOINO;BEATRICE FARAGLIA;C.F. ANDREULA;DANTE GALEONE;DOMÉNICO RIBATTI;DONATA MININNI;FP SELVAGGI;FRANCESCO CARNEVALE;FRANCESCO DAMMACCO;FRANCO A. CARNEVALE;FRANCO SCALDAFERRI;GIORGINA SPECCHIA","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY","22;8;4;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PEDIATRICS;CANCER RESEARCH;CARDIOLOGY;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;PATHOLOGY;ANESTHESIA;CELL BIOLOGY;PSYCHIATRY;ANATOMY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;NURSING;ONCOLOGY;QUANTUM MECHANICS;RADIOLOGY;ARTIFICIAL INTELLIGENCE;BIOINFORMATICS;CHROMATOGRAPHY;CLINICAL PSYCHOLOGY;COMBINATORIAL CHEMISTRY;COMBINATORICS;CONDENSED MATTER PHYSICS;DEVELOPMENTAL PSYCHOLOGY;ELECTRICAL ENGINEERING;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;EPISTEMOLOGY;FINANCE;FINANCIAL ECONOMICS;GERONTOLOGY;INTENSIVE CARE MEDICINE;MACROECONOMICS;NEUROSCIENCE;OBSTETRICS;OPTICS;OPTOELECTRONICS;ORTHODONTICS;PHARMACOLOGY;PSYCHOTHERAPIST;SOCIAL PSYCHOLOGY;STEREOCHEMISTRY;UROLOGY","15;9;6;5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENE;ANGIOGENESIS;CHEMOTHERAPY;MYOCARDIAL INFARCTION;ANTIBODY;ENZYME;KINASE;NEUROLOGY;QUALITY OF LIFE (HEALTHCARE);RECEPTOR;TRANSPLANTATION;ABDOMINAL SURGERY;ADENOSINE;AGENESIS;ALTERNATIVE MEDICINE;ANASTOMOSIS;ANEMIA;APNEA;APOPTOSIS;ATRIAL FIBRILLATION;AUTOPSY;BAND GAP;BIOPSY;BLOOD VESSEL;BONE MARROW;BROAD SPECTRUM;CARDIOPULMONARY BYPASS;CELL CULTURE;CELL GROWTH;CLINICAL TRIAL;COAGULOPATHY;COHORT;COLOBOMA;COMPLICATION;CONDUCTIVITY;CORONAL PLANE;DEPRESSION (ECONOMICS);DERIVATIVE (FINANCE);DIABETES MELLITUS;DIALYSIS;DISCONTINUATION;DNA;DRUG;EPIDURAL SPACE;EPILEPSY;ERYTHROPOIETIN;EXTRACELLULAR MATRIX;FAILURE TO THRIVE;FERRITIN;FINITE-DIFFERENCE TIME-DOMAIN METHOD;GOLDENHAR SYNDROME;HEART DISEASE;HEMODIALYSIS;HEMOGLOBIN;HEPARIN;HEPATITIS;HYOID BONE;HYPOPLASIA;HYPOTONIA;ILEUS;IN VITRO;INTERVENTION (COUNSELING);LARYNX;LASER;LEUKEMIA;LUMBAR;MAGNETIC RESONANCE IMAGING;MALIGNANCY;MATRIX (CHEMICAL ANALYSIS);MAXWELL'S EQUATIONS;MECHANISM (BIOLOGY);MULTIPLE MYELOMA;NEPHROLOGY;NEUROSURGERY;NUCLEOSIDE;OBSTRUCTIVE SLEEP APNEA;ODDS RATIO;OSCILLATION (CELL SIGNALING);PERSONALITY;PHOSPHORYLATION;PHOTONIC CRYSTAL;PHOTONICS;PLATELET;PONS;POPULATION;PREGNANCY;PSYCHOLOGICAL ADAPTATION;PSYCHOSOCIAL;RANDOMIZED CONTROLLED TRIAL;REHABILITATION;RESUSCITATION;RETROSPECTIVE COHORT STUDY;SAGITTAL PLANE;SATURATION (GRAPH THEORY);SCARS;SCIATICA;SELECTION (GENETIC ALGORITHM);SEPSIS;SOFT PALATE;SPECULATION;STENT;THROMBOSIS;TONGUE;TRANSMISSION (TELECOMMUNICATIONS);VACCINATION;VEGF RECEPTORS;YOUNG ADULT","4;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEOVASCULARIZATION;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;PROTEIN KINASE A;AUTOCRINE SIGNALLING;BACK PAIN;BREAST CANCER;CANCER CELL;CELL CYCLE;CLINICAL ENDPOINT;CONVENTIONAL PCI;CORONARY ANGIOGRAPHY;CYTARABINE;DARBEPOETIN ALFA;EPIGLOTTIS;FETUS;FIBRONECTIN;GASTRECTOMY;GESTATIONAL AGE;GROWTH INHIBITION;HEPARIN-INDUCED THROMBOCYTOPENIA;HEPATITIS A;HUMAN GENETICS;INOSINE;INTEGRIN;INTERVERTEBRAL DISK;IRON DEFICIENCY;KIDNEY TRANSPLANTATION;LAMININ;LATERAL RECESS;LOW BACK PAIN;LUPUS ERYTHEMATOSUS;LYMPHOBLASTIC LEUKEMIA;MATRIGEL;MECHANISM OF ACTION;MINNESOTA MULTIPHASIC PERSONALITY INVENTORY;MUTANT;MUTATION;PERFORMANCE STATUS;PHENOTYPE;POLYSOMNOGRAPHY;PROGRAMMED CELL DEATH;PROSTATE;PROSTATE CANCER;PROTEASE;PROTEIN KINASE B;PURINE;RESTENOSIS;SEROCONVERSION;SOLID TUMOR;TETRALOGY OF FALLOT;THALIDOMIDE;THROMBIN;THROMBOLYSIS;THYMIDINE;THYMIDINE PHOSPHORYLASE;TRANSFECTION;VASCULAR ENDOTHELIAL GROWTH FACTOR;WARFARIN","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE LYMPHOCYTIC LEUKEMIA;ARGATROBAN;AUTOPHOSPHORYLATION;CASPASE;CASPASE 3;CORONARY STENT;CYCLIN D1;CYCLIN-DEPENDENT KINASE;DABIGATRAN;DISCOID LUPUS ERYTHEMATOSUS;HEPATITIS A VACCINE;HIRUDIN;HORMONAL THERAPY;HORMONE THERAPY;HYPOPNEA;KIDNEY TRANSPLANT;PRENATAL DIAGNOSIS;PROSTATE-SPECIFIC ANTIGEN;PURINE NUCLEOSIDE PHOSPHORYLASE;STAUROSPORINE;TENASCIN;TRANSFERRIN SATURATION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;AGED;TREATMENT OUTCOME;VINBLASTINE;;KIDNEY FAILURE, CHRONIC;MIDDLE AGED;MYOCARDIAL INFARCTION;POSTOPERATIVE COMPLICATIONS;RECOMBINANT PROTEINS;ADOLESCENT;ANEMIA;BREAST NEOPLASMS;DIABETES MELLITUS;ENZYME INHIBITORS;METABOLISM, INBORN ERRORS;AGED, 80 AND OVER","21;14;13;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;4","DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;ABDOMINAL COMPARTMENT SYNDROME AND INTRA-ABDOMINAL HYPERTENSION;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPILEPSY AND SEIZURES;GASTRIC CANCER RESEARCH AND TREATMENT;GENETICS AND DEVELOPMENT OF CRANIOFACIAL ABNORMALITIES;HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS;HEPATITIS E INFECTION AND TREATMENT;HUBRIS SYNDROME IN LEADERSHIP AND POLITICS;KIDNEY TRANSPLANTATION;LIPID METABOLISM IN CANCER PATHOGENESIS;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;MOLECULAR PHYSIOLOGY OF PURINERGIC SIGNALLING;NATURAL KILLER CELLS IN IMMUNITY;PANCREATIC ISLET DYSFUNCTION AND REGENERATION","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;NEURORADIOLOGY;ACUTE LYMPHOCYTIC LEUKEMIA;ADOLESCENT AND YOUNG ADULT ONCOLOGY;AGENESIS;BACK PAIN;BONE MARROW MICROENVIRONMENT;BROAD SPECTRUM;CANCER;CANCER IMMUNOEDITING;CANCER THERAPY;CLINICAL ENDPOINT;COLOBOMA;COPING;CORONARY STENT;CORONARY STENTS;DARBEPOETIN ALFA;DEPRESSION (ECONOMICS);DERIVATIVE (FINANCE)","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HORMONE THERAPY;ITALIAN PATIENTS;MULTIPLE MYELOMA;ABSENT PULMONARY;ACTIVE PHOTONIC;ACUTE LYMPHOBLASTIC;ADULT GIMEMA;ALFA NESP;ALTERED EXPRESSION;ANTIANGIOGENIC DRUG;ANTITUMOR ACTIVITY;APNEA-HYPOPNEA SYNDROME;AUTOCRINE LOOP;BAND GAP;BIOCHEMICAL FEATURES;BONE MARROW;BREAST CANCER;CADAVERIC KIDNEY;CANCER CELLS;CANCER CHEMOTHERAPY;CASPASE INHIBITS;CELLS INDEPENDENT;CHARACTERISTICS ASSOCIATIONS;CHILDREN UNDERGOING;CHRONIC KIDNEY;CLINICAL EXPERIENCE;CORONARY INTERVENTION;CORONARY STENT;CT ASSESSMENT;DARBEPOIETIN ALFA","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LYMPHOCYTE COUNT;CANCER PATIENTS;COLORECTAL CANCER;LUNG CANCER;PROSTATE CANCER;RESPONSE RATE;TPASE INHIBITORS;ABDOMINAL SURGERY;ANGIOGENIC ACTIVITY;APACHE II;BREAST CANCER;CANCER WEEKLY;CLINICAL BENEFIT;CORONARY ARTERY;DEVELOPMENTAL DELAY;DIABETES DIAGNOSED;DIABETES MELLITUS;HORMONE-REFRACTORY PROSTATE;HT ARM;HT VERSUS;KATP CHANNEL;LIVER DYSFUNCTION;LYMPHOCYTOPENIC PATIENTS;METASTATIC CANCER;NORMAL LYMPHOCYTE;OBJECTIVE TUMOR;ORGAN FAILURES;PATIENTS TREATED;PERMANENT DIABETES;PRETREATMENT LYMPHOCYTE","5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.04,3,5,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,1,0,92,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,350,2.56,0,0,20,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","ATHEROSCLEROSIS;BIOMEDICAL IMAGING;CARDIOVASCULAR;CLINICAL RESEARCH;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","1;1;1;1;1;1","CARDIOVASCULAR","1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2005,27,7.33333333333333,1.40740740740741,0.444444444444444,0.148148148148148,0.444444444444444,1.08571428571429,0.923076923076923,0.8,0.923076923076923,0.185185185185185,0,9,2,5,6,0.33,0.07,0.19,0.22,36.37,0.686962767977939,NA,0.333333333333333,0.666666666666667,0.307,0,0.25,0,"P ARCIPRETE;NICOLA BIZZARO;B FAVOINO;ALMA BONINSEGNA;PAOLO TREROTOLI;MARCO PRADELLA;ELIO TONUTTI;MARILINA TAMPOIA;DANILO VILLALTA;ACHILLE CITTADINI;RENATO TOZZOLI;MARCO LIGUORI;ANTONELLA PERILLO;GABRIELLA CALVIELLO;MAURIZIO LUNATI;MANDI W. MUSSO;PAOLA PALOZZA;CESARE DI BARI;TERESA SCARABAGGIO;ROSSELLA TOMAIUOLO","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","P ARCIPRETE;ROBERT O. BONOW;GABRIELE DUBINI;DARIO TROISE;VINCENZO STEFANO LUISI;LEONARDO MENDOLICCHIO;FELICE VADRUCCIO;L RANIERI;GIOVANNI BIRICOLTI;MIHAI GHEORGHIADE;ITALO DE LUCA;ALMA BONINSEGNA;PAOLO TREROTOLI;ACHILLE CITTADINI;B FAVOINO;ALESSANDRA GABALLO;FRANCA DICUONZO;A. CARELLA;ANTONIO OROFINO;MICHELE PALMA","0.92;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.32;0.32;0.32;0.28;0.25;0.25;0.25;0.25;0.25","P ARCIPRETE;B FAVOINO;ALMA BONINSEGNA;MARILINA TAMPOIA;ACHILLE CITTADINI;CESARE DI BARI;A. CIMMINO;LUISA CACCIAVILLANI;NICOLA SANTORO;ALESSANDRA GABALLO;GIOVANNI LUZZI;MATTEO SIMONACCI;PIETRO VENEZIA;SABINO ILICETO;VITO MARANGELLI;ANGELA POLIZZI;SARA PONTAROLLO;DARIO TROISE;GIUSEPPE MARINELLI;FRANCESCA DI MARCO","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","P ARCIPRETE;DARIO TROISE;LEONARDO MENDOLICCHIO;FELICE VADRUCCIO;L RANIERI;ITALO DE LUCA;ALMA BONINSEGNA;ACHILLE CITTADINI;B FAVOINO;ALESSANDRA GABALLO;VINCENZO CASSANO;A. CIMMINO;MATTEO SIMONACCI;GIUSEPPE MARINELLI;TOMMASO DE PALO;LUISA CACCIAVILLANI;SABINO ILICETO;VITO MARANGELLI;SARA PONTAROLLO;FRANCESCA DI MARCO","0.92;0.33;0.33;0.33;0.33;0.33;0.32;0.32;0.28;0.25;0.25;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17","CARLOS A. BACINO;DEBORAH BARTHOLDI;DORIEN J.M. PETERS;DUNJA NIEDRIST;FRANCESCO PAPADIA;GERT‐JAN B. VAN OMMEN;JEROEN ROELFSEMA;JOHAN T. DEN DUNNEN;MARTIJN H. BREUNING;RAOUL C. M. HENNEKAM;STEFAN J. WHITE;YAVUZ ARIYÜREK;DANILO VILLALTA;ELIO TONUTTI;MARCO LIGUORI;MARCO PRADELLA;MARILINA TAMPOIA;NICOLA BIZZARO;RENATO TOZZOLI;DANIA GIROLAMI","439;439;439;439;439;439;439;439;439;439;439;439;122;122;122;122;122;122;122;111","FRANCESCO PAPADIA;MARILINA TAMPOIA;NICOLA SANTORO;ACHILLE CITTADINI;ALMA BONINSEGNA;CESARE DI BARI;ANGELA POLIZZI;N RIGILLO;TERESA SANTOSTASI;MAURIZIO MEMEO;FRANCESCA DI SERIO;FRANCESCO MANFREDI;P ARCIPRETE;B FAVOINO;GIUSEPPE MARINELLI;ALESSANDRA GABALLO;ANTONIO STANZIANO;MARINA DE TOMMASO;DARIO TROISE;L RANIERI","439;122;101;55;55;47;44;44;44;33;24;21;21;17;17;14;9;9;3;3","B FAVOINO;MARILINA TAMPOIA;P ARCIPRETE;A. CIMMINO;ACHILLE CITTADINI;ALESSANDRA GABALLO;ALMA BONINSEGNA;ANGELA POLIZZI;ANTONIO STANZIANO;CESARE DI BARI;DARIO TROISE;FELICE VADRUCCIO;FRANCESCA DI MARCO;FRANCESCA DI SERIO;FRANCESCO MANFREDI;FRANCESCO PAPADIA;GINO GEROSA;GIOVANNI LUZZI;GIUSEPPE MARINELLI;L RANIERI","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;MATERIALS SCIENCE;PHYSICS;GEOGRAPHY;GEOLOGY;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;SOCIOLOGY","23;11;5;4;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;CARDIOLOGY;BIOCHEMISTRY;GENETICS;SURGERY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PSYCHIATRY;CANCER RESEARCH;PROGRAMMING LANGUAGE;RADIOLOGY;CELL BIOLOGY;METALLURGY;OPERATING SYSTEM;ANATOMY;ANESTHESIA;ANIMAL SCIENCE;ARCHAEOLOGY;CHROMATOGRAPHY;COMPUTATIONAL BIOLOGY;DEMOGRAPHY;EMERGENCY MEDICINE;ENDOCRINOLOGY;FAMILY MEDICINE;GASTROENTEROLOGY;GEOMORPHOLOGY;INTENSIVE CARE MEDICINE;LINGUISTICS;MECHANICS;MEDICAL EMERGENCY;MEDICAL PHYSICS;MOLECULAR BIOLOGY;NUCLEAR MAGNETIC RESONANCE;NUCLEAR MEDICINE;OBSTETRICS;ORGANIC CHEMISTRY;PALEONTOLOGY;PEDIATRICS;PHYSICAL CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;PHYSIOLOGY;STATISTICS;UROLOGY;VIROLOGY","14;7;6;5;5;5;4;4;4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;POPULATION;ANTIBODY;ANTIGEN;CREATININE;DISEASE;ENZYME;MYOCARDIAL INFARCTION;NEUROLOGY;VENTRICLE;AGENESIS;ALBUMIN;AMITRIPTYLINE;ANASTOMOSIS;ANEURYSM;AORTIC VALVE;APOPTOSIS;BIOPSY;BONE MARROW;CARDIAC PACING;CARDIAC TAMPONADE;CARDIOPULMONARY BYPASS;CARDIOTHORACIC SURGERY;CAROTENOID;CELL GROWTH;CEREBELLUM;CHEST PAIN;CIRCULATION (FLUID DYNAMICS);CIRRHOSIS;CLONING (PROGRAMMING);CLUSTER (SPACECRAFT);CORPUS CALLOSUM;CREATINE KINASE;CROSS-SECTIONAL STUDY;CYSTIC FIBROSIS;DIALYSIS;DNA;EMERGENCY DEPARTMENT;EPIDEMIOLOGY;FILTRATION (MATHEMATICS);GIEMSA STAIN;HEAD (GEOLOGY);HEART FAILURE;HEMATOLOGY;HEMODYNAMICS;HEPATITIS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMIGRATION;IMMUNE SYSTEM;INTERVENTIONAL CARDIOLOGY;IODINE;LESION;LUNG CANCER;LYMPHOCYTE;LYMPHOMA;MAGNESIUM;MAGNETIC RESONANCE IMAGING;MEDICAL DIAGNOSIS;MEDICAL LABORATORY;MIGRAINE;MONOCYTE;NODULE (GEOLOGY);PERFUSION;POINT OF CARE;POINT-OF-CARE TESTING;PREGNANCY;PSYCHOLOGICAL INTERVENTION;PUNCHING;RECEPTOR;RENAL FUNCTION;RUBINSTEIN–TAYBI SYNDROME;SAGITTAL PLANE;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);SEQUENCE (BIOLOGY);STAINING;SUBSTITUTION (LOGIC);SYSTEMIC CIRCULATION;TAR (COMPUTING);TELANGIECTASIA;THYROID;TOLUIDINE;TRIAGE;TURNAROUND TIME;ULTRAFILTRATION (RENAL);UPGRADE;UREA;VASCULAR DISEASE;VISUAL ANALOGUE SCALE","4;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD UREA NITROGEN;HUMAN LEUKOCYTE ANTIGEN;MUTATION;ACUTE CORONARY SYNDROME;AFTERLOAD;AGENESIS OF THE CORPUS CALLOSUM;ALLELE;ANAPLASTIC LARGE-CELL LYMPHOMA;ANTIPSYCHOTIC;AORTIC VALVE STENOSIS;ARIPIPRAZOLE;AUTOANTIBODY;AUTOIMMUNE HEPATITIS;CELL CYCLE;CEREBELLAR HEMISPHERE;CHROMATIN;CLOZAPINE;COELIAC DISEASE;DIFFUSION MRI;DNA DAMAGE;DOUBLE OUTLET RIGHT VENTRICLE;EOSIN;EXON;FETUS;FIXATION (POPULATION GENETICS);FONTAN PROCEDURE;GENOTYPE;GESTATIONAL AGE;H&E STAIN;HAEMATOXYLIN;HISTONE;IN VIVO MAGNETIC RESONANCE SPECTROSCOPY;IODINE DEFICIENCY;ION CHANNEL;LACTATE DEHYDROGENASE;LYCOPENE;MALIGNANT PLEURAL EFFUSION;NEURORADIOLOGY;NUCLEOTIDE;OLANZAPINE;PERFORATION;PERICARDIOCENTESIS;PORTAL HYPERTENSION;PRELOAD;PROTEIN KINASE B;QUETIAPINE;RISPERIDONE;SEROLOGY;T-CELL LYMPHOMA;TELANGIECTASES;TENSION HEADACHE;THYROID CANCER;THYROID NODULES;TISSUE TRANSGLUTAMINASE;TRANSCRIPTION FACTOR;UNSTABLE ANGINA;VENOUS RETURN CURVE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANAPLASTIC LYMPHOMA KINASE;AORTIC VALVULOPLASTY;ATYPICAL ANTIPSYCHOTIC;CELL CYCLE CHECKPOINT;CREB;CYCLIN D1;ENDOMYSIUM;HAPLOTYPE;HISTONE H4;HLA-DRB1;MOLECULAR EPIDEMIOLOGY;PALIPERIDONE;POINT MUTATION;PRENATAL DIAGNOSIS;TRPM7","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ITALY;MIDDLE AGED;;ADOLESCENT;MYOCARDIAL INFARCTION;ADULT;CHILD;AGED;CYSTIC FIBROSIS;FIBROBLASTS;HAPLOTYPES;HEART RUPTURE;HORSES;LYMPHOMA, LARGE B-CELL, DIFFUSE;NUCLEAR PROTEINS;PAPILLARY MUSCLES;STRESS, PHYSIOLOGICAL","19;13;8;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4","SURGICAL VENTRICULAR RECONSTRUCTION IN MYOCARDIAL INFARCTION;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;BEHAVIORAL INTERVENTIONS IN SPECIAL EDUCATION;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GENETIC AND DEVELOPMENTAL STUDIES OF LIMB MALFORMATIONS;HEALTH ECONOMICS AND QUALITY OF LIFE ASSESSMENT;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;LABORATORY MEDICINE AND TESTING PROCEDURES;LYMPHOID NEOPLASMS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MTOR SIGNALING IN GROWTH AND DISEASE;REGULATORY T CELL DEVELOPMENT AND FUNCTION;ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR;ROLE OF MAGNESIUM IN HEALTH AND DISEASE","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","POSTINFARCTION VENTRICULAR SEPTAL DEFECT;BLOOD UREA NITROGEN;CELIAC DISEASE;AFTERLOAD;AGENESIS;ANAPLASTIC LARGE-CELL LYMPHOMA;ANTIPSYCHOTIC DRUGS;AORTIC VALVULOPLASTY;ARIPIPRAZOLE;AUTOIMMUNE HEPATITIS;AVAILABILITY OF MEDICINES;CANCER;CARDIAC PACING;CARDIAC RUPTURE;CARDIAC SURGERY RISK MODELS;CARDIOTHORACIC SURGERY;CBP AND EP300 MUTATIONS;CELL LINE AUTHENTICATION;CEREBELLAR HEMISPHERE;CFTR","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL EVALUATION;ACTIVITY REDUCTION;ACUTE MYOCARDIAL;ANALISI FARMACOECONOMICA;ANATOMIC SUBSTRATES;ANTI-TISSUE TRANGLUTAMINASE;ANTIBRADYCARDIA INDICATIONS;ANTIPSICOTICI ATIPICI;AORTIC VALVULOPLASTY;ARM-LIFTING RESPONSES;ARRESTING CELL;AUTOIMMUNE HEPATITIS;BIVENTRICULAR PACING;BONE MARROW;CARDIAC MARKERS;CARDIAC PERFORATION;CELIAC DISEASE;CELL CYCLE;CELL LYMPHOMA;CELLS SELECTED;CELLULAR PARAMETERS;CENTRAL LABORATORY;CHARACTERISTICS ASSOCIATIONS;CHRONIC TENSION-TYPE;CIRCULATING RECOMBINANT;CLINICAL IMPLICATIONS;COMPREHENSIVE CYSTIC;CON OLANZAPINA;CORPUS CALLOSUM;CRONICI CON","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","THYROID NODULES;CREB-BINDING PROTEIN;AIH PATIENTS;CORPUS CALLOSUM;IGG ANTI-TTG;IODINE DEFICIENCY;MILD IODINE;PSYCHOTIC DISORDERS;UNDETECTABLE DOSE;ABERRANT CHROMATIN;ACETYL TRANSFERASE;ACETYL TRANSFERASES;CEREBRAL EXTRA-CEREBRAL;CHROMATIN REGULATION;CHRONIC HEPATITIS;CONGENITAL DISORDER;DIRECT LINK;ENTIRE CREB-BINDING;EP GENE;EXPOSED FEMALES;EXPOSED WORKERS;GENE CBP;GENE EXPRESSION;HISTONE ACETYL;IGA ANTI-TTG;INTRAGENIC DUPLICATION;LARGER REARRANGEMENTS;LIGATION-DEPENDENT PROBE;MID-SAGITTAL PLANE;MULTIPLE LIGATION-DEPENDENT","8;6;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.04,3,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,27,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,480,2.86,0,0,59,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES","1;1",NA,NA,"6.1 PHARMACEUTICALS","1","PROSTATE CANCER","1",NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2006,33,8.33333333333333,1.54545454545455,0.484848484848485,0.121212121212121,0.484848484848485,1.0625,0.941176470588235,0.8,0.941176470588235,0.424242424242424,3,13,8,4,7,0.39,0.24,0.12,0.21,32.45,0.635389283337709,NA,0.333333333333333,0.666666666666667,0.438,0.055,0.15,0,"ANA VILLAR;ANGIOLA ROCINO;JAN ASTERMARK;PIER PAOLO CLAUDIO;ANTONIO GIORDANO;ELISEO MATTIOLI;LG MANTOVANI;MATTIA GENTILE;JERZY WINDYGA;H. MARIJKE VAN DEN BERG;MARIO VON DEPKA;MARTA MORADO;D. PALADINI;PAOLO VOLPE;ROSARIO GARRIDO;M. SCHIAVONI;A. GRINGERI;AFRICA FERNÁNDEZ-L;TERESA QUARTICELLI;RICCARDINA TESSE","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","R NUMO;EMILIO JIRILLO;FABIO DI MARTINO;D. PALADINI;PAOLO VOLPE;TERESA QUARTICELLI;ANDREA VISCONTI;D. SARACENO;G. ZUMBO;MATTIA GENTILE;L LARICCHIA;L MORELLI;GIOVANNA ORSINI;LUIGI MARIO CHIECHI;DARÍO RAMALLO;VITO LUISI;R MOLININI;ELENA DEL PILAR DÍAZ MERA;F MININNI;ANA VILLAR","1;1;1;0.64;0.64;0.5;0.5;0.5;0.5;0.27;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.18","ELISEO MATTIOLI;MATTIA GENTILE;PAOLO VOLPE;M. SCHIAVONI;TERESA QUARTICELLI;R NUMO;G BARBONE;L POLLICE;ROBERTO RUSSO;TRIPALDI CLELIA;D. SARACENO;G. VOLPE;PAOLO MAGGI;P CICALA;VITTORIO GAUDIOMONTE;GIOVANNI MAUROGIOVANNI;C. TORELLI;A DAMMACCO;RITA FISCHETTO;TOMMASO DEPALO","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","R NUMO;EMILIO JIRILLO;FABIO DI MARTINO;PAOLO VOLPE;TERESA QUARTICELLI;D. SARACENO;G. ZUMBO;MATTIA GENTILE;GIOVANNA ORSINI;VITO LUISI;M. SCHIAVONI;ELISEO MATTIOLI;G BARBONE;TRIPALDI CLELIA;P CICALA;LUIGI DE LUCA TUPPUTI SCHINOSA;NICOLA MARRAUDINO;P. TUNZI;MARILINA TAMPOIA;GIUSEPPE FIORE","1;1;1;0.64;0.5;0.5;0.5;0.27;0.25;0.2;0.18;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.14","A. DE CANIO;A.M. MAGISTÀ;ELENA LIONETTI;ENZO IERARDI;GIOVANNI MAUROGIOVANNI;LUCIANO CAVALLO;RUGGIERO FRANCAVILLA;S. CASTELLANETA;VITO LEONARDO MINIELLO;D. PALADINI;PAOLO VOLPE;A. GRINGERI;ANA VILLAR;ANGIOLA ROCINO;H. MARIJKE VAN DEN BERG;JAN ASTERMARK;JERZY WINDYGA;LG MANTOVANI;M. SCHIAVONI;MARIO VON DEPKA","164;164;164;164;164;164;164;164;164;155;155;151;151;151;151;151;151;151;151;151","GIOVANNI MAUROGIOVANNI;PAOLO VOLPE;M. SCHIAVONI;ELISEO MATTIOLI;ROBERTO RUSSO;MATTIA GENTILE;GENNARO M. LENATO;ROSELLA BELLOMO;MARILINA TAMPOIA;PAOLO MAGGI;PALMA SORINO;RITA FISCHETTO;L POLLICE;LUIGI SELVAGGI;GIUSEPPE FIORE;LUIGI DE LUCA TUPPUTI SCHINOSA;NICOLA BRIENZA;NICOLA MARRAUDINO;P CICALA;P. TUNZI","164;155;151;107;101;65;58;54;44;40;36;33;31;31;29;29;29;29;29;29","ELISEO MATTIOLI;M. SCHIAVONI;PAOLO VOLPE;A DAMMACCO;C. TORELLI;D.A. CARINGELLA;G LUZZI;G. VOLPE;GENNARO M. LENATO;GIOVANNI MAUROGIOVANNI;GIUSEPPE FIORE;L POLLICE;LUIGI DE LUCA TUPPUTI SCHINOSA;LUIGI SELVAGGI;MARCO DECUZZI;MARILINA TAMPOIA;MARIO GIORDANO;MATTIA GENTILE;MICHELE PIOMBINO;NICOLA BRIENZA","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;MATERIALS SCIENCE","32;13;2;2;2;2;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;ENVIRONMENTAL HEALTH;PEDIATRICS;SURGERY;CARDIOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;BIOCHEMISTRY;DERMATOLOGY;GASTROENTEROLOGY;ANESTHESIA;CANCER RESEARCH;ENDOCRINOLOGY;GENERAL SURGERY;MICROBIOLOGY;MOLECULAR BIOLOGY;OBSTETRICS;ONCOLOGY;OPTICS;PHYSICAL THERAPY;VIROLOGY","23;11;10;5;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","GENE;PREGNANCY;DISEASE;POPULATION;CHEMOTHERAPY;ANTIBODY;CANCER;CLINICAL TRIAL;CONCOMITANT;ETIOLOGY;HAEMOPHILIA;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);PERITONEAL DIALYSIS;RANDOMIZED CONTROLLED TRIAL;REGIMEN;TELANGIECTASIA;ULTRASOUND;VIRUS;ADJUVANT;ADVERSE EFFECT;ALTERNATIVE MEDICINE;AMPUTATION;ANTHROPOMETRY;ANTIBIOTICS;ANTIGEN;AREA UNDER THE CURVE;ARTERITIS;ARTERY;ASBESTOS;ATROPHY;AUTOPSY;BACTERIA;BIOPSY;BLOOD FLOW;BLOOD TRANSFUSION;CARBOHYDRATE METABOLISM;CARCINOMA;CARDIAC SURGERY;CATALYSIS;CEREBELLUM;COAGULATION;COGNITION;COHORT;COMPUTED TOMOGRAPHY;CONFIDENCE INTERVAL;DIABETES MELLITUS;DIALYSIS;DOSE;DOSING;ELECTROENCEPHALOGRAPHY;EMBARRASSMENT;ENZYME;EPILEPSY;ESOPHAGUS;FOURTH VENTRICLE;GRANULOCYTE;HEALTH SURVEILLANCE;HEART DISEASE;HEART FAILURE;HELICOBACTER PYLORI;HEMODYNAMICS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);HYDROCEPHALUS;HYPOPLASIA;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;IN VITRO;INSULIN;INTRACARDIAC INJECTION;LEPROSY;LESION;MALNUTRITION;MODALITY (HUMAN–COMPUTER INTERACTION);MULTIPLEX;MYOCARDIAL INFARCTION;MYOCLONUS;NEUROIMAGING;OBSERVATIONAL STUDY;OCCUPATIONAL EXPOSURE;ODDS RATIO;OMEPRAZOLE;PENIS;PERFUSION;PERITONITIS;PHYSICAL EXAMINATION;PRIMARY BILIARY CIRRHOSIS;PROSPECTIVE COHORT STUDY;QRS COMPLEX;RADIATION THERAPY;RESPIRATORY DISTRESS;SALIVA;SALIVARY GLAND;SCINTIGRAPHY;SEX ORGAN;SHORT STATURE;STEM CELL;SUBMANDIBULAR GLAND;SUDDEN CARDIAC DEATH;SUPERIOR MESENTERIC ARTERY;TEACHING HOSPITAL;TENTORIUM;TRANSPLANTATION;TREATMENT MODALITY;TUBERCULOSIS;VENTRICULAR TACHYCARDIA","5;5;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETUS;GESTATIONAL AGE;GESTATION;HAEMOPHILIA A;ADJUVANT THERAPY;ALLELE;AMOXICILLIN;ASBESTOSIS;AUTOANTIBODY;BASAL (MEDICINE);BREATH TEST;BURULI ULCER;BYPASS GRAFTING;CARDIAC OUTPUT;CD34;CELL CYCLE;CEREBELLAR VERMIS;CHROMOSOME;CLARITHROMYCIN;DANDY–WALKER SYNDROME;EJECTION FRACTION;ENCEPHALITIS;ESOPHAGEAL DISEASE;EXON;GENE EXPRESSION;GENOTYPE;GLYCEMIC;GREAT ARTERIES;HELICOBACTER PYLORI INFECTION;HERPES SIMPLEX VIRUS;INSULIN RESISTANCE;METRONIDAZOLE;MULTIDETECTOR COMPUTED TOMOGRAPHY;MUTANT;MUTATION;MYCOBACTERIUM;MYCOBACTERIUM ULCERANS;NEUROPSYCHOLOGY;NEUTROPENIA;OVARIAN CANCER;PERTECHNETATE;PHENOTYPE;PLACEBO;PLATINUM;PROBIOTIC;PROGRESSIVE MYOCLONUS EPILEPSY;PROLIFERATING CELL NUCLEAR ANTIGEN;PROTHROMBIN COMPLEX;RARE DISEASE;RECOMBINANT DNA;REVASCULARIZATION;RHEUMATIC DISEASE;RIFAMPICIN;RNA;SEROLOGY;SIALADENITIS;SKINFOLD THICKNESS;SPLANCHNIC;TEMOZOLOMIDE;TETRALOGY OF FALLOT;TISSUE TRANSGLUTAMINASE;TYPE 2 DIABETES;UMBILICAL VEIN;VIRAL DISEASE;VIRAL LOAD","4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;ABSOLUTE NEUTROPHIL COUNT;AMNIOTIC FLUID;ANTIRETROVIRAL THERAPY;BREAKPOINT;CARDIAC RESYNCHRONIZATION THERAPY;CONGENITAL CYSTIC ADENOMATOID MALFORMATION;ENDOGLIN;EZH2;FLUORESCENCE IN SITU HYBRIDIZATION;GENITAL HERPES;GENOTYPING;GLUCOSE HOMEOSTASIS;GLYCATED HEMOGLOBIN;HAPLOINSUFFICIENCY;IMPAIRED GLUCOSE TOLERANCE;INSULIN SENSITIVITY;KARYOTYPE;LACTOBACILLUS REUTERI;MISSENSE MUTATION;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEUROPSYCHOLOGICAL ASSESSMENT;OFF-PUMP CORONARY ARTERY BYPASS;PULMONARY HYPOPLASIA;REVERSE TRANSCRIPTASE;SIDA;SPLANCHNIC CIRCULATION;TINIDAZOLE;UREA BREATH TEST","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;CHILD;FETAL DISEASES;FACTOR IX;FACTOR VIII;HEMOPHILIA A;HEMOPHILIA B;ITALY;HIV PROTEASE INHIBITORS;INTESTINAL NEOPLASMS;PREGNANCY;SPONDYLARTHROPATHIES;STOMACH NEOPLASMS;TREATMENT OUTCOME;","29;23;18;14;14;12;7;7;6;6;6;6;6;5;5;5;5;5;5;4","DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;MANAGEMENT AND TREATMENT OF HEMOPHILIA;BODY COMPOSITION ASSESSMENT AND ANALYSIS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;DIAGNOSIS, TREATMENT, AND EPIDEMIOLOGY OF NONTUBERCULOUS MYCOBACTERIAL DISEASES;DIAGNOSTIC APPROACH TO FEVER OF UNKNOWN ORIGIN;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPILEPSY AND SEIZURES;EVOLUTION AND USAGE OF ANATOMICAL NOMENCLATURE;GENETIC BASIS OF NEUTROPENIA DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLIOMAS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER EPIGENETICS;CONCOMITANT;ETIOLOGY;HEREDITARY HEMORRHAGIC TELANGIECTASIA;REGIMEN;ABSOLUTE NEUTROPHIL COUNT;ACVRL1;ADJUVANT THERAPY;ARTERITIS;ASBESTOS EXPOSURE;ASBESTOSIS;BARRETT'S ESOPHAGUS;BASAL (MEDICINE);BIOELECTRICAL IMPEDANCE ANALYSIS;BLEEDING CONTROL;BREAKPOINT;BURULI ULCER;CARBOHYDRATE METABOLISM;CARDIAC OUTPUT;CEREBELLAR MALFORMATIONS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PERITONEAL DIALYSIS;PRBP VEGF;VEGF EZH;ACUTE BLEEDS;ADENOMATOID MALFORMATION;ADULTONSET RASMUSSENS;AFRICANA ISOLAMENTO;ANATOMICALELECTROGRAPHICCLINICAL FEATURES;ANESTHESIOLOGICAL PROCEDURES;ANTIIHELICOBACTER PYLORII;ANTITISSUE TRANSGLUTAMINASE;ARTERITIS PATIENTS;ARTERY BLOOD;BARRETTS ESOPHAGUS;BILIARY CIRRHOSIS;BIOPTICI PROVENIENTI;BIVENTRICULAR CARDIOVERTER;BLOOD FLOW;BURULI LA;BYPASSING AGENTS;CARDIOVERTER DEFIBRILLATOR;CAROTID PLAQUES;CEREBELLAR ABNORMALITIES;CHRONIC NEUTROPENIA;CHRONIC PERITONEAL;CLINICAL ASPECTS;CLINICAL FEATURES;CLINICAL TRIAL;COMPARATIVE STUDY;CONGENITAL CYSTIC","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GESTATIONAL AGE;NEUROPSYCHOLOGICAL OUTCOME;SHOX DELETIONS;BLOOD FLOW;DANDYWALKER MALFORMATION;HIV RNA;NONNUCLEOSIDE REVERSE-TRANSCRIPTASE;REVERSE-TRANSCRIPTASE INHIBITOR;STATISTICALLY SIGNIFICANT;SUPERIOR MESENTERIC;VEGF EZH;CARDIAC OUTPUT;DANDYWALKER VARIANT;EXPRESSION LEVELS;EXTRACARDIAC ANOMALIES;FALSE POSITIVE;GASTRIC CANCER;HIV GENOTYPING;MLPA ANALYSIS;NORMAL CONTROLS;POSITIVE RESULTS;POSTERIOR FOSSA;PRETERM TWINS;PROTEASE INHIBITOR;RULE-BASED INTERPRETATION;UNRELATED FAMILIES;VIRTUAL PHENOTYPE;ALK MUTANTS;ANTITTG IGA;CELL PHYSIOL","5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2",5,0.15,6,1,0,0,0,1,1,0,1,1,0,0,0,0,1,0,0,0,0,0,0,50,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3.33,293.67,6.25,1,0.33,37,0,0,0,0,1,0,1,1,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","3;3;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PREVENTION;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;CARDIOVASCULAR;COMPLEMENTARY AND INTEGRATIVE HEALTH;DIGESTIVE DISEASES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;INFECTIOUS DISEASES;INFLAMMATORY BOWEL DISEASE;KIDNEY DISEASE;NUTRITION","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;ORAL AND GASTROINTESTINAL","1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","2;1","COLON AND RECTAL CANCER","1","3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2007,31,11,2.19354838709677,0.225806451612903,0.225806451612903,0.354838709677419,1.07936507936508,0.875,0.875,0.916666666666667,0.387096774193548,1,17,8,1,4,0.55,0.26,0.03,0.13,40.55,0.768311241050695,NA,0.354838709677419,0.774193548387097,0.336,0,0,0,"ROBERTO BOCCALON;ANDREA SALTERI;M CASACCHIA;RITA FISCHETTO;LINA MINERVINI;ANDREA BALLERINI;GIANCARLO BONCOMPAGNI;FRANCESCO MARGARI;ROBERTO RIGHI;FEDERICO RUSSO;SONIA FREDIANI;CLAUDIA CARDUCCI;MARCELLO BAGNASCO;MARCELLA ZOLLINO;GIAMPAOLA PESCE;ROMANO TENCONI;ELIO TONUTTI;MARILINA TAMPOIA;DANILO VILLALTA;MARIA GRAZIA ALESSIO","3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","GIANLUIGI GIANNELLI;ROBERTO CORCIULO;RODOLFO RUSSO;GIOVANNI FM STRIPPOLI;THEODORE F. LOGAN;MACY I. LEVINE;ROBERTO BOCCALON;ANDREA SALTERI;M CASACCHIA;LINA MINERVINI;ANDREA BALLERINI;GIANCARLO BONCOMPAGNI;FRANCESCO MARGARI;ROBERTO RIGHI;FEDERICO RUSSO;CLAUDIO FURINO;MARCO TAMIETTO;NICOLA CARDASCIA;ROSANNA GENERO;BÉATRICE DE GELDER","1;0.5;0.5;0.33;0.33;0.33;0.28;0.28;0.28;0.28;0.28;0.28;0.28;0.28;0.28;0.25;0.25;0.25;0.25;0.25","RITA FISCHETTO;FRANCESCO MARGARI;MARILINA TAMPOIA;JOHN KOMNINOS;ALESSANDRO SGAMBATO;DOMENICO PAPARELLA;MARIE‐LOUISE SYRÉN;CLAUDIO FURINO;FLORA PUTEO;MARISA SANTOSTEFANO;SOON KOO BAIK;KWANG CHEOL KOH;R BELLANTUONO;SI HYUN BAE;NICOLA CARDASCIA;ROBERTO CORCIULO;ROSANNA GENERO;SILVANA TEDESCHI;TOMMASO DEPALO;ALBERTO EDEFONTI","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GIANLUIGI GIANNELLI;ROBERTO CORCIULO;GIOVANNI FM STRIPPOLI;FRANCESCO MARGARI;CLAUDIO FURINO;NICOLA CARDASCIA;ROSANNA GENERO;LUIGI SBORGIA;FRANCESCO BOSCIA;MARILINA TAMPOIA;VINCENZO PAGLIARULO;ARCANGELO PAGLIARULO;FLORA PUTEO;TOMMASO DEPALO;MARIO GIORDANO;DOMENICA A. CARINGELLA;GIOVANNI LAPADULA;DOMENICO PAPARELLA;LUIGI DE LUCA TUPPUTI SCHINOSA;NICOLA MARRAUDINO","1;0.5;0.33;0.28;0.25;0.25;0.25;0.25;0.25;0.24;0.2;0.2;0.17;0.17;0.17;0.17;0.14;0.12;0.12;0.12","RITA FISCHETTO;MARCELLA ZOLLINO;ADRIANA ZATTERALE;ALBERT SCHINZEL;ALDO BONFANTE;ALESSANDRA FERLINI;ALESSANDRA TURCI;ANNALISA VETRO;C. PREVIDERÈ;CECILIA ANICHINI;CORRADO ROMANO;ELENA ROSSI;ELISA FAZZI;EMANUELA MENEGHELLI;FAUSTINA LALATTA;FORTUNATO LONARDO;FRANCA BERNARDI;FRANCESCA NOVARA;FRANCISCO TEJADA;G CALABRESE","318;293;279;279;279;279;279;279;279;279;279;279;279;279;279;279;279;279;279;279","RITA FISCHETTO;MARILINA TAMPOIA;FRANCO A. CARNEVALE;ROSANNA GENERO;SALVATORE GRASSO;GIOVANNI LAPADULA;ALBERTO BETTINELLI;ALBERTO EDEFONTI;IVANA PELA;JOHN KOMNINOS;LUCIANO BECCARIA;MARIE‐LOUISE SYRÉN;MARIO G. BIANCHETTI;MARISA SANTOSTEFANO;NICOLÒ GHIRINGHELLI BORSA;R BELLANTUONO;RAFFAELE CALABRESE;SILVANA TEDESCHI;MASSIMO LEVRERO;PIETRO ANDREONÉ","318;121;96;87;77;62;61;61;61;61;61;61;61;61;61;61;61;61;60;60","RITA FISCHETTO;FRANCESCO MARGARI;MARILINA TAMPOIA;A GENTILE;ACHILLE CITTADINI;ALBERTO BETTINELLI;ALBERTO EDEFONTI;ALESSANDRO SGAMBATO;ARCANGELO PAGLIARULO;CLAUDIO FURINO;DANIELA MESSERI;DOMENICA A. CARINGELLA;EMILIO JIRILLO;FLORA PUTEO;FRANCESCO BOSCIA;FRANCO A. CARNEVALE;GIOVANNI FM STRIPPOLI;GIOVANNI LAPADULA;GIUSEPPE PIERUCCI;IVANA PELA","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ECONOMICS;BUSINESS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS","27;13;3;3;2;2;1;1;1;1","INTERNAL MEDICINE;PSYCHIATRY;BIOCHEMISTRY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;PATHOLOGY;EMERGENCY MEDICINE;ENDOCRINOLOGY;SURGERY;MICROBIOLOGY;PEDIATRICS;PHARMACOLOGY;CANCER RESEARCH;CARDIOLOGY;MACROECONOMICS;ONCOLOGY;RADIOLOGY;UROLOGY;VIROLOGY","18;7;6;6;6;6;5;4;4;4;3;3;3;2;2;2;2;2;2;2","GENE;IN VITRO;PSYCHIATRIC HOSPITAL;ANTIBIOTICS;ANTIBODY;ANTIGEN;CANCER;DEPRESSION (ECONOMICS);DIABETES MELLITUS;DISEASE;DRUG;ENZYME;EPIDEMIOLOGY;GERIATRIC PSYCHIATRY;NEUROLOGY;OBSERVATIONAL STUDY;PERITONEAL DIALYSIS;RECEPTOR;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);URETER;URINARY SYSTEM;VIRUS","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CHROMOSOME;CHRONIC HEPATITIS;MUTATION;TISSUE TRANSGLUTAMINASE;ANAPHYLAXIS;ANAPLASTIC LARGE-CELL LYMPHOMA;ANTIBIOTIC PROPHYLAXIS;ATTENTIONAL BIAS;AURA;BIPOLAR DISORDER;BLADDER CANCER;BONE CEMENT;BRIEF PSYCHIATRIC RATING SCALE;CARDIOPULMONARY RESUSCITATION;CD8;CELL ADHESION;CELL CYCLE;CHEMORADIOTHERAPY;CHROMOSOMAL TRANSLOCATION;COELIAC DISEASE;CYSTOGRAPHY;CYSTOSCOPY;CYTOTOXIC T CELL;DIABETIC RETINOPATHY;DIAGNOSIS OF SCHIZOPHRENIA;DIFFUSION MRI;EFFECTIVE DIFFUSION COEFFICIENT;EJECTION FRACTION;ENDOTHELIN RECEPTOR;FLUID-ATTENUATED INVERSION RECOVERY;FLUORESCEIN ANGIOGRAPHY;GENE REARRANGEMENT;GENOTYPE;GENTAMICIN;GLIADIN;GLOBAL ASSESSMENT OF FUNCTIONING;HEART RATE;HEMISPATIAL NEGLECT;HEPATITIS B VIRUS;HUMAN GENETICS;HYDRONEPHROSIS;IMMUNOGLOBULIN G;IMMUNOPHENOTYPING;INTERLEUKIN;LEGIONELLA;LEGIONELLA PNEUMOPHILA;LIPID PROFILE;MALIGNANT PLEURAL EFFUSION;MAXIMUM BUBBLE PRESSURE METHOD;NEURORADIOLOGY;NULL CELL;OLFACTORY RECEPTOR;PERIPHERAL BLOOD MONONUCLEAR CELL;PHENOTYPE;POLYPHENOL;PRESSURE SUPPORT VENTILATION;PROTEINURIA;PSYCHIATRIC DIAGNOSIS;PSYCHIATRIC EPIDEMIOLOGY;REFLUX;RENAL PELVIS;RETINOPATHY;SEROLOGY;T CELL;T-CELL LYMPHOMA;TENSION HEADACHE;UNILATERAL NEGLECT;VISUAL ATTENTION;VITRECTOMY;VON WILLEBRAND FACTOR;WHITE MATTER","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KARYOTYPE;LAMIVUDINE;ANAPLASTIC LYMPHOMA KINASE;BOSENTAN;BREAKPOINT;CARDIAC RESYNCHRONIZATION THERAPY;CHROMOSOME 4;COMPOUND HETEROZYGOSITY;CYTOGENETICS;E-SELECTIN;ENDOMYSIUM;EPIRETINAL MEMBRANE;FRACTIONAL ANISOTROPY;GENTAMICIN SULFATE;HBSAG;INTERFACE (MATTER);LEGIONNAIRES' DISEASE;MISSENSE MUTATION;MOLECULAR MEDICINE;N2PC;PERFORIN;POLYMORPHISM (COMPUTER SCIENCE);RESPIRATORY RATE;SOLUBLE CELL ADHESION MOLECULES;T-CELL RECEPTOR;VESICOURETERAL REFLUX;VESICOURETERIC REFLUX","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;CELIAC DISEASE;CHILD;IGA DEFICIENCY;ADOLESCENT;AGED;CHILD, PRESCHOOL;TRANSGLUTAMINASES;ANTI-RETROVIRAL AGENTS;AUTOANTIBODIES;CARDIOVASCULAR AGENTS;CARNITINE;FLAVONOIDS;HODGKIN DISEASE;HYPERTENSION, PULMONARY","23;17;15;9;8;8;8;8;8;6;5;5;5;4;4;4;4;4;4;4","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEPATITIS B INFECTION AND TREATMENT;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;SCHIZOPHRENIA RESEARCH AND TREATMENT;ASSESSMENT OF DECISIONAL CAPACITY IN PSYCHIATRY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF URTICARIA;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC BASIS OF NEUTROPENIA DISORDERS;GLIOMAS;INFLAMMATION AND OBESITY-RELATED METABOLIC DISORDERS;INTERACTIONS OF LEGIONELLA AND AMOEBAE IN DISEASE;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;LYMPHOID NEOPLASMS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;PSYCHIATRIC HOSPITAL;ADEFOVIR;CHROMOSOME DUPLICATION;DEPRESSION (ECONOMICS);GERIATRIC PSYCHIATRY;TISSUE TRANSGLUTAMINASE;ANAPLASTIC LARGE-CELL LYMPHOMA;ANTIRETROVIRAL THERAPY;ATTENTIONAL BIAS;BLADDER EXSTROPHY;BONE CEMENT;BREAKPOINT;CARDIOVASCULAR EVALUATION;CARNITINE;CELIAC DISEASE;CHEMORADIOTHERAPY;CHROMOSOMAL INVERSION;CHROMOSOMAL REARRANGEMENT;CHROMOSOME 4","5;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","HOSPITAL PSYCHIATRIC;ACUTE HOSPITAL;ADEFOVIR MONOTHERAPY;ADHESION MOLECULES;CELIAC DISEASE;CHRONIC HEPATITIS;CLINICAL FEATURES;DISEASE PATIENTS;IGA DEFICIENCY;ITALIAN ACUTE;PATIENTS ADMITTED;PSYCHIATRIC WARDS;SELECTIVE IGA;ACRYLIC CEMENT;ACUTE PATIENTS;AFFORDABLE FIXED-DOSE;ANTI-RETROVIRAL DRUG;ANTIBODY ASSAYS;ANTITISSUE TRANSGLUTAMINASE;ANXIETYDEPRESSIVE DISORDER;APD CYCLERS;ARTERIAL BUFFER;ARTERIAL HYPERTENSION;ATTENTIONAL DEFICITS;BACTERIOLOGICAL DIAGNOSIS;BALANCED RECIPROCAL;BIALLELIC MUTATIONS;BLADDER NEOPLASMS;BLOOD MONONUCLEAR;BODY LANGUAGE","3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FPA PATIENTS;INDUCTION TEST;PNEUMOPHILA SG;RECIPROCAL TRANSLOCATIONS;BODILY EXPRESSIONS;DE NOVO;NAIVE PATIENTS;NR -ON;PREVIOUS CLASSIC;TRANSFUSION REQUIREMENTS;WK NAIVE;ADHESION MOLECULE;AGE YRS;APPARENTLY BALANCED;ARRAY CGH;ATTENTIONAL SELECTION;BODY LANGUAGE;FEARFUL BODY;HOSPITAL PSYCHIATRIC;HOSPITAL STAY;RESPIRATORY RATE;VISUAL AWARENESS;ACUTE HOSPITAL;ADULT THALASSAEMIC;AGGRESSION SCALE;AGGRESSIVE BEHAVIOR;AGGRESSIVE BEHAVIOUR;ALT NA;ATYPICAL DRUGS;CALLED SPDCS","5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2",3,0.1,8,4.5,0,0,0,0,4.75,0,0,4.5,0,1,0,0,1,0,0,0,0,0.5,0,71,71.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,254,1.59,0,0,15,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE","1;1","CARDIOVASCULAR;CLINICAL RESEARCH;HYPERTENSION","1;1;1","CARDIOVASCULAR","1","7.1 INDIVIDUAL CARE NEEDS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2008,34,9.82352941176471,1.64705882352941,0.205882352941176,0.205882352941176,0.264705882352941,1.03703703703704,0.875,0.875,0.9,0.411764705882353,0,15,9,2,5,0.44,0.26,0.06,0.15,44.59,0.812588212049135,NA,0.294117647058824,0.794117647058823,0.256,0.159,0,0.141,"DARÍO RAMALLO;R MOLININI;ALESSANDRO SGAMBATO;NICOLA LAFORGIA;RITA FISCHETTO;VITO LUISI;LUIGI DE LUCA TUPPUTI SCHINOSA;BRUNELLA LICCHELLI;VITTORIO PATELLA;E S MERA;LUIGI MEMO;MICHAEL B. PETERSEN;GIORGIA MANGILI;BARBARA CARLINI;GRAZIELLA CARIDI;GIOVANNI NERI;ANNA MARIA ORENGO;MARCEL M.A.M. MANNENS;GIOVANNI SORGE;CAROLINE SIMONE","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","VINCENZO PINTO;DARÍO RAMALLO;R MOLININI;CRISTINA ROSSI;VITO LUISI;BRUNELLA LICCHELLI;VITTORIO PATELLA;E S MERA;GIOVANNI ANTONACI;COSIMO TORTORELLA;SALVATORE ANTONACI;OLIVIA SIMONE;ALESSANDRO SGAMBATO;PIERO LISI;ROBERTO POLIGNANO;VALENTINA DINI;G PANNARALE;P BONADEO;TIZIANA PICCOLO;MARCO ROMANELLI","0.5;0.5;0.5;0.5;0.33;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.24;0.2;0.2;0.2;0.2;0.2;0.2;0.2","ALESSANDRO SGAMBATO;NICOLA LAFORGIA;RITA FISCHETTO;VITO LUISI;LUIGI DE LUCA TUPPUTI SCHINOSA;E S MERA;BENITO FANELLI;HARIDIMOS MARKOGIANNAKIS;ANDREAS MANOURAS;ARTEMISIA PAPADIMA;VINCENZO PINTO;PIERO LISI;GIOVANNI MAUROGIOVANNI;NIKOLAOS V. MICHALOPOULOS;ANNA BELFIORE;PANAGIOTIS KEKIS;V. DE ROBERTIS;KONSTANTINOS FILIS;STEFANO FAVALE;ALESSANDRO RETTINO","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VINCENZO PINTO;CRISTINA ROSSI;VITO LUISI;E S MERA;OLIVIA SIMONE;ALESSANDRO SGAMBATO;PIERO LISI;G PANNARALE;TIZIANA PICCOLO;P CORATELLI;E. VALICENTI;GIULIO MAGGIO;LUIGI DE LUCA TUPPUTI SCHINOSA;BENITO FANELLI;VITO PESCE;FABIO DI MARTINO;HAIHUA LIANG;KANGMIN DUAN;FRANCESCO PAOLO SCHENA;CHEN HUANG","0.5;0.5;0.33;0.33;0.25;0.24;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17","FLAVIO VINCENTI;FRANCESCO PAOLO SCHENA;I.A. HAUSER;J.M. GRINYÓ;ROWAN G. WALKER;STEVEN PARASKEVAS;RITA FISCHETTO;AGOSTINA DE CRESCENZO;ANDREA RICCIO;ANGELA SPARAGO;DEBORAH MACKAY;FAUSTINA LALATTA;FLAVIA CERRATO;GAETANO VERDE;I. KAREN TEMPLE;JET BLIEK;JONATHAN L A CALLAWAY;LIDIA LARIZZA;LUCIO GIORDANO;MARCEL M.A.M. MANNENS","301;301;301;301;301;301;217;215;215;215;215;215;215;215;215;215;215;215;215;215","FRANCESCO PAOLO SCHENA;RITA FISCHETTO;ANNA BELFIORE;ALESSANDRO SGAMBATO;GIOVANNI MAUROGIOVANNI;LUIGI DE LUCA TUPPUTI SCHINOSA;GIANFRANCO AMODIO;GIANFRANCO ANTONELLI;GENNARO CORMIO;FRANCESCO MANFREDI;MARIA PIA PRUDENZANO;GIULIO MAGGIO;PAOLO VOLPE;V. DE ROBERTIS;DOMÉNICO RIBATTI;FRANCO A. CARNEVALE;ACHILLE CITTADINI;ALESSANDRO RETTINO;BARBARA DE PAOLA;MARIA PIA TRISORIO LIUZZI","301;217;174;145;145;100;52;52;49;40;38;35;35;35;34;28;26;26;26;24","ALESSANDRO SGAMBATO;RITA FISCHETTO;ACHILLE CITTADINI;AGATA CALVARIO;ALESSANDRO RETTINO;ANDREAS MANOURAS;ANNA BELFIORE;ANNA BOZZI;ARTEMISIA PAPADIMA;BARBARA DE PAOLA;BENITO FANELLI;CHEN HUANG;CRISTINA ROSSI;DOMÉNICO RIBATTI;E. VALICENTI;FABIO DI MARTINO;FRANCESCO MANFREDI;FRANCESCO PAOLO SCHENA;FRANCO A. CARNEVALE;G PANNARALE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;MATERIALS SCIENCE;PSYCHOLOGY;CHEMISTRY;ENGINEERING;ECONOMICS;GEOLOGY","29;13;3;3;2;2;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;SURGERY;RADIOLOGY;ENVIRONMENTAL HEALTH;PEDIATRICS;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;CARDIOLOGY;IMMUNOLOGY;NEUROSCIENCE;ANATOMY;DERMATOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;METALLURGY;MOLECULAR BIOLOGY;OBSTETRICS;PSYCHIATRY","20;11;10;8;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CANCER;GENE;PREGNANCY;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;ALTERNATIVE MEDICINE;AORTA;ARTHROPLASTY;ASBESTOS;BLOOD PRESSURE;CELL CULTURE;DISEASE;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;LESION;MALIGNANCY;OCCUPATIONAL EXPOSURE;RECEPTOR;SALIVARY GLAND;ADIPOSE TISSUE;ALCOHOL;ALDOSTERONE;ANTIBIOTICS;ANTIBODY;APOPTOSIS;ARRIVAL TIME;ARTERIAL TREE;ARTERY;ARTHRITIS;ATAXIA;ATRIAL FIBRILLATION;BACTERIA;BIOMARKER;BODY MASS INDEX;CALCIUM;CARDIAC SURGERY;CAUDA EQUINA SYNDROME;CEREBRAL VENTRICLE;CHEMOTHERAPY;COMPUTED TOMOGRAPHY;CONFIDENCE INTERVAL;CONSCIOUSNESS;CORROSION;CYST;DIFFERENTIAL DIAGNOSIS;DISSECTION (MEDICAL);EPILEPSY;ETIOLOGY;EXPLORATORY LAPAROTOMY;FLOW CYTOMETRY;GRADING (ENGINEERING);HEALTH CARE;HELICOBACTER PYLORI;HEMATOLOGY;HORMONE;IBUPROFEN;IMPLANT;IN VITRO;INDIGESTION;INOTROPE;INTENSIVE CARE UNIT;KERATOCONJUNCTIVITIS SICCA;LACRIMAL GLAND;LACTOFERRIN;LAPAROTOMY;LEAD (GEOLOGY);LIPOMA;MAGNETIC RESONANCE IMAGING;MECHANICAL VENTILATION;MEDICAL MICROBIOLOGY;MESOTHELIOMA;MULTIPLE DISABILITIES;MYOCARDIAL INFARCTION;NAP;NODULE (GEOLOGY);OCCUPATIONAL SAFETY AND HEALTH;OLFACTORY SYSTEM;ORAL ADMINISTRATION;ORTHOPEDIC SURGERY;OSTEOLYSIS;PAIN RELIEF;PAROTID GLAND;PATHOGENESIS;PATHOLOGICAL;PHALANX;POISON CONTROL;POLIOMYELITIS;POPULATION;PROXIMAL PHALANX;PUBLIC HEALTH;QUADRANT (ABDOMEN);RETROSPECTIVE COHORT STUDY;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;SALIVA;SARCOMA;SEPSIS;SEROUS FLUID;SERVICE (BUSINESS);SMOOTH MUSCLE;SPINAL CORD;SPINAL FUSION;SSS*;STEM CELL;STEROID USE;SURGICAL ONCOLOGY;TITANIUM;TOTAL KNEE ARTHROPLASTY;TRANSPLANTATION;TRUNK;ULTRASOUND;VACCINATION;VENTRICLE;VIRUS;WEAKNESS","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETUS;PLACEBO;ADENOCARCINOMA;ALCOHOL INTAKE;ALLELE;ANGIOLIPOMA;ANNEXIN;AORTIC DISSECTION;ASBESTOS CEMENT;ASBESTOSIS;BREATH TEST;CALPONIN;CANCER CELL;CAUDA EQUINA;CD34;CELL CYCLE;CHINESE HAMSTER OVARY CELL;CHROMOSOME;CHRYSOTILE;CLINICAL ENDPOINT;COELIAC DISEASE;CONUS MEDULLARIS;CORONARY ARTERIES;CREVICE CORROSION;EPIDERMAL GROWTH FACTOR RECEPTOR;EPIGENETICS;ESSENTIAL HYPERTENSION;EUROSCORE;GENE EXPRESSION;GENOTYPE;GESTATION;GNAS COMPLEX LOCUS;GREAT ARTERIES;GROWTH FACTOR RECEPTOR;HEART RATE;HELICOBACTER PYLORI INFECTION;HEPATOCYTE GROWTH FACTOR;HERD IMMUNITY;HUMAN FACTORS AND ERGONOMICS;HUMAN GENETICS;HYPERALDOSTERONISM;HYPOREFLEXIA;IMMUNITY;IMMUNIZATION;IMMUNOTHERAPY;IMPRINTING (PSYCHOLOGY);KIDNEY TRANSPLANTATION;LUPUS NEPHRITIS;METHYLATION;MUTATION;NAPROXEN;NEONATAL SEPSIS;NEUROBLASTOMA;OLFACTORY RECEPTOR;OVARIAN CANCER;OVERWEIGHT;PARATHYROID HORMONE;PERIPROSTHETIC;PLEOMORPHISM (CYTOLOGY);POLIOVIRUS;PRIMARY ALDOSTERONISM;PROBIOTIC;PROGRAMMED CELL DEATH;RENIN–ANGIOTENSIN SYSTEM;RNA;SALIVARY PROTEINS;SANDHOFF DISEASE;SEROLOGY;SOFT TISSUE SARCOMA;STEROID;STRESS SHIELDING;STROMA;SURVIVIN;SYSTEMIC LUPUS ERYTHEMATOSUS;TOLERABILITY;TRANSFECTION;TROPONIN;TROPONIN I;TROPONIN T;UMBILICAL VEIN","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;BRADYCARDIA;C-MET;CHROMOSOME 4;COMPOUND HETEROZYGOSITY;CROSSOVER STUDY;DNA METHYLATION;FRAMESHIFT MUTATION;INACTIVATED POLIOVIRUS VACCINE;KIDNEY TRANSPLANT;LACTOBACILLUS REUTERI;MISSENSE MUTATION;MOLECULAR MEDICINE;MUCINOUS CARCINOMA;NAPROXEN SODIUM;PLASMA RENIN ACTIVITY;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);PSEUDOHYPOPARATHYROIDISM;RNA SPLICING;SMALL FOR GESTATIONAL AGE;SOLITARY FIBROUS TUMOR;TRANSPOSITION OF THE GREAT VESSELS;TROPONIN C;UNDIFFERENTIATED PLEOMORPHIC SARCOMA;UREA BREATH TEST;VENTRICULOMEGALY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;TREATMENT OUTCOME;ADRENAL CORTEX HORMONES;MENINGITIS, ASEPTIC;;CARCINOMA, HEPATOCELLULAR;COMMUNICABLE DISEASES, EMERGING;CYSTS;LIVER DISEASES;PERIPHERAL NERVOUS SYSTEM DISEASES;RISK ASSESSMENT;ADOLESCENT;ANGIOLIPOMA;BIOMARKERS, TUMOR","29;18;17;11;9;7;7;7;6;6;5;5;5;5;5;5;5;4;4;4","AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GRANULAR CELL TUMOR: CLINICAL AND PATHOLOGICAL CHARACTERISTICS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS;HIP ARTHROPLASTY TECHNIQUES AND MATERIALS","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ASBESTOS EXPOSURE;ABDOMINAL WALL DEFECTS;ALCOHOL INTAKE;ALDOSTERONE;ANGIOLIPOMA;ANTICOAGULATION THERAPY;AORTIC DISSECTION;ARRHYTHMIAS;ARRIVAL TIME;ARTERIAL TREE;ASBESTOS CEMENT;ASBESTOSIS;BECKWITH–WIEDEMANN SYNDROME;CALPONIN;CARDIAC RESYNCHRONIZATION THERAPY;CARDIAC SCREENING;CAUDA EQUINA;CAUDA EQUINA SYNDROME;CELL SIGNALING;CELL-PENETRATING PEPTIDES","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COELIAC DISEASE;ACUTE AORTIC;ADOLESCENTS LIVING;AGE NEWBORN;ALCOHOL RELATED;ALDOSTERONE CONCENTRATIONS;ANTI-TNF THERAPY;AORTIC DISSECTION;APULIA SOUTHERN;ARTERIAL TRUNKS;ASBESTOS EXPOSED;ASBESTOS-RELATED DISEASES;ATRIAL TACHYARRHYTHMIAS;BECKWITHWIEDEMANN SYNDROME;BODY MASS;BORDER REGION;BOVINE LACTOFERRIN;BRADYTACHY SYNDROME;BURDEN II;CARCINOMA HEPG;CARDIAC SURGERY;CASE-CONTROL MULTICENTRIC;CAUDA EQUINA;CELL VACCINE;CEREBRAL VENTRICULOMEGALY;CHILD CAUDA;CLINICAL IMPROVEMENT;CLOSEDLOOP RATE;CROSS-OVER STUDY;DEVELOPMENTAL DISABILITIES","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","STANDARD STEROIDS;VERSUS STANDARD;OVARIAN CANCER;MONTH GFR;MUCINOUS OVARIAN;RENAL TRANSPLANT;STEROID WITHDRAWAL;TRANSPLANT PATIENTS;ANTI-TNFΑ THERAPY;CELL DEATH;HYPERTENSIVE PATIENTS;LIGAMENTUM TERES;MATERNALLY METHYLATED;PH PATIENTS;POLIO VACCINE;ACHIEVES SIMILAR;ACUTE REJECTION;ALDOSTERONE-PRODUCING ADENOMA;ANALYSIS MEDIAN;APULIA REGION;BASILIXIMAB STEROID;BIOPSY-PROVEN ACUTE;BLOOD VESSELS;BPAR GRAFT;CANCER RECEIVED;COMPLETE STEROID;COMPUTED TOMOGRAPHY;CSA-ME EC-MPS;CSA-ME ENTERIC-COATED;CYCLOSPORINE MICROEMULSION","16;6;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",4,0.12,10.18,5.25,0,1,1,0,4,0,1,5.25,0,2,1.75,0,3,0,0,1.75,0,0.25,0,100.25,100.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,7.33,553.89,16.98,2,0.22,43.56,0,0,0,2,4,0,2,1,0,9,0,0,0,0,0,0,0,7,2,0,8,0,0,1,0,0,0,0,0,0,"Italy;Germany;Switzerland","3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY","9;5;3;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;CARDIOVASCULAR;HEART DISEASE;HEMATOLOGY;TRANSPLANTATION;BIOMEDICAL IMAGING;OVARIAN CANCER;STEM CELL RESEARCH;AGING;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;CHILDHOOD LEUKEMIA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;COMPARATIVE EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;HEART DISEASE - CORONARY HEART DISEASE;INFLAMMATORY BOWEL DISEASE","8;5;5;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;BLOOD;RESPIRATORY","4;3;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;6.7 PHYSICAL;7.3 MANAGEMENT AND DECISION MAKING","8;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;OVARIAN CANCER;HODGKIN'S DISEASE;NON-HODGKIN'S LYMPHOMA","2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2009,25,13.6,1.8,0.24,0.12,0.4,1.07142857142857,0.857142857142857,0.75,1.11111111111111,0.44,0,17,3,1,2,0.68,0.12,0.04,0.08,49.92,1.07918283030878,NA,0.28,0.92,0.316,0,0,0.175,"NICOLA SANTORO;FRANCO LOCATELLI;LUCA LO NIGRO;ANDREA BIONDI;GIUSEPPE BASSO;CARMELO RIZZARI;CONCETTA MICALIZZI;ANDREA PESSION;VALENTINO CONTER;FIORINA CASALE;PAOLO MAGGI;CHIARA MESSINA;DANIELA SILVESTRI;ROSANNA PARASOLE;GIULIO ROSSI;DOMÉNICO RIBATTI;MAURIZIO ARICÒ;MARILINA TAMPOIA;MARIA GRAZIA ALESSIO;GIOVANNI CAZZANIGA","3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","ROBERTO CORCIULO;RODOLFO RUSSO;DOMÉNICO RIBATTI;MARIO COLUCCI;FABRIZIO SEMERARO;CONCETTA T. AMMOLLO;N. SEMERARO;PAOLO MAGGI;MARILINA TAMPOIA;MARIA GRAZIA ALESSIO;GIUSEPPE ANGELELLI;ARNALDO SCARDAPANE;AMATO ANTONIO STABILE IANORA;PASQUALE PEDOTE;MARCO MOSCHETTA;LUISA RONCALI;MARIELLA ERREDE;ANGELO VACCA;FRANCESCO GIROLAMO;ROBERTO RIA","0.5;0.5;0.27;0.25;0.25;0.25;0.25;0.23;0.22;0.22;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17","NICOLA SANTORO;PAOLO MAGGI;DOMÉNICO RIBATTI;MARILINA TAMPOIA;LUISA RONCALI;ALESSANDRO SGAMBATO;RAFFAELLA DEPALO;CESARE DI BARI;MARIELLA ERREDE;DELIO GAGLIARDI;FRANCESCO GIROLAMO;DANIELA VIRGINTINO;VITO LONGO;MARIO COLUCCI;ROBERTO TAMMA;BEATRICE NICO;CHIARA BELLACOSA;ROBERTO CORCIULO;RITA FISCHETTO;STEFANO BETTOCCHI","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ROBERTO CORCIULO;DOMÉNICO RIBATTI;MARIO COLUCCI;FABRIZIO SEMERARO;CONCETTA T. AMMOLLO;N. SEMERARO;PAOLO MAGGI;MARILINA TAMPOIA;MARCO MOSCHETTA;LUISA RONCALI;MARIELLA ERREDE;FRANCESCO GIROLAMO;DANIELA VIRGINTINO;VINCENZO BENAGIANO;G. ACUTO;GUIDO REGINA;PAOLO FLACE;NICOLA SANTORO;DELIO GAGLIARDI;ANNAMARIA D. PELLEGRINO","0.5;0.27;0.25;0.25;0.25;0.25;0.23;0.22;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.15;0.14;0.14","ALBA A. BRANDES;ALBERTO FABBRI;ANDRÉS JM FERRERI;ATTILIO GUARINI;CATERINA STELITANO;CATRINA UHLMANN;DANIELE VALLISA;EMANUELE ZUCCA;FEDERICO CALIGARIS‐CAPPIO;FIORELLA ILARIUCCI;FRANCESCO ZAJA;FRANCO CAVALLI;GAETANO CORAZZELLI;GERASIMUS A PANGALIS;GIAN MARCO AONDIO;GIUSEPPE AVVISATI;GIUSEPPE ROSSI;GRAZIELLA PINOTTI;HENRY GÓMEZ;JOSÉ FAJARDO","630;630;630;630;630;630;630;630;630;630;630;630;630;630;630;630;630;630;630;630","ATTILIO GUARINI;S GENCO;FRANCESCO PAOLO SUSCA;GINEVRA GUANTI;MARILENA DI GIACOMO;ALESSANDRO SGAMBATO;BEATRICE NICO;DOMÉNICO RIBATTI;ROBERTO TAMMA;TIZIANA ANNESE;VITO LONGO;CESARE DI BARI;RITA FISCHETTO;MARCO MOSCHETTA;CONCETTA T. AMMOLLO;FABRIZIO SEMERARO;MARIO COLUCCI;N. SEMERARO;MARILINA TAMPOIA;GENNARO CORMIO","630;107;69;69;69;68;48;48;48;48;48;46;41;39;34;34;34;34;32;31","NICOLA SANTORO;MARILINA TAMPOIA;ALESSANDRO SGAMBATO;ATTILIO GUARINI;BEATRICE NICO;CESARE DI BARI;CHIARA BELLACOSA;CONCETTA T. AMMOLLO;DANIELA VIRGINTINO;DOMENICO SINESI;DOMÉNICO RIBATTI;FABRIZIO SEMERARO;FILOMENAMILA LORUSSO;FRANCESCO GIROLAMO;FRANCESCO PAOLO SUSCA;G. ACUTO;G. PERTOSA;GENNARO CORMIO;GINEVRA GUANTI;GUIDO REGINA","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY","24;8;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;IMMUNOLOGY;PEDIATRICS;GENETICS;BIOCHEMISTRY;ENDOCRINOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;RADIOLOGY;ANDROLOGY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;OPTICS;PHYSICAL THERAPY;ANESTHESIA;CARDIOLOGY;CELL BIOLOGY;CLINICAL PSYCHOLOGY;EMERGENCY MEDICINE;EPISTEMOLOGY;GASTROENTEROLOGY;GYNECOLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;NURSING;OBSTETRICS;PHARMACOLOGY;SOCIAL PSYCHOLOGY;STATISTICS;VIROLOGY","18;8;7;6;5;4;4;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CHEMOTHERAPY;GENE;POPULATION;ANTIBODY;COMORBIDITY;COMPUTED TOMOGRAPHY;DISEASE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INCIDENCE (GEOMETRY);LEUKEMIA;LUNG;PREDNISONE;PREGNANCY;PROSPECTIVE COHORT STUDY;TRANSPLANTATION;ACETYLCHOLINE;AIRWAY;ALLERGY;AMAUROSIS;APOPTOSIS;AQUAPORIN 4;ASTHMA;BRAIN TUMOR;CALCIUM;CENTRAL NERVOUS SYSTEM;CEREBRAL CORTEX;CEREBROSPINAL FLUID;CHOLINERGIC;COAGULATION;COHORT;COHORT STUDY;CORTEX (ANATOMY);DISORDERS OF SEX DEVELOPMENT;DISTRESS;EMBRYO;ENZYME;FIBRIN;FIBRINOLYSIS;FLEXIBILITY (ENGINEERING);FOLLICULAR PHASE;GENDER IDENTITY;GLIOBLASTOMA;GLYCOPROTEIN;HEMODIALYSIS;HORMONE;HUMAN BRAIN;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;IMMUNOPATHOLOGY;INTERQUARTILE RANGE;LUNG CANCER;LYMPHOCYTE;LYMPHOMA;MECHANISM (BIOLOGY);MEMBRANE;METHOTREXATE;MIGRAINE;MONOCYTE;MORPHOLOGY (BIOLOGY);MUCIN;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;NEOCORTEX;NEUROLOGICAL EXAMINATION;OBSERVATIONAL STUDY;PERITONEAL DIALYSIS;PLASMINOGEN ACTIVATOR;PLATELET;POSTERIOR PARIETAL CORTEX;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;REGIMEN;RESPIRATORY DISTRESS;RESPIRATORY SYSTEM;RETROSPECTIVE COHORT STUDY;SENSITIZATION;TESTOSTERONE (PATCH);TISSUE PLASMINOGEN ACTIVATOR;ULTRASOUND;VIRUS","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHROMOSOME;HEMATOPOIETIC STEM CELL TRANSPLANTATION;LYMPHOBLASTIC LEUKEMIA;MINIMAL RESIDUAL DISEASE;MUTATION;ACUTE RESPIRATORY DISTRESS;ADENOCARCINOMA;ANDROGEN;ANTIMETABOLITE;ANTIPHOSPHOLIPID SYNDROME;AUTOIMMUNE DISEASE;AUTOIMMUNITY;B CELL;BLOOD–BRAIN BARRIER;BREAST CANCER;BRONCHOCONSTRICTION;CHARLSON COMORBIDITY INDEX;CHOLINE ACETYLTRANSFERASE;CHOLINERGIC NEURON;CHROMOSOMAL TRANSLOCATION;CLINICAL ENDPOINT;CRYOPRESERVATION;CUMULATIVE INCIDENCE;CYTARABINE;DEHYDROGENASE;ENCEPHALITIS;ENDOCRINE SYSTEM;EPIDERMAL GROWTH FACTOR;EPIDERMAL GROWTH FACTOR RECEPTOR;FETUS;GENDER IDENTITY DISORDER;IMMUNODEFICIENCY;INFARCTION;INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS;MIGRAINE TREATMENT;MULTIDETECTOR COMPUTED TOMOGRAPHY;OVARIAN CANCER;OVARIAN FOLLICLE;PARATHYROID HORMONE;PHASES OF CLINICAL RESEARCH;PHOSPHOLIPID;THROMBIN;TISSUE FACTOR;TRIPTANS;TYROSINE KINASE;VIRAL LOAD","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE LYMPHOCYTIC LEUKEMIA;KARYOTYPE;AMNIOTIC FLUID;ANDROSTENEDIONE;ANTIRETROVIRAL THERAPY;ASPARAGINASE;B-CELL ACTIVATING FACTOR;BREAKPOINT;CARDIOLIPIN;CEBPA;CHOLINERGIC FIBERS;CYTOGENETICS;ESTROGEN RECEPTOR;HYDROXYSTEROID DEHYDROGENASE;OVARIAN CORTEX;PRENATAL DIAGNOSIS;VIRAL ENCEPHALITIS","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;ADULT;FEMALE;MIDDLE AGED;MALE;AGED;ITALY;HIV INFECTIONS;;ADOLESCENT;AGED, 80 AND OVER;ANTI-ASTHMATIC AGENTS;ANTI-HIV AGENTS;ANTINEOPLASTIC AGENTS;AQUAPORIN 4;ARTERITIS;ATHEROSCLEROSIS;BRAIN NEOPLASMS;CENTRAL NERVOUS SYSTEM NEOPLASMS;CHILD","20;12;12;11;10;9;9;8;5;4;4;4;4;4;4;4;4;4;4;4","EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN LUNG CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;FERTILITY PRESERVATION IN CANCER PATIENTS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;IMPACT OF HIV INFECTION ON CARDIOVASCULAR HEALTH;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MINERAL METABOLISM IN CHRONIC KIDNEY DISEASE;MOLECULAR BIOLOGY OF STEROIDOGENESIS AND DISORDERS;MOLECULAR MECHANISMS OF AQUAPORINS IN PHYSIOLOGY AND DISEASE;NEURAL MECHANISMS OF MEMORY FORMATION AND SPATIAL NAVIGATION;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;PREVENTION AND MANAGEMENT OF SURGICAL SITE INFECTIONS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HIV INFECTION;ACUTE LYMPHOBLASTIC LEUKEMIA;ACUTE LYMPHOCYTIC LEUKEMIA;HIV;MINIMAL RESIDUAL DISEASE;TREATMENT;ACUTE MYELOID LEUKEMIA;ALLERGIC CONTACT DERMATITIS;AMAUROSIS;ANTIPHOSPHOLIPID SYNDROME;ANTIRETROVIRAL THERAPY;AQUAPORIN 4;AQUAPORINS;ASPARAGINASE;B CELL ABNORMALITIES;BIOMARKER ANALYSIS;BRAIN EDEMA;BRAIN TUMOR;BREAKPOINT;CEBPA","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE LYMPHOBLASTIC;HIGH-DOSE METHOTREXATE;LYMPHOBLASTIC LEUKEMIA;ACETYLTRANSFERASE-CONTAINING NEURONS;ACTIVE ANTIRETROVIRAL;ACUTE RESPIRATORY;AFFECTING AIRWAY;AIEOP-LAM PROTOCOL;AIRWAY REMODELLING;ALLERGIC DISEASE;AML TREATED;ANTI-ANGIOGENIC ACTIVITY;ANTIBODY DETECTION;ANTIPHOSPHOLIPID SYNDROME;ANTIRETROVIRAL THERAPY;ANTIΒ GLYCOPROTEIN;APD CURRENT;APOPTOTIC FACTORS;AQUAPORIN- CONTRIBUTES;AUTOMATED METHOD;B-MODE ULTRASOUND;BALANCED CHROMOSOME;BLYMPHOCYTE STIMULATOR;BOWEL INFARCTION;BRAIN OEDEMA;CALM-AF FUSION;CANCER RESULTS;CAROTID PLAQUES;CEBPA MUTATIONS;CELIAC DISEASE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FIBRINOLYSIS INHIBITOR;TREATED CHILDREN;ACTIVATABLE FIBRINOLYSIS;HIGH-DOSE METHOTREXATE;THROMBIN ACTIVATABLE;TISSUE FACTOR;ΜM CAREBASTINE;CHOLINERGIC NEURONS;COMPLETE REMISSION;HAEMODIALYSIS PATIENTS;IGAD PATIENTS;INHIBITOR ACTIVATION;PRIMARY CNS;ALL-CAUSE MORTALITY;ALLERGIC RHINITIS;AMNIOTIC FLUID;BLOOD SAMPLES;CAM ASSAY;CD PATIENTS;CD T-LYMPHOCYTE;CEREBRAL CORTEX;CHOLINERGIC INNERVATION;CHORIONIC VILLUS;CHROMOSOME REARRANGEMENTS;CYTARABINE ACHIEVED;EC LINES;EGFR MUTATIONS;FETAL BLOOD;FLUID CHORIONIC;GROWTH FACTOR","5;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.04,9.35,15,0,0,0,0,2,0,0,17,0,1,12,0,0,1,2,8,1,1,0,342,343,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,8,619.82,26.19,4,0.36,60,0,0,2,0,3,0,1,5,0,7,4,0,0,0,0,0,0,10,0,1,11,0,0,0,0,0,0,0,0,0,"United States;France;Italy;Japan","6;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","11;7;6;3;1;1;1;1;1","CLINICAL RESEARCH;CANCER;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;BRAIN DISORDERS;LYMPHOMA;PEDIATRIC;STEM CELL RESEARCH;AGING;BIOENGINEERING;BIOTECHNOLOGY;CARDIOVASCULAR;DIGESTIVE DISEASES;GENETICS;HEALTH SERVICES;HEART DISEASE;MENTAL HEALTH;NEUROSCIENCES;PANCREATIC CANCER","11;7;6;5;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR","4;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING","8;2;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NON-HODGKIN'S LYMPHOMA;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;LUNG CANCER;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER;PROSTATE CANCER;SARCOMA","2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2010,24,10.6666666666667,2.58333333333333,0.5,0.166666666666667,0.5,1.08771929824561,1,0.8,1,0.458333333333333,2,14,4,3,3,0.58,0.17,0.12,0.12,31.54,0.697969735240195,NA,0.333333333333333,0.791666666666667,0.396,0.126,0.15,0.126,"ALESSANDRO SGAMBATO;NICOLA BIZZARO;ALMA BONINSEGNA;GIANNICOLA GENOVESE;MARILINA TAMPOIA;ACHILLE CITTADINI;TANIA ATTIÉ‐BITACH;SOUMAYA MOUGOU-ZERELLI;ANTONIO TRABACCA;CLAUDIA FILIPPINI;F. BONIFAZI;NADIA ELKHARTOUFI;BENITO FANELLI;MICHELE SARDARO;CLAUDIO COCO;VINCENZO RUTIGLIANO;DANIELA PASERO;CLAUDIA ALPINI;CLAUDIA CIMAGLIA;ELISABETTA SIRONI","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ROBERTO CORCIULO;BERNARDINO SACCOMANNI;MARIA BURZIO;LUCIA VERNÒ;ALFONSO RAMUNNI;LUIGI ROSSI;NICOLA BIZZARO;MARILINA TAMPOIA;BENITO FANELLI;VINCENZO RUTIGLIANO;EUGENIO LELLA;ANNA BELFIORE;GIUSEPPE PALASCIANO;MARIA PAOLA LANZILLOTTO;ANTONIO OROFINO;MICHELE D’AMATO;STEFANO CAVALLO;VINCENZO OSTILIO PALMIERI;ALESSANDRO SGAMBATO;ALMA BONINSEGNA","1;1;0.25;0.25;0.25;0.25;0.24;0.24;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.18;0.18","ALESSANDRO SGAMBATO;ALMA BONINSEGNA;GIANNICOLA GENOVESE;MARILINA TAMPOIA;ACHILLE CITTADINI;DELIO GAGLIARDI;MICHELE VETRUGNO;B FAVOINO;F. RAFANELLI;ALFREDO DI LEO;ANGELO VACCA;CLAUDIO FURINO;MARIA RENDINA;F PIPINO;GIUSEPPE SOLARINO;R GUARRACINO;EUGENIO LELLA;SILVANA GUERRIERO;NICOLA CARDASCIA;ANNA BELFIORE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ROBERTO CORCIULO;BERNARDINO SACCOMANNI;ALFONSO RAMUNNI;MARILINA TAMPOIA;EUGENIO LELLA;ANNA BELFIORE;GIUSEPPE PALASCIANO;ANTONIO OROFINO;STEFANO CAVALLO;VINCENZO OSTILIO PALMIERI;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;GIANNICOLA GENOVESE;ACHILLE CITTADINI;DELIO GAGLIARDI;MICHELE VETRUGNO;CLAUDIO FURINO;SILVANA GUERRIERO;NICOLA CARDASCIA;PAOLO FERRERI","1;1;0.25;0.24;0.2;0.2;0.2;0.2;0.2;0.2;0.18;0.18;0.18;0.18;0.17;0.17;0.17;0.17;0.17;0.17","ARTHUR S. SLUTSKY;CLAUDIA FILIPPINI;DANIELA PASERO;ELISABETH ZAVALA;ERICA L. MARTIN;FRANÇESCO DELLA CORTE;G. CORNARA;ILARIA MASTROMAURO;LUCIANA MASCIA;M.J. ARGUÍS;MARINA MUNARI;MAURIZIO BERARDINO;NICOLETTA VIVALDI;P MALACARNE;PAOLO DEL GAUDIO;PIER PAOLO DONADIO;SALVATORE GRASSO;SERGIO LIVIGNI;SILVIA BOIFAVA;V. MARCO RANIERI","321;321;321;321;321;321;321;321;321;321;321;321;321;321;321;321;321;321;321;321","SALVATORE GRASSO;S GENCO;RITA FISCHETTO;ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;GIANNICOLA GENOVESE;E LAUTA;SIMONETTA SIMONETTI;ALESSANDRO RETTINO;F. RAFANELLI;FEDERICA ERRICO;MARILINA TAMPOIA;ANDREA CAMERINI;PAOLO LAMBERTI;AGATA CALVARIO;ANNA BOZZI;DANTE GALEONE;DELIO GAGLIARDI;VITTORIO SCIRUICCHIO","321;97;89;67;67;67;67;58;46;44;44;44;31;23;22;12;12;6;6;6","ACHILLE CITTADINI;ALESSANDRO SGAMBATO;ALMA BONINSEGNA;GIANNICOLA GENOVESE;MARILINA TAMPOIA;AGATA CALVARIO;ALESSANDRO RETTINO;ALFONSO RAMUNNI;ANDREA CAMERINI;ANDREA PIAZZOLLA;ANGELO VACCA;ANNA BOZZI;ANTONIO OROFINO;BERNARDINO SACCOMANNI;CLAUDIO MORI;DANTE GALEONE;DELIO GAGLIARDI;DOMENICO LUP;E LAUTA;E NIZAMI","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ART;ECONOMICS;GEOGRAPHY;GEOLOGY","22;8;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;IMMUNOLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;ENDOCRINOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;MOLECULAR BIOLOGY;PEDIATRICS;PHARMACOLOGY;PSYCHIATRY;RADIOLOGY;VIROLOGY;ANATOMY;ARCHAEOLOGY;BIOTECHNOLOGY;CARDIOLOGY;CELL BIOLOGY;DENTISTRY;GENERAL SURGERY;GYNECOLOGY;MACROECONOMICS;MEDICAL PHYSICS;OCEANOGRAPHY;ONCOLOGY;OPHTHALMOLOGY;PHYSICAL THERAPY;TOXICOLOGY","14;10;6;5;5;4;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;ANTIBODY;POPULATION;RANDOMIZED CONTROLLED TRIAL;TRANSPLANTATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANTIGEN;ANXIETY;ORTHOPEDIC SURGERY;RESPIRATORY SYSTEM;SPORTS MEDICINE;AIRWAY;ALLERGY;AMINO ACID;ANESTHETIC;APNEA;BLOOD PRESSURE;BLOOD VISCOSITY;CANCER;CELL;CELL CULTURE;CILIUM;COHORT;COMORBIDITY;COMPARTMENT (SHIP);COMPLICATION;CORNEA;CRANIOTOMY;CREATINE KINASE;DEPRESSION (ECONOMICS);DIABETES MELLITUS;DISCONTINUATION;DISEASE;DISSECTION (MEDICAL);DUCHENNE MUSCULAR DYSTROPHY;ENDOTHELIAL DYSFUNCTION;ENDOTHELIUM;FERMENTATION;FIBRINOGEN;FLOW CYTOMETRY;FOREIGN BODIES;FOREIGN BODY;HEMODIALYSIS;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;IN VIVO;INFLAMMATION;INGESTION;INTERVENTION (COUNSELING);INTOXICATIVE INHALANT;LUNG;MAGNETIC RESONANCE IMAGING;MEDICAL LITERATURE;METABOLISM;MICROCIRCULATION;MIGRAINE;MUSCULAR DYSTROPHY;NAUSEA;OBESITY;OPTICAL COHERENCE TOMOGRAPHY;ORAL AND MAXILLOFACIAL SURGERY;ORAL MEDICINE;PELVIS;PERFUSION;PERITONEAL DIALYSIS;PERITONITIS;PHARMACOGENOMICS;PINNA;PLATELET;POLIOMYELITIS;PROPOFOL;PSYCHOPATHOLOGY;REFUGEE;RENAL CELL CARCINOMA;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;SENSITIZATION;SEVOFLURANE;SHIVERING;SLING (WEAPON);SPINA BIFIDA;STEM CELL;ULTRASOUND;URINARY BLADDER;URINARY INCONTINENCE;VASODILATION;VIRUS;VOMITING","6;4;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","WESTERN BLOT;AUTOANTIBODY;ALLELE;ALLERGEN;ANTERIOR EYE SEGMENT;APHERESIS;AURA;BREAST CANCER;BUTYRATE;CALCINEURIN;CANCER STEM CELL;CELLULAR DIFFERENTIATION;CILIOGENESIS;CLINICAL ENDPOINT;CROSS REACTIONS;CYTOCHROME P450;DYSTROPHIN;EMERGENCE DELIRIUM;ENDOMETRIAL CANCER;EX VIVO;EXON;FOREIGN BODY INGESTION;HUMAN LEUKOCYTE ANTIGEN;IMMUNITY;IMMUNIZATION;IMMUNOFLUORESCENCE;IMMUNOSTAINING;INDIRECT IMMUNOFLUORESCENCE;JOUBERT SYNDROME;LAMININ;LIVER TRANSPLANTATION;LUNG TRANSPLANTATION;METABOLIC SYNDROME;MICROALBUMINURIA;MONOCLONAL ANTIBODY;MULTICENTER STUDY;MUTATION;NECK OF URINARY BLADDER;OSTEOARTHRITIS;PANIC;PANIC DISORDER;PARKINSON'S DISEASE;PHENOTYPE;PLACEBO;POLIOVIRUS;PROINFLAMMATORY CYTOKINE;REMIFENTANIL;RNA;SEROLOGY;SODIUM BUTYRATE;TAURINE;TENSION HEADACHE;TIDAL VOLUME;TITER;ULTRASOUND BIOMICROSCOPY","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABDOMINAL OBESITY;AEROALLERGEN;ANTI-DSDNA ANTIBODIES;ANTI-NUCLEAR ANTIBODY;CILIOPATHIES;CILIOPATHY;CROSS-REACTIVITY;CYP2D6;DYSKINESIA;DYSTROGLYCAN;FIBRILLARIN;FOOD ALLERGENS;IIF;LEVODOPA;MDX MOUSE;MIGRAINE WITH AURA;MISSENSE MUTATION;NEPHRONOPHTHISIS;PROBAND;TAMOXIFEN","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AUTOANTIBODIES;ADULT;AGED;COLONIC NEOPLASMS;LEVODOPA;PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;POLIOMYELITIS;ADOLESCENT;AGED, 80 AND OVER;ANTIGENS, CD;ANTIGENS, NEOPLASM;ANTIPARKINSON AGENTS;ANXIETY DISORDERS;AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM;CARBIDOPA","15;10;10;8;7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3","MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ANESTHESIA AND SEDATION MANAGEMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;CANCER STEM CELLS AND TUMOR METASTASIS;CELLULAR RESPONSE TO OSMOTIC STRESS AND METABOLISM;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;MANAGEMENT OF INGESTED FOREIGN BODIES AND FOOD IMPACTIONS;MECHANISMS OF ESTROGEN RECEPTOR SIGNALING;OPTICAL COHERENCE TOMOGRAPHY IMAGING;ORAL MUCOSAL DISORDERS AND MALIGNANT TRANSFORMATION RISK;ORGAN TRANSPLANTATION AND REJECTION;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;PELVIC FLOOR DISORDERS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LUNG TRANSPLANT;SPORTS MEDICINE;TREATMENT;ABDOMINAL OBESITY;AEROALLERGEN;ALLERGEN EXPOSURE;ANTERIOR EYE SEGMENT;ANTI-DSDNA ANTIBODIES;ARTHROSCOPIC MANAGEMENT;BREAST CANCER;CANCER STEM CELLS;CARBIDOPA;CELL CYCLE;CILIOGENESIS;CILIOPATHIES;CILIOPATHY;CLINICAL ENDPOINT;COMPARTMENT (SHIP);CREATINE KINASE;CROSS-REACTIVITY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTERIOR SEGMENT;ADVANCED PARKINSONS;ALLERGEN COMPONENT;ANESTHESIA RESULTS;ANTEROMEDIAL COMPARTMENT;ANTINEURONAL ANTIBODIES;ARTICLE LOCALIZED;ASIAN REFUGEES;AUTONOMIC CEPHALALGIA;BLADDER NECK;BODY INGESTION;BOY PRELIMINARY;BUTYRATEINDUCED DIFFERENTIATION;CANCER CELLS;CARDIOVASCULAR RISK;CD EXPRESSION;CELL CARCINOMA;CELLS IMPLICATIONS;COHERENCE TOMOGRAPHY;COLON CANCER;COMBINED TREATMENT;COMPONENT RESOLVED;DE NOVO;DEPRESSIVE DISORDERS;DIABETES MELLITUS;DIAGNOSTIC ACCURACY;DM PP;DOMAIN OPTICAL;DUCHENNE MUSCULAR;DUE ATTENTION","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TENSION-TYPE HEADACHE;VENTILATORY STRATEGY;PDN TAURINE;PROTECTIVE STRATEGY;CONVENTIONAL STRATEGY;IMMUNOCAP ISAC;ORGAN DONORS;PROTECTIVE VENTILATORY;ACTIVE PERIOD;APNEA TESTS;AUTONOMIC SIGNS;BLOOD TEST;BODY WEIGHT;BRAIN DEATH;CM HO;CM NA;COMBINATION PDN;CONJUNCTIVAL INJECTION;CONVENTIONAL VENTILATORY;CRD BLOOD;ELIGIBILITY CRITERIA;HO APNEA;LASTING DAYS;LIVER INVOLVEMENT;LUNG PROTECTIVE;MKS FETUSES;MLKG NA;MULTIVARIATE ANALYSIS;NUCLEAR EXPRESSION;OBSESSIVE-COMPULSIVE DISORDER","9;6;5;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",3,0.12,4.02,4,0,1,0,0,7,0,0,4,0,0,1,0,0,0,0,1,0,0,0,53,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,8.4,251.6,8.77,2,0.4,53.4,0,0,2,0,2,0,0,1,0,4,1,0,0,0,0,0,0,4,1,0,5,0,0,0,0,0,0,0,0,0,"United States","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","5;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;RARE DISEASES;AGING;CHILDHOOD LEUKEMIA;PEDIATRIC;PEDIATRIC CANCER;UROLOGIC DISEASES","3;3;2;2;2;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","5;1","LEUKEMIA / LEUKAEMIA;BLADDER CANCER;OVARIAN CANCER","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2011,41,10.4146341463415,1.8780487804878,0.341463414634146,0.365853658536585,0.365853658536585,1.24193548387097,1.07692307692308,1.07142857142857,1.07142857142857,0.341463414634146,0,14,13,5,6,0.34,0.32,0.12,0.15,30.61,0.719648976675255,NA,0.219512195121951,0.780487804878049,0.335,0.211,0.234,0.211,"FABIO CARDINALE;RITA FISCHETTO;ANDREA MARZULLO;DARIO TROISE;FRANCESCO PAPADIA;FLORENZO IANNONE;IOLANDA CHINELLATO;PAOLO MAGGI;FRANCESCO PAOLO ANNECCHINO;ANGELA GERNONE;NICOLA QUARANTA;GIOVANNI LAPADULA;EMILIO JIRILLO;LUISA DE GENNARO;G CARUSO;ORAZIO GABRIELLI;VINCENZO CASSANO;FELICITA JIRILLO;NATALE DANIELE BRUNETTI;LEOPOLDO ZELANTE","3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","EMILIO JIRILLO;FELICITA JIRILLO;THEA MAGRONE;ANGELA GERNONE;VINCENZO PAGLIARULO;ARCANGELO PAGLIARULO;ANDREA MARZULLO;DARIO TROISE;FLORENZO IANNONE;GIOVANNI LAPADULA;FRANCESCO PAPADIA;GIUSEPPE SOLARINO;L. TRALCE;DOMÉNICO RIBATTI;LUISA DE GENNARO;DIEGO GUIDOLIN;NATALE DANIELE BRUNETTI;ANDREA PIAZZOLLA;ENRICO CRIVELLATO;GIULIA DELLEGROTTAGLIE","0.67;0.67;0.67;0.58;0.58;0.58;0.42;0.42;0.37;0.37;0.35;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","FABIO CARDINALE;RITA FISCHETTO;DARIO TROISE;FRANCESCO PAPADIA;IOLANDA CHINELLATO;PAOLO MAGGI;FRANCESCO PAOLO ANNECCHINO;ANGELA GERNONE;NICOLA QUARANTA;GIOVANNI LAPADULA;EMILIO JIRILLO;VINCENZO CASSANO;FELICITA JIRILLO;THEA MAGRONE;C. BONALI;VINCENZO PAGLIARULO;ANTONIO DI COSTE;GIANFRANCO ANTONELLI;ARCANGELO PAGLIARULO;S. BELLO","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","EMILIO JIRILLO;FELICITA JIRILLO;THEA MAGRONE;ANGELA GERNONE;VINCENZO PAGLIARULO;ARCANGELO PAGLIARULO;DARIO TROISE;GIOVANNI LAPADULA;FRANCESCO PAPADIA;GIUSEPPE SOLARINO;L. TRALCE;DOMÉNICO RIBATTI;ANDREA PIAZZOLLA;G. DE GIORGI;PAOLO DOTTI;ALBERTO PETTENÒ;GIANFRANCO ANTONELLI;FABIO CARDINALE;NICOLA QUARANTA;IOLANDA CHINELLATO","0.67;0.67;0.67;0.58;0.58;0.58;0.42;0.37;0.35;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.32;0.28;0.27","ALESSANDRO LEVIS;ALESSANDRO M. GIANNI;ALESSANDRO PULSONI;ALESSANDRO RAMBALDI;ANDREA GALLAMINI;ANDREA ROSSI;ANNA MARINA LIBERATI;DELIA ROTA SCALABRINI;ENRICO MARIA POGLIANI;ERCOLE BRUSAMOLINO;FRANCESCO ZAJA;GIANNI BONADONNA;GIORGINA SPECCHIA;MANUEL GOTTI;PATRIZIA PREGNO;PIER LUIGI ZINZANI;PINUCCIA VALAGUSSA;SIMONETTA VIVIANI;UMBERTO VITOLO;V. BONFANTE","401;401;401;401;401;401;401;401;401;401;401;401;401;401;401;401;401;401;401;401","GIORGINA SPECCHIA;RITA FISCHETTO;FABIO CARDINALE;CESARE DI BARI;IOLANDA CHINELLATO;M. PERULLI;FRANCESCO PAPADIA;GIANFRANCO ANTONELLI;PALMA SORINO;ALESSIO DANILO INCHINGOLO;FRANCESCAPAOLA MAGAZZINO;GENNARO CORMIO;MARCO MARINACCIO;PAOLO MAGGI;SIMONETTA SIMONETTI;DANIELE AMORUSO;ANDREA PIAZZOLLA;G. DE GIORGI;GIUSEPPE SOLARINO;STEFANIA PIETANZA","401;165;131;97;97;97;84;84;66;64;44;44;44;41;41;40;35;35;35;30","FABIO CARDINALE;FRANCESCO PAPADIA;RITA FISCHETTO;ANGELA GERNONE;ANTONIO DI COSTE;ARCANGELO PAGLIARULO;C. BONALI;DARIO TROISE;GIANFRANCO ANTONELLI;NICOLA QUARANTA;VINCENZO PAGLIARULO;ADDOLORATA CORRADO;ALESSIO DANILO INCHINGOLO;ANDREA PIAZZOLLA;ANNALUCIA SERAFINO;CESARE DI BARI;COSIMA LASARACINA;COSIMO D’AMICO;CRESCENZA ABBINANTE;DANIELE AMORUSO","3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;ART;CHEMISTRY;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE","35;15;5;4;2;2;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;ENDOCRINOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PATHOLOGY;PEDIATRICS;ANATOMY;BIOCHEMISTRY;CARDIOLOGY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;OPHTHALMOLOGY;OPTICS;ARTIFICIAL INTELLIGENCE;EMERGENCY MEDICINE;FAMILY MEDICINE;FOOD SCIENCE;GENERAL SURGERY;GYNECOLOGY;LAW;NEUROSCIENCE;PALEONTOLOGY;PHYSICAL THERAPY;PSYCHIATRY;UROLOGY;VIROLOGY","22;13;6;5;5;5;5;5;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","GENE;CANCER;ADVERSE EFFECT;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);PERICARDIAL EFFUSION;POPULATION;REGIMEN;ARTHRITIS;ASTHMA;ATRIAL FIBRILLATION;CALCIFICATION;CHEMOTHERAPY;COMORBIDITY;DIABETES MELLITUS;DISEASE;EMERGENCY DEPARTMENT;FERMENTATION;HEART FAILURE;HOST (BIOLOGY);HUMAN IMMUNODEFICIENCY VIRUS (HIV);OBSERVATIONAL STUDY;PERICARDIUM;RENAL FUNCTION;TERATOMA","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PHENOTYPE;CHROMOSOME;MUTATION;PSORIATIC ARTHRITIS;VIRAL LOAD;ACUTE CORONARY SYNDROME;ACUTE MYOCARDITIS;ALLELE;BREAST CANCER;BRONCHOCONSTRICTION;CALCINOSIS;CD44;CHONDROCYTE;CLINICAL ENDPOINT;CLINICAL IMMUNOLOGY;CYCLOPHOSPHAMIDE;CYSTATIN C;CYTOCHROME P450;DACARBAZINE;DOCETAXEL;DYSBIOSIS;EJECTION FRACTION;ELECTRORETINOGRAPHY;ENDOSCOPIC STENTING;ENZYME REPLACEMENT THERAPY;ERG;ERYTHROMYCIN;EXON;FAST TWITCH MUSCLE;FETUS;FIBRONECTIN;GENE EXPRESSION;GENOTYPE;GERM CELL TUMORS;HEPATITIS B VIRUS;HIP FRACTURE;HODGKIN'S LYMPHOMA;HUMAN GENETICS;INFLIXIMAB;INTEGRIN;LAPAROSCOPIC SURGERY;LEFLUNOMIDE;LYSOSOMAL STORAGE DISEASE;MICROPENIS;MITOCHONDRIAL TOXICITY;MONOARTHRITIS;MUSCLE ATROPHY;MUSCLE FATIGUE;MYCOPLASMA PNEUMONIAE;NECK PAIN;NEPHROTOXICITY;OSTEOARTHRITIS;OVARIAN CANCER;PANCREATIC CANCER;PLACEBO;POLYARTHRITIS;PROSTATE CANCER;QUALITY SCORE;RESPIRATORY TRACT INFECTIONS;SALVAGE THERAPY;SCLERODERMA (FUNGUS);SIMILARITY (GEOMETRY);SOLEUS MUSCLE;SULFATASE;TAURINE;TRABECULECTOMY;VENTRICULAR ASSIST DEVICE;VERTEBRAL COMPRESSION FRACTURE;VINBLASTINE;VIRAL DISEASE;VIRAL MYOCARDITIS;VITRECTOMY;YOLK SAC","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MISSENSE MUTATION;ANTIRETROVIRAL THERAPY;ARTICULAR CARTILAGE;BLEB (MEDICINE);BREAKPOINT;CARDIAC RESYNCHRONIZATION THERAPY;COMPOUND HETEROZYGOSITY;CYP2D6;FRAMESHIFT MUTATION;GENOTYPING;HAPLOINSUFFICIENCY;IMMATURE TERATOMA;IN UTERO;KARYOTYPE;LAMIVUDINE;MACROLIDE ANTIBIOTICS;MICRODELETION SYNDROME;MUCOPOLYSACCHARIDOSIS TYPE II;PROBAND;SANGER SEQUENCING;SCLERODACTYLY;SOX9;TAMOXIFEN;VINCRISTINE;ZIDOVUDINE","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;MIDDLE AGED;ITALY;ATRIAL FIBRILLATION;ADENINE;ADULT;ASTHMA;CHILD;AGED;ANTI-HIV AGENTS;DEOXYCYTIDINE;HEART NEOPLASMS;TERATOMA;ADOLESCENT;AGED, 80 AND OVER;ORGANOPHOSPHONATES;CALCINOSIS","28;23;18;12;12;11;9;8;8;8;8;7;7;7;7;7;6;6;6;5","DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIVERSITY AND FUNCTION OF GUT MICROBIOME;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ASTHMA;ATRIAL FIBRILLATION;BODY ART AND MODIFICATION PRACTICES IN SOCIETY;BROWN ADIPOSE TISSUE FUNCTION AND PHYSIOLOGY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;DIAGNOSIS AND TREATMENT OF SPINAL INFECTIONS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;IMPACT OF HEALTH LITERACY ON HEALTH OUTCOMES;IMPACT OF HEARING LOSS ON COGNITIVE FUNCTION;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;ATRIAL FIBRILLATION;EMTRICITABINE;HOST-MICROBIAL INTERACTIONS;TREATMENT;ABACAVIR;ABVD;ACUTE MYOCARDITIS;AGGRECAN;ANTICOAGULANT THERAPY;ANTIRETROVIRAL THERAPY;ARRHYTHMIA DETECTION;ASSOCIATION (PSYCHOLOGY);ASTHMA;ATAZANAVIR;ATRIAL FLUTTER;AUDITORY PROCESSING;BLEB (MEDICINE);BODY PIERCING;BODY PIERCINGS","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ATRIAL FIBRILLATION;ATTAINING HEALTHY;ELDERLY PATIENTS;EMERGENCY MEDICAL;FERMENTED MILK;HEALTHY AGING;HIV-INFECTED PATIENTS;HOSTMICROBIOTA HOMEOSTASIS;INTRAPERICARDIAL TERATOMA;MEDICAL SERVICE;PSORIATIC ARTHRITIS;ABVD VERSUS;ACCOUNT CONJECTURAL;ACPE PATIENTS;ACUTE CARDIOGENIC;ANATOMIC INJURY;ANTERIOR SEGMET;ANTIRETROVIRAL-EXPERIENCED HIV-INFECTED;ARTHRITIS EFFICACY;ASSIST DEVICE;ASTHMA CONTROL;AT-HOME TELE-CARDIOLOGY;ATTENDING OSTEOPOROSIS;AUTOSOMAL RECESSIVE;BETA INTEGRINS;BLEB FUNCTION;BODY RECOLLAPSE;CALCIUM PHOSPHATE;CANCER MCRPC;CARCINOMA MRCC","2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ARTICULAR CARTILAGE;BETA BETA;INTEGRIN EXPRESSION;KABUKI SYNDROME;MLL GENE;ALPHA ALPHA;ANOMALIESMENTAL RETARDATION;ARTHRITIS PSA;ATRIAL THERAPY;BETA CHAINS;BETA INTEGRINS;CELL CYCLE;CHONDROCYTES STRONGLY;CHRONIC KIDNEY;CONGENITAL ANOMALIESMENTAL;CYCLE ANALYSIS;DEVELOPMENTAL DELAY;FETAL CHONDROCYTES;FILTRATION RATE;FOLLOW-UP PERIOD;GFR ESTIMATED;GLOMERULAR FILTRATION;HF PATIENTS;HIGH-DOSE SALVAGE;HODGKINS LYMPHOMA;INITIAL THERAPY;INITIAL TREATMENT;INTERVERTEBRAL DISC;KIDNEY DISEASE;MOLECULAR INVESTIGATION","3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",4,0.1,10.63,11,1,1,0,0,1,1,0,11.25,0,1,14.5,0,6,0,3,11,4,0.25,0,103.25,103.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,5,489.67,9.84,2,0.33,73,0,0,1,0,2,0,0,3,0,3,3,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"Finland;Germany;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","6;4;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;AGING;CANCER;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;KIDNEY DISEASE;NUTRITION;PEDIATRIC;PREVENTION;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;TRANSPLANTATION","5;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;RENAL AND UROGENITAL","2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","3;1;1","MYELOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",1,5262963,404843.31,6,13,8,1,4,67473.8846153846,0.607642501001812,"APOTEX (CANADA);AZIENDA OSPEDALIERA DI PADOVA;AZIENDA UNIVERSITARIA OSPEDALIERA CONSORZIALE - POLICLINICO BARI;CAIRO UNIVERSITY;CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE;GIANNI BENZI PHARMACOLOGICAL RESEARCH FOUNDATION;LEIDEN UNIVERSITY;MINISTRY OF HEALTH;NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS;OSPEDALE ANTONIO CARDARELLI;OSPEDALE VINCENZO CERVELLO;UNIVERSITY COLLEGE LONDON;UNIVERSITÄTSKLINIKUM ERLANGEN","1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2010-SINGLE-STAGE (CALL FOR PROPOSAL)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","1;1","HEMATOLOGY;ORPHAN DRUG;RARE DISEASES","1;1;1","BLOOD","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2012,38,10.9210526315789,2.52631578947368,0.421052631578947,0.342105263157895,0.447368421052632,1.10344827586207,1.06666666666667,1.08333333333333,1,0.368421052631579,1,17,7,6,3,0.45,0.18,0.16,0.08,40.68,0.974044349511253,4.69856459330144,0.368421052631579,0.68421052631579,0.362,0.155,0.17,0.169,"FILIPPO CADEMARTIRI;MARIO GIORDANO;LORETO GESUALDO;TODD C. VILLINES;ROBERTO VIOLINI;AUGUSTIN DELAGO;KAVITHA M. CHINNAIYAN;TRACY Q. CALLISTER;CARLO SABBÀ;MOUAZ H. AL‐MALLAH;JAMES K. MIN;FRANCESCO PAOLO ANNECCHINO;R BELLANTUONO;STEPHAN ACHENBACH;VICTOR CHENG;BENJAMIN J.W. CHOW;MARTIN HADAMITZKY;GIUSEPPE ANGELELLI;ERICA MAFFEI;R. RODRIGUES-DIEZ","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MARIO GIORDANO;GIUSEPPE CASTELLANO;ROBERTO VIOLINI;UGO VAIRO;CLAUDIA CURCI;EMILIO NUZZOLESE;NUNZIO CIRULLI;FRANCESCO PAOLO ANNECCHINO;LORETO GESUALDO;CHRISTIAN PASCONE;MICHELE PASCONE;MICHELE DI CANDIA;ZIYAD M. HIJAZI;BERNARD DI RENZO;NICOLA SANTORO;ROBERTO RUSSO;GIOVANNI ALESSIO;ANGELA GERNONE;NICOLA CARDASCIA;ROBERTO CORCIULO","1.24;0.61;0.53;0.53;0.5;0.5;0.5;0.39;0.36;0.33;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25","FILIPPO CADEMARTIRI;MARIO GIORDANO;LORETO GESUALDO;ROBERTO VIOLINI;CARLO SABBÀ;FRANCESCO PAOLO ANNECCHINO;R BELLANTUONO;GIUSEPPE ANGELELLI;ERICA MAFFEI;GIUSEPPE CASTELLANO;ARNALDO SCARDAPANE;AMATO ANTONIO STABILE IANORA;UGO VAIRO;PATRIZIA SUPPRESSA;MARCO MOSCHETTA;F. LORUSSO;CHRISTIAN PASCONE;RITA RIZZI;CLAUDIA CURCI;EMILIO NUZZOLESE","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MARIO GIORDANO;GIUSEPPE CASTELLANO;ROBERTO VIOLINI;UGO VAIRO;CLAUDIA CURCI;EMILIO NUZZOLESE;FRANCESCO PAOLO ANNECCHINO;LORETO GESUALDO;CHRISTIAN PASCONE;MICHELE PASCONE;MICHELE DI CANDIA;BERNARD DI RENZO;ROBERTO RUSSO;GIOVANNI ALESSIO;ANGELA GERNONE;NICOLA CARDASCIA;ROBERTO CORCIULO;FRANCO SILVESTRIS;CARLO SBORGIA;MICHELE SCALERA","1.24;0.61;0.53;0.53;0.5;0.5;0.39;0.36;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25","ALESSANDRA IURLO;ALESSANDRO MARIA VANNUCCHI;ALESSIA TIEGHI;ANNA RITA SCORTECHINI;ANTONIO SPADEA;ARIANNA MASCIULLI;CATERINA MUSOLINO;DANIELA CILLONI;DAVIDE RAPEZZI;ELENA MARIA ELLI;ELISA RUMI;EMANUELE ANGELUCCI;FRANCESCA LUNGHI;GIORGINA SPECCHIA;GIOVANNI QUARTA;GIUSEPPE VISANI;GUIDO FINAZZI;MARCO RUGGERI;MARCO SCARANO;MARIA LUIGIA RANDI","719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719;719","GIORGINA SPECCHIA;GIOVANNI MESSINA;ERICA MAFFEI;STEFANO FAVALE;AMATO ANTONIO STABILE IANORA;ARNALDO SCARDAPANE;F. LORUSSO;GIUSEPPE ANGELELLI;MARCO MOSCHETTA;VINCENZO MONTINARO;GIAN PAOLO FADINI;ACHILLE CITTADINI;ALESSANDO RETTINO;ALESSANDRO SGAMBATO;STEFANO SIOLETIC;EDOARDO GUASTAMACCHIA;FRANCESCO RESTA;ANTONELLA VIMERCATI;M. FIUME;MARIA LUISA PEPE","719;190;160;73;62;62;62;62;62;49;47;46;46;46;46;42;42;37;37;37","AMATO ANTONIO STABILE IANORA;ARNALDO SCARDAPANE;ERICA MAFFEI;F. LORUSSO;GIOVANNI MESSINA;GIUSEPPE ANGELELLI;MARCO MOSCHETTA;MARIO GIORDANO;UGO VAIRO;ACHILLE CITTADINI;ALBINA TUMMOLO;ALESSANDO RETTINO;ALESSANDRO SGAMBATO;ANGELO VACCA;ANNALISA FIORELLA;ANTONELLA VIMERCATI;ANTONIETTA FONTANA;B FAVOINO;CARLO SABBÀ;CESARE DI BARI","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;POLITICAL SCIENCE","36;5;5;4;3;2;1;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;PSYCHIATRY;IMMUNOLOGY;RADIOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;GENETICS;PATHOLOGY;PEDIATRICS;CELL BIOLOGY;DERMATOLOGY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;MACROECONOMICS;NURSING;OPTICS;QUANTUM MECHANICS","27;9;9;7;6;6;5;3;3;3;3;3;2;2;2;2;2;2;2;2","ANTIBODY;DISEASE;ADVERSE EFFECT;ANXIETY;CHEMOTHERAPY;CLINICAL TRIAL;CONFIDENCE INTERVAL;DEPRESSION (ECONOMICS);DIALYSIS;GENE;INTERVENTION (COUNSELING);KIDNEY;LEUKEMIA;MAGNETIC RESONANCE IMAGING;NEPHROLOGY;NEUROLOGY;PERCUTANEOUS;PERITONEAL DIALYSIS;POPULATION;PULMONARY ARTERY;REGIMEN;STENT;THYROID;TRANSPLANTATION;VISUAL ANALOGUE SCALE","4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CLINICAL ENDPOINT;HAZARD RATIO;NEURORADIOLOGY;ALEMTUZUMAB;ANTIDEPRESSANT;APHERESIS;AUTOANTIBODY;BECK DEPRESSION INVENTORY;BREAST REDUCTION;C1-INHIBITOR;CALCINEURIN;CARCINOGENESIS;CD34;CELL CYCLE;CHRONIC LYMPHOCYTIC LEUKEMIA;COMPLEMENT SYSTEM;COMPUTED TOMOGRAPHIC;COMPUTED TOMOGRAPHIC ANGIOGRAPHY;CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;CONTRAINDICATION;CORONARY ANGIOGRAPHY;CORONARY ATHEROSCLEROSIS;CYANOBACTERIA;CYCLOPHOSPHAMIDE;DEFIBRILLATION THRESHOLD;DEMENTIA;DOCETAXEL;EUTHYROID;FETUS;FIBROBLAST;FOCAL NODULAR HYPERPLASIA;GENE EXPRESSION;GESTATIONAL AGE;HUMAN LEUKOCYTE ANTIGEN;HYDROTHORAX;IMMUNOADSORPTION;LYMPHOBLASTIC LEUKEMIA;MOVEMENT DISORDERS;MULTICENTER STUDY;MYOFIBROBLAST;NEUTROPENIA;OPEN LABEL;PELVIC ENDOMETRIOSIS;PLASMAPHERESIS;PLEURODESIS;PORTAL HYPERTENSION;POSITIVE PREDICATIVE VALUE;PROGENITOR CELL;PROSTATE;PROSTATE CANCER;PROTEINURIA;PSEUDOANEURYSM;PULMONARY ATRESIA;RETT SYNDROME;RITUXIMAB;STUNNING;TELANGIECTASES;TETRALOGY OF FALLOT;THORACENTESIS;THORACIC AORTA;THROMBOTIC MICROANGIOPATHY;THYROID FUNCTION;THYROID FUNCTION TESTS;THYROIDITIS;TISSUE TRANSGLUTAMINASE;TRANSCRIPTION FACTOR;TRIIODOTHYRONINE;VENTRICULAR ASSIST DEVICE;VIRAL LOAD;WNT SIGNALING PATHWAY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTI-NUCLEAR ANTIBODY;ANTIRETROVIRAL THERAPY;ATYPICAL HEMOLYTIC UREMIC SYNDROME;BETA-CATENIN;CATENIN;CITALOPRAM;CYCLIN D1;ECULIZUMAB;ESCITALOPRAM;FLUDARABINE;LDL APHERESIS;MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR;NODULAR REGENERATIVE HYPERPLASIA;OFATUMUMAB;PAROXETINE;PROMOTER;SERTRALINE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ADULT;MIDDLE AGED;DEPRESSION;ITALY;ADOLESCENT;AGED;CORONARY ARTERY DISEASE;PULMONARY VALVE INSUFFICIENCY;TREATMENT OUTCOME;CHILD;TETRALOGY OF FALLOT;HEART VALVE PROSTHESIS IMPLANTATION;HIV INFECTIONS;STRESS, PSYCHOLOGICAL;ARTERIAL OCCLUSIVE DISEASES;ARTERIOVENOUS MALFORMATIONS","26;18;18;12;12;11;9;8;7;7;7;7;7;6;6;5;5;5;4;4","EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;BODY DYSMORPHIC DISORDER: PSYCHOSOCIAL, CLINICAL, AND TREATMENT ASPECTS;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GLOBAL BURDEN OF GROUP A STREPTOCOCCAL DISEASES;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;HEALTH ECONOMICS AND QUALITY OF LIFE ASSESSMENT;HEREDITARY ANGIOEDEMA: MOLECULAR MECHANISMS AND CLINICAL MANAGEMENT;IMPACT OF MATERNAL MENTAL HEALTH ON OFFSPRING","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL ENDPOINT;DEPRESSION (ECONOMICS);INTRAVASCULAR ULTRASOUND;LEFT VENTRICULAR ASSIST DEVICE;NEURORADIOLOGY;PULMONARY VALVE REPLACEMENT;REGIMEN;VENTRICULAR ASSIST DEVICE;ABNORMALITY;ACUTE KIDNEY INJURY;ANTIRETROVIRAL THERAPY;ANTIRETROVIRAL TREATMENT;AORTIC ANEURYSMS;AREOLA;ARRHYTHMIAS;AUTOANTIBODIES;BETA-CATENIN;BREAST REDUCTION;C1 INHIBITOR DEFICIENCY;C1-INHIBITOR","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","EDWARDS SAPIEN;PERITONEAL DIALYSIS;ABSTRACT CORONARY;ACUTE HYDROTHORAX;ALTERNATIVE APPROACH;ANGIOEDEMA EUROPEAN;ANTE-PARTUM DEPRESSION;AORTIC BRANCH;ARTERY DISEASE;ARTERY PSEUDOANEURYSMS;ASSISTANCE DEVICE;ATYPICAL HEMOLYTIC;AXIAL LENGTH;BABYS CONGENITAL;BIFURCATION STENTING;BIOPROSTHESIS VALVE-IN-VALVE;BIPHENYLS SMOKING;BRANCH ARTERY;BREATHING DISTURBANCES;CANCER MCRPC;CARDIAC ARRHYTHMIAS;CARDIOVASCULAR EVENTS;CARDIOVERTER-DEFIBRILLATOR IMPLANT;CASTRATION-RESISTANT PROSTATE;CATARACT DENSITY;CENTRAL NERVOUS;CHILDHOOD VERNAL;CHILDREN PROCEDURES;CHRONIC KIDNEY;CIRCULATING PROGENITOR","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","OSMOLALITY-INDUCED MCP-;PERITONEAL DIALYSIS;PROGENITOR CELLS;TRANSCRIPTION FACTOR;CALCINEURIN INHIBITORS;CONFIDENCE INTERVAL;DEFIBRILLATION TESTING;HAZARD RATIO;IDIOPATHIC NEPHROTIC;MCP- EXPRESSION;MELANOMA CELLS;NEPHROTIC SYNDROME;POLYCYTHEMIA VERA;RENAL FIBROSIS;SENSITIVITY ANALYSES;TESTING DT;AMBULATORY PERITONEAL;ANTI-HINT-SPECIFIC ANTIBODY;BASELINE PROTEINURIA;CARLO SIMULATIONS;CHEMICAL PLEURODESIS;CIRCULATING CD;CIRCULATING PROGENITOR;CIRCULATORY SUPPORT;CONTINUOUS AMBULATORY;CONTROL SUBJECTS;DM PATIENTS;EVACUATIVE THORACENTESIS;HEMATOCRIT TARGET;ICD IMPLANT","4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2",6,0.16,7.88,8,8.5,3,0,4,6.25,0,1,8,0,1,1,0,1,2.5,8.5,41.5,7.75,0,0,88.25,88.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,3.89,963.28,22.22,5,0.28,57.61,0,0,5,0,4,0,1,8,0,13,5,0,0,0,0,0,0,16,1,1,17,0,0,1,0,0,0,0,0,0,"United States;Belgium;Germany;Italy;Japan","2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3203 DENTISTRY;3209 NEUROSCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","18;9;5;3;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;NEURODEGENERATIVE;RARE DISEASES;HEMATOLOGY;NEUROSCIENCES;PREVENTION;AGING;CARDIOVASCULAR;CHRONIC PAIN;DIGESTIVE DISEASES;HEART DISEASE;KIDNEY DISEASE;LYMPHOMA;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;TRANSPLANTATION;ARTHRITIS","17;10;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1","CANCER;CARDIOVASCULAR;BLOOD;INJURIES AND ACCIDENTS;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL","2;2;1;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.4 POPULATION SCREENING;5.1 PHARMACEUTICALS","11;2;2;1;1;1","NON-HODGKIN'S LYMPHOMA;BREAST CANCER;LIVER CANCER;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2013,49,11.734693877551,1.93877551020408,0.36734693877551,0.122448979591837,0.448979591836735,1.25,1.05882352941176,1,1.04761904761905,0.489795918367347,2,26,9,6,4,0.53,0.18,0.12,0.08,21.39,0.6129602478858,4.81018518518519,0.224489795918367,0.836734693877551,0.418,0.226,0.32,0.24,"BARI BA PIAZZA GIULIO CESARE;FILIPPO CADEMARTIRI;FRANCESCO PAPADIA;NICOLA BIZZARO;ANGELA GERNONE;ERICA MAFFEI;MARILINA TAMPOIA;ARCANGELO PAGLIARULO;G. DI GIUSEPPE;VINCENZA LILLO;GUIDO ANTONELLI;GIUSEPPE DE GIROLAMO;ANGELO GHEZZI;VERA LOIZZI;ELENA BARTOLONI;ANTONIO VITARELLI;CLAUDIA ALPINI;DAMIANO BARONCINI;NICOLA SANTORO;MAURIZIO MARGAGLIONE","5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","PAOLA CRAMAROSSA;ROBERTO RUSSO;FILIPPO CADEMARTIRI;ERICA MAFFEI;TERESA ARCADI;ARCANGELO PAGLIARULO;FRANCESCO PAPADIA;BARI BA PIAZZA GIULIO CESARE;CARMELA MARSEGLIA;ELOISA DIOMEDE;MARCO MARSANO;G. DI GIUSEPPE;GUIDO ANTONELLI;LUISA DE GENNARO;NATALE DANIELE BRUNETTI;GIULIA DELLEGROTTAGLIE;MATTEO DI BIASE;NICOLA BIZZARO;MARILINA TAMPOIA;ANTONIO VITARELLI","1.08;1;0.67;0.57;0.53;0.44;0.43;0.42;0.33;0.33;0.33;0.31;0.31;0.31;0.31;0.31;0.31;0.28;0.28;0.28","FILIPPO CADEMARTIRI;FRANCESCO PAPADIA;ANGELA GERNONE;ERICA MAFFEI;MARILINA TAMPOIA;ARCANGELO PAGLIARULO;VINCENZA LILLO;GUIDO ANTONELLI;VERA LOIZZI;ANTONIO VITARELLI;NICOLA SANTORO;MARIA TROJANO;PAOLA CRAMAROSSA;DAMIANO PAOLICELLI;FABIEN ZOULIM;TERESA ARCADI;TOMMASO DE PALO;PAOLA GIORDANO;LUCIA DIVENUTO;FRANCESCA DI MAURO","4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1","PAOLA CRAMAROSSA;ROBERTO RUSSO;FILIPPO CADEMARTIRI;ERICA MAFFEI;TERESA ARCADI;ARCANGELO PAGLIARULO;FRANCESCO PAPADIA;CARMELA MARSEGLIA;GUIDO ANTONELLI;MARILINA TAMPOIA;ANTONIO VITARELLI;LUCIA DIVENUTO;ANGELA GERNONE;CLAUDIO CASTELLI;L. GIULIANI;V. GOTTI;GIUSEPPE LOCATELLI;DI SCIASCIO;PAOLA GIORDANO;VINCENZA LILLO","1.08;1;0.67;0.57;0.53;0.44;0.43;0.33;0.31;0.28;0.28;0.28;0.27;0.25;0.25;0.25;0.25;0.25;0.23;0.2","ERICA MAFFEI;FILIPPO CADEMARTIRI;ALLISON DUNNING;AUGUSTIN DELAGO;BENJAMIN J.W. CHOW;DANIEL S. BERMAN;FAY Y. LIN;GIL RAFF;GUDRUN FEUCHTNER;HYUK‐JAE CHANG;JAMES K. MIN;JONATHON LEIPSIC;JÖRG HAUSLEITER;KAVITHA M. CHINNAIYAN;LESLEE J. SHAW;MARTIN HADAMITZKY;MATTHEW J. BUDOFF;MILLIE GOMEZ;MOUAZ H. AL‐MALLAH;PHILIPP A. KAUFMANN","260;260;235;235;235;235;235;235;235;235;235;235;235;235;235;235;235;235;235;235","ERICA MAFFEI;NICOLA SANTORO;GIORGINA SPECCHIA;MARILINA TAMPOIA;FRANCESCO PAPADIA;ALESSANDRO DELL’ERBA;STEFANO FAVALE;PAOLA GIORDANO;ANTONIO VITARELLI;ARCANGELO PAGLIARULO;LUCIA DIVENUTO;VINCENZO PAGLIARULO;MASSIMO GRASSI;FLORA PUTEO;MARIA LUISA PEPE;TOMMASO DE PALO;TERESA ARCADI;ADRIANA PASTORE;FRANCESCO MARGARI;MADDALENA TOTO","260;216;119;82;55;52;46;44;41;41;41;41;40;32;32;32;23;18;18;18","FRANCESCO PAPADIA;ERICA MAFFEI;ANGELA GERNONE;ANTONIO VITARELLI;ARCANGELO PAGLIARULO;DAMIANO PAOLICELLI;GUIDO ANTONELLI;LUCIA DIVENUTO;MARIA TROJANO;MARILINA TAMPOIA;NICOLA SANTORO;PAOLA CRAMAROSSA;PAOLA GIORDANO;VINCENZA LILLO;A. CIMMINO;ADRIANA PASTORE;ALBINA TUMMOLO;ALESSANDRO DELL’ERBA;ANNA MARIA MORETTI;CARMEN MARTINO","4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY","47;8;4;3;3;3;3;1;1;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;PEDIATRICS;RADIOLOGY;SURGERY;CARDIOLOGY;IMMUNOLOGY;GENETICS;INTENSIVE CARE MEDICINE;ONCOLOGY;PATHOLOGY;VIROLOGY;PSYCHIATRY;ECONOMIC GROWTH;EMERGENCY MEDICINE;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;PHARMACOLOGY;ASTRONOMY;BIOCHEMISTRY;GYNECOLOGY;MECHANICAL ENGINEERING;MEDICAL EDUCATION;MEDICAL EMERGENCY;NURSING;PHYSICAL THERAPY;UROLOGY","34;11;8;8;8;7;7;6;5;5;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","GENE;CANCER;MYOCARDIAL INFARCTION;ANTIBODY;CHEMOTHERAPY;DISCONTINUATION;VIRUS;ADVERSE EFFECT;AMINO ACID;CLINICAL TRIAL;COHORT;DISEASE;HEALTH CARE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);POPULATION;RHEUMATOID ARTHRITIS;ANGIOGRAPHY;ATRIAL FIBRILLATION;CLINICAL SIGNIFICANCE;CORONARY ARTERY DISEASE;HEPATOCELLULAR CARCINOMA;LEIOMYOMA;LEUKEMIA;MULTIPLE SCLEROSIS;OBSERVATIONAL STUDY;PATHOLOGICAL;PENIS;PERITONEAL DIALYSIS;PRIMARY (ASTRONOMY);PROSPECTIVE COHORT STUDY;PROSTHESIS;RHEUMATOLOGY;STROKE (ENGINE)","6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;AUTOANTIBODY;BREAST CANCER;CHRONIC HEPATITIS;ALLELE;CLINICAL ENDPOINT;CORONARY ANGIOGRAPHY;DOCETAXEL;GENOTYPE;NATALIZUMAB;PHENOTYPE;PHENYLALANINE;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;PROSTATE CANCER;SEROLOGY;TENOFOVIR;AGE OF ONSET;AMBULATORY BLOOD PRESSURE;ANTIDEPRESSANT;ARGININE;BETA THALASSEMIA;BONE CEMENT;BONE MINERAL;CARDIAC FUNCTION CURVE;CHILDHOOD ABSENCE EPILEPSY;COLORECTAL CANCER;COMPLETE REMISSION;COMPUTED TOMOGRAPHIC;COMPUTED TOMOGRAPHIC ANGIOGRAPHY;CORPUS SPONGIOSUM;DIABETIC RETINOPATHY;EJECTION FRACTION;EPSTEIN–BARR VIRUS;ERECTILE FUNCTION;ESSENTIAL THROMBOCYTHEMIA;ETANERCEPT;GABOR FILTER;GENETIC ANALYSIS;GLANS;HEAT WAVE;HEPATITIS B VIRUS;HYDROXYCARBAMIDE;ILEOCECAL VALVE;IMMUNOFLUORESCENCE;IN SILICO;INFLIXIMAB;INTEGRASE;INTERIM ANALYSIS;KIDNEY TRANSPLANTATION;LIPOPROTEIN LIPASE;LIVER FIBROSIS;LOCUS (GENETICS);LYMPHOBLASTIC LEUKEMIA;MAJOR DEPRESSIVE DISORDER;METASTASIS;METHYLATION;MITOXANTRONE;MONOCLONAL ANTIBODY;NEURORADIOLOGY;OCCULT;PEDIGREE CHART;PENILE PROSTHESIS;PERCUTANEOUS CORONARY INTERVENTION;PEYRONIE'S DISEASE;RANDOMIZATION;RHEUMATOID FACTOR;ROBUSTNESS (EVOLUTION);SOFT TISSUE SARCOMA;SORAFENIB;TEMOZOLOMIDE;THRESHOLDING;TITER;TOLERABILITY;URETHROPLASTY;VENOUS THROMBOEMBOLISM;VENOUS THROMBOSIS;VIMENTIN;VIRAL LOAD;VITRECTOMY;WARFARIN","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANDROGEN DEPRIVATION THERAPY;COMPOUND HETEROZYGOSITY;HYPERPHENYLALANINEMIA;LAMIVUDINE;PHENYLALANINE HYDROXYLASE;PROBAND;TAXANE;ALLELIC HETEROGENEITY;ANAGRELIDE;ANDROGEN RECEPTOR;ANTIBODY TITER;ANTIRETROVIRAL THERAPY;CHORDEE;DIABETIC MACULAR EDEMA;ESCITALOPRAM;GENE MUTATION;GENETIC HETEROGENEITY;GENOTYPE-PHENOTYPE DISTINCTION;HBSAG;HEMICOLECTOMY;MACE;MAMMOGRAPHY;METHYLTRANSFERASE;MISSENSE MUTATION;MONOCLONAL;OSTEOPENIA;PENILE CURVATURE;TRABECTEDIN;UREA CYCLE","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADOLESCENT;ADULT;BRAIN;CORONARY ARTERY DISEASE;RETROSPECTIVE STUDIES;ARTHRITIS, RHEUMATOID;AUTOANTIBODIES;BRAIN NEOPLASMS;CARCINOMA, SMALL CELL;CORONARY ANGIOGRAPHY;HYPERLIPOPROTEINEMIA TYPE I;ITALY;PAROTID NEOPLASMS;PHENYLKETONURIAS;AGED","25;24;18;15;8;7;7;7;6;6;5;5;5;5;5;5;5;5;5;4","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;HEPATITIS B INFECTION AND TREATMENT;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;RHEUMATOID ARTHRITIS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLINICAL AND PATHOLOGICAL ASPECTS OF URACHAL CARCINOMA;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;ATRIAL FIBRILLATION;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;ECONOMY OF KNOWLEDGE AND INNOVATION;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION","3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;DISCONTINUATION;DISEASE-MODIFYING ANTIRHEUMATIC DRUGS;CABAZITAXEL;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT;CLINICAL SIGNIFICANCE;COMPOUND HETEROZYGOSITY;COMPUTED TOMOGRAPHY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;ENTECAVIR;HYPERPHENYLALANINEMIA;NATALIZUMAB;PACLITAXEL;PERITONEAL DIALYSIS;PHENYLALANINE HYDROXYLASE;PHENYLKETONURIA;PRIMARY (ASTRONOMY);PROBAND;STROKE (ENGINE)","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CHRONIC HEPATITIS;CITRULLINATED PEPTIDE;RHEUMATOID ARTHRITIS;ANTI-CYCLIC CITRULLINATED;BLOOD PRESSURE;MUTATION ANALYSIS;NATALIZUMAB DISCONTINUATION;PERITONEAL DIALYSIS;PRIMARY VAGINAL;PROSPECTIVE STUDY;TY-STOP STUDY;VAGINAL LEIOMYOMA;ABSENCE EPILEPSY;ACCESS PROGRAMME;ACTIVE SMOKERS;ACUTE LYMPHOBLASTIC;ACUTE MYELOID;ADDITIONAL PEG-INTERFERON;ADHERENCE TELEBPMET;ADULT COLO-COLONIC;AIEOP AML;AML MULTICENTER;AMSCX INFLATABLE;ANMCO STATEMENT;ANRS HB;ANTI MUTATED;ANTI-BRAIN AUTOANTIBODIES;ANTI-VIRAL CITRULLINATED;ANTIBODY TITER;ARCA DATABASE","3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD PRESSURE;PAST SMOKERS;AMS CX;CURRENT SMOKERS;HR CI;NP EOAE;PENILE PROSTHESIS;PRESSURE CONTROL;TELE-CARDIOLOGY SUPPORT;ACUTE COLONIC;ARTERY DISEASE;CARDIOVASCULAR RISK;CLINICAL RISK;COLONIC INTUSSUSCEPTION;COMPUTED TOMOGRAPHY;CORONARY ARTERY;EXPERT PANEL;GENDER MEDICINE;HEART DISEASE;HEAT WAVES;ICER VALUES;INFLATABLE PENILE;METABOLIC SYNDROME;MYOCARDIAL INFARCTION;OPTIMIZED SCORE;PANAYIOTOPOULOSS CRITERIA;PRE-HOSPITAL ECG;PROXIMAL SEGMENTS;RAL FAILURE;ABDOMINAL PAIN","8;7;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2",4,0.08,7,3,0,0,0,1,0,0,2,3,0,0,2.5,0,0,1,1,2.5,0,0,0,63.5,63.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,5.55,1417.27,14.86,1,0.09,40.18,0,1,2,0,1,0,0,7,0,4,7,0,0,0,0,0,0,10,1,0,11,0,0,0,0,0,0,0,0,0,"Italy;United States","2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3204 IMMUNOLOGY;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","10;5;3;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;PATIENT SAFETY;AGING;CARDIOVASCULAR;ASSISTIVE TECHNOLOGY;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BRAIN DISORDERS;DEPRESSION;HEALTH SERVICES;HEART DISEASE;LUNG;LYMPHOMA;MENTAL HEALTH;NEURODEGENERATIVE;NEUROSCIENCES","9;5;5;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;CARDIOVASCULAR;NEUROLOGICAL","2;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY","3;1;1","LEUKEMIA / LEUKAEMIA;ENDOMETRIAL CANCER;NON-HODGKIN'S LYMPHOMA","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",1,5476875,497897.73,5,11,7,1,4,167053.43006993,0.29331932890865,"ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;AZIENDA UNIVERSITARIA OSPEDALIERA CONSORZIALE - POLICLINICO BARI;CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE;DOMPÉ (ITALY);ERASMUS MC;FEDERACIÓN ESPAÑOLA DE PADRES DE NIÑOS CON CÁNCER;ISTITUTO GIANNINA GASLINI;PHARM (ITALY);TARTU UNIVERSITY HOSPITAL;UNIVERSITY COLLEGE LONDON;UNIVERSITÄTSKLINIKUM ERLANGEN","1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2013-INNOVATION-1 (CALL FOR PROPOSAL)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","1;1;1","CHRONIC PAIN;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PAIN RESEARCH;PATIENT SAFETY","1;1;1;1;1","GENERIC HEALTH RELEVANCE","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1",NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","4;2","PREVENTION;SEXUAL AND GENDER MINORITIES (SGM/LGBT*)","1;1",NA,NA,"2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2014,58,11.7931034482759,1.96551724137931,0.379310344827586,0.241379310344828,0.413793103448276,1.37349397590361,1.22222222222222,1.16666666666667,1.2,0.448275862068966,6,23,16,7,6,0.4,0.28,0.12,0.1,25.45,0.673382651195828,4.81304347826087,0.241379310344828,0.827586206896552,0.532,0.259,0.294,0.272,"FILIPPO CADEMARTIRI;T PIROLO;ANGELA GERNONE;FABIO CARDINALE;LUISA SANTANGELO;ERICA MAFFEI;E MASSARI;M. LOMBARDI;VITTORIO SCIRUICCHIO;MARIO GIORDANO;UGO VAIRO;MARINA DE TOMMASO;MARIA ROSARIA TAGLIENTE;NICOLA BIZZARO;GIOVANNI FRANCO;A. MONACO;GAIA RIZZO;ANGELA NUZZI;ROBERTO RUSSO;CLAUDIA SERPINO","4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","ANGELA GERNONE;ROBERTO RUSSO;DAMIANA MAUROGIOVANNI;GAF ANGELINI;LUISA SANTANGELO;MARIO GIORDANO;FILIPPO CADEMARTIRI;T PIROLO;E MASSARI;M. LOMBARDI;UGO VAIRO;MARIA ROSARIA TAGLIENTE;ERICA MAFFEI;NENAD BUKVIĆ;JOHN W. ELLING;TERESA ARCADI;VITTORIO SCIRUICCHIO;MARINA DE TOMMASO;GAIA RIZZO;LUCA CIPRIAN","2.04;2;1;1;0.75;0.75;0.63;0.57;0.57;0.57;0.57;0.57;0.53;0.5;0.5;0.5;0.46;0.42;0.33;0.33","FILIPPO CADEMARTIRI;T PIROLO;ANGELA GERNONE;FABIO CARDINALE;LUISA SANTANGELO;ERICA MAFFEI;E MASSARI;M. LOMBARDI;VITTORIO SCIRUICCHIO;MARIO GIORDANO;UGO VAIRO;MARINA DE TOMMASO;MARIA ROSARIA TAGLIENTE;A. MONACO;ROBERTO RUSSO;LUCA CIPRIAN;ORLANDO TODARELLO;SALVATORE ANDREA MASTROLIA;RUGGIERO FRANCAVILLA;MARILINA TAMPOIA","4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","ANGELA GERNONE;ROBERTO RUSSO;DAMIANA MAUROGIOVANNI;GAF ANGELINI;LUISA SANTANGELO;MARIO GIORDANO;FILIPPO CADEMARTIRI;T PIROLO;E MASSARI;M. LOMBARDI;UGO VAIRO;MARIA ROSARIA TAGLIENTE;ERICA MAFFEI;NENAD BUKVIĆ;VITTORIO SCIRUICCHIO;MARINA DE TOMMASO;LUCA CIPRIAN;ANDREA PIAZZOLLA;ALESSANDRO CORAN;THEA MAGRONE","2.04;2;1;1;0.75;0.75;0.63;0.57;0.57;0.57;0.57;0.57;0.53;0.5;0.46;0.42;0.33;0.33;0.33;0.33","ALESSANDRO BUSCA;ANNA CANDONI;ANNAMARIA NOSARI;ANTONIO SPADEA;CHIARA CATTANEO;DOMENICO PASTORE;ENRICO MARIA TRECARICHI;LIVIO PAGANO;M. TUMBARELLO;MORENA CAIRA;NICOLA VIANELLI;ROSA FANCI;GIOACCHINO SCARANO;ANGIOLA ROCINO;AUGUSTO B. FEDERICI;FLORA PEYVANDI;FRANCESCO RODEGHIERO;GIANCARLO CASTAMAN;M. G. MAZZUCCONI;MARIO SCHIAVONI","199;199;199;199;199;199;199;199;199;199;199;199;180;131;131;131;131;131;131;131","DOMENICO PASTORE;MARIO SCHIAVONI;P. DIAFERIA;FRANCESCA DI SERIO;RITA FISCHETTO;FABIO CARDINALE;ELEONORA VECCHIO;GIANFRANCO ANTONELLI;MARIANNA DELUSSI;MARINA DE TOMMASO;PAOLO LIVREA;VITTORIO SCIRUICCHIO;ANDREA PIAZZOLLA;SALVATORE GRASSO;ERICA MAFFEI;FILIPPO CADEMARTIRI;SALVATORE ANDREA MASTROLIA;VITO LEONARDO MINIELLO;LUISA SANTANGELO;MARIO GIORDANO","199;131;128;113;92;88;70;70;70;70;70;70;67;60;48;48;45;40;38;38","FILIPPO CADEMARTIRI;ANGELA GERNONE;E MASSARI;ERICA MAFFEI;M. LOMBARDI;MARIA ROSARIA TAGLIENTE;T PIROLO;UGO VAIRO;FABIO CARDINALE;LUISA SANTANGELO;MARIO GIORDANO;A. MONACO;ALESSANDRO CORAN;ANDREA PIAZZOLLA;GIANFRANCO ANTONELLI;MARILINA TAMPOIA;SALVATORE ANDREA MASTROLIA;VITTORIO SCIRUICCHIO;ALBERTO GAETA;ANNA DIANA","4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;GEOLOGY;MATHEMATICS;PHYSICS;POLITICAL SCIENCE;BUSINESS;ECONOMICS;ENGINEERING;GEOGRAPHY;HISTORY;PHILOSOPHY","54;14;6;3;2;2;2;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GASTROENTEROLOGY;PEDIATRICS;CARDIOLOGY;GENETICS;ENDOCRINOLOGY;IMMUNOLOGY;ONCOLOGY;BIOCHEMISTRY;PSYCHIATRY;RADIOLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;NEUROSCIENCE;PALEONTOLOGY;PHYSICAL THERAPY;ANATOMY;ARCHAEOLOGY;EMERGENCY MEDICINE;LAW;MEDICAL EMERGENCY;MICROBIOLOGY;PHYSICAL MEDICINE AND REHABILITATION;UROLOGY","43;12;11;10;9;8;7;6;6;6;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","DISEASE;GENE;MYOCARDIAL INFARCTION;ANGIOPLASTY;CALCIUM;CHEMOTHERAPY;CLINICAL TRIAL;MAGNETIC RESONANCE IMAGING;POPULATION;RENAL CELL CARCINOMA;RETROSPECTIVE COHORT STUDY;TRANSPLANTATION;ANTIBODY;ARTERY;ASYMPTOMATIC;BALLOON;BODY MASS INDEX;CALCIFICATION;CANCER;COGNITION;COHORT;CORONARY ARTERY DISEASE;DEFORMITY;DIALYSIS;DYSPHAGIA;FAMILY HISTORY;HEART FAILURE;INSULIN;KIDNEY;LESION;LUNG;LYMPHOMA;NEPHROTIC SYNDROME;NEUROSURGERY;PERITONEAL DIALYSIS;PLATELET;PNEUMONIA;PREGNANCY;PRIMARY BILIARY CIRRHOSIS;RADIOGRAPHY;RECEPTOR;RESPIRATORY DISTRESS;RESPIRATORY SYSTEM;STENOSIS;SWALLOWING;VENTRICLE;VITAMIN D AND NEUROLOGY","12;7;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUNTINGTON'S DISEASE;PARATHYROID HORMONE;PERCUTANEOUS CORONARY INTERVENTION;WESTERN BLOT;AUTOANTIBODY;AUTOIMMUNE DISEASE;CARDIAC MAGNETIC RESONANCE IMAGING;CLINICAL ENDPOINT;FETUS;MUTATION;NOCICEPTION;PHENOTYPE;RECOMBINANT DNA;SUNITINIB;ULCERATIVE COLITIS;ACINETOBACTER;AGE OF ONSET;ALEMTUZUMAB;AMIKACIN;AMNIOTIC FLUID EMBOLISM;ANGINA;ANTIBIOTIC RESISTANCE;ARDS;ARTHRODESIS;ASPIRATION PNEUMONIA;BACK PAIN;BASAL (MEDICINE);BLOATING;BOTULINUM NEUROTOXIN;BRONCHOALVEOLAR LAVAGE;CALCITRIOL RECEPTOR;CALCIUM OXALATE;CARDIAC MAGNETIC RESONANCE;CARDIOMYOPATHY;CD20;CHOREA;CHRONIC HEPATITIS;CHRONIC LYMPHOCYTIC LEUKEMIA;CHRONIC MIGRAINE;CIPROFLOXACIN;CLUSTER HEADACHE;CONVENTIONAL PCI;CROHN'S DISEASE;CYCLOPHOSPHAMIDE;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;DEGENERATIVE DISC DISEASE;DEMENTIA;DENTINOGENESIS IMPERFECTA;DOPAMINE RECEPTOR D2;DOPAMINERGIC;ECHOGENICITY;EJECTION FRACTION;ELECTROCARDIOGRAPHY IN MYOCARDIAL INFARCTION;EPIGENETICS;EVENT-RELATED POTENTIAL;FOOD ALLERGY;GEMCITABINE;GERM CELL;GERM CELL TUMORS;GESTATIONAL AGE;GLIADIN;HEART RATE;HEAT WAVE;HODGKIN LYMPHOMA;HUMAN GENETICS;HYPERCALCAEMIA;HYPERCALCIURIA;INFLAMMATORY BOWEL DISEASE;INFLIXIMAB;INSULIN RESISTANCE;INTERIM ANALYSIS;INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS;JOINT EFFUSION;KIDNEY TRANSPLANTATION;LIPID PROFILE;LIPOBLASTOMA;LIVER TRANSPLANTATION;LONG QT SYNDROME;LORDOSIS;LOW BACK PAIN;LUMBAR LORDOSIS;LUNG FUNCTION;MOOD DISORDERS;MULTICENTER STUDY;MYCOPLASMA PNEUMONIAE;NEPHROCALCINOSIS;OCCLUDIN;OSTEITIS;OSTEOMALACIA;OVARIAN CANCER;OVERWEIGHT;PARKINSON'S DISEASE;PATHOGNOMONIC;PECTUS CARINATUM;PEDIGREE CHART;PREECLAMPSIA;PREFRONTAL CORTEX;PROGRESSION-FREE SURVIVAL;PROGRESSIVE DISEASE;PROLACTIN;PROTEINURIA;PSEUDOMONAS AERUGINOSA;RESPIRATORY EPITHELIUM;RESTENOSIS;RITUXIMAB;SENSORY GATING;SORAFENIB;SPINAL DEFORMITY;ST ELEVATION;STAPHYLOCOCCUS AUREUS;TACROLIMUS;TELEMEDICINE;TESTICULAR CANCER;THROMBIN;TIDAL VOLUME;TOPOTECAN;TROPONIN;UNSTABLE ANGINA;VITAMIN D DEFICIENCY;VON WILLEBRAND FACTOR;WAIST;WORKING MEMORY","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMNIOTIC FLUID;ANTI-NUCLEAR ANTIBODY;BILIARY CIRRHOSIS;IIF;MISSENSE MUTATION;PAZOPANIB;SECONDARY HYPERPARATHYROIDISM;ACINETOBACTER BAUMANNII;BENDAMUSTINE;BROMOCRIPTINE;CENTRAL SENSITIZATION;CHILDHOOD OBESITY;CHLORAMBUCIL;COMPOUND HETEROZYGOSITY;CYP24A1;FETAL DISTRESS;FLUDARABINE;FRAMESHIFT MUTATION;FUSION PROTEIN;GENETIC HETEROGENEITY;HAPLOINSUFFICIENCY;HYPERALGESIA;IGHV@;IMIPENEM;LAMIVUDINE;LEFT VENTRICULAR NONCOMPACTION;MACE;MEROPENEM;N100;OSWESTRY DISABILITY INDEX;PIPERACILLIN;PLACENTA;PRIMARY ANGIOPLASTY;RESPIRATORY RATE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SMALL FOR GESTATIONAL AGE;TESTICULAR GERM CELL TUMOR;UNDERWEIGHT;VANCOMYCIN;VON WILLEBRAND DISEASE;WHEAT ALLERGY","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;;FEMALE;ADULT;MIDDLE AGED;AGED;ITALY;ADOLESCENT;CARCINOMA, RENAL CELL;CHILD;KIDNEY NEOPLASMS;HEART VENTRICLES;LUMBAR VERTEBRAE;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;AGED, 80 AND OVER;CHILD, PRESCHOOL;COLITIS, ULCERATIVE;CROHN DISEASE","33;26;24;24;15;15;12;9;7;7;7;7;6;6;6;6;5;5;5;5","MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;RENAL CELL CARCINOMA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;HEPATITIS B INFECTION AND TREATMENT;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;ADVANCES IN PHOTOACOUSTIC IMAGING AND TOMOGRAPHY;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ASTHMA;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;EPIDEMIOLOGY AND TREATMENT OF MICROSCOPIC COLITIS;FORENSIC TOXICOLOGY METHODS AND ANALYSIS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;TREATMENT;AUTOANTIBODIES;BILIARY CIRRHOSIS;CLINICAL ENDPOINT;IIF;MITOCHONDRIAL DYSFUNCTION;NONSENSE MUTATION;PAZOPANIB;PERITONEAL DIALYSIS;PRIMARY BILIARY CIRRHOSIS;RENAL CELL CARCINOMA;SPINAL DEFORMITY;VITAMIN D;ACINETOBACTER BAUMANNII;ACUTE RESPIRATORY DISTRESS SYNDROME;ADOLESCENT IDIOPATHIC SCOLIOSIS;ALLODYNIA;AMBULANCE SERVICE;AMIKACIN","3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CELL CARCINOMA;HUNTINGTONS DISEASE;METASTATIC RENAL;RENAL CELL;ARTERY DISEASE;AUTOANTIBODY PROFILING;BILIARY CIRRHOSIS;CORONARY ARTERY;EMERGENCY MEDICAL;LINE-BLOT ASSAY;MEDICAL SERVICE;MONOCENTRIC EXPERIENCE;MULTIPLEXED LINE-BLOT;MYOCARDIAL INFARCTION;OVARIAN CANCER;PERITONEAL DIALYSIS;PRIMARY BILIARY;RISK FACTORS;ST-ELEVATION MYOCARDIAL;ACUTE RESPIRATORY;ACUTE ST-ELEVATION;ADULT SCOLIOSIS;AGE-RELATED DEFORMITY;AIRWAY EPITHELIUM;ALGAIECKLONIA BICYCLISIITRIBULUS;AMNIOTIC FLUID;AMNIOTIC MESENCHYMAL;AMPLATZER VASCULAR;ANALYSIS PATHOGENIC;ANATOMIC ISOLATED","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CORONARY ARTERY;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMN;ARTERY DISEASE;IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMN FONTSTYLEITALICMMLMNMMLMATH;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;CAD CORONARY;MONTHS CI;ADVERSE CARDIOVASCULAR;CARDIOVASCULAR EVENTS;GRAM-NEGATIVE BACTERIA;MAJOR ADVERSE;MYOCARDIAL INFARCTION;PATIENTS TREATED;PERICRANIAL TENDERNESS;PRIMARY HEADACHE;RISK FACTORS;CONFIDENCE INTERVAL;MACE MAJOR;MP STRAINS;ABDOMINAL PAIN;ALLODYNIA PERICRANIAL;ANGINA TYPICALITY;CELIAC DISEASE;CENTRAL SENSITIZATION;DIFFERENCE MMLMATH;DISEASE EXTENT;DISEASE RISK;FACTORS ANGINA;FIRST-EPISODE PSYCHOSIS;GENETIC DISORDERS","13;13;12;12;12;11;6;5;5;5;5;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3",9,0.16,4,2,1.75,0,1,1,1,1,1,2,0,0,2,0,1,0,2,2,1,0,0,111,111,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,6,564.6,12.35,4,0.4,54.1,0,0,2,0,1,0,0,7,0,3,7,0,0,0,0,0,0,8,1,1,10,0,0,0,0,0,0,0,0,0,"United States;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3215 REPRODUCTIVE MEDICINE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;44 HUMAN SOCIETY;4403 DEMOGRAPHY","8;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;RARE DISEASES;HEMATOLOGY;PREVENTION;INFECTIOUS DISEASES;KIDNEY DISEASE;VACCINE RELATED;AGING;ANTIMICROBIAL RESISTANCE;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;BIOENGINEERING;CARDIOVASCULAR;CONTRACEPTION/REPRODUCTION;EMERGING INFECTIOUS DISEASES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","9;5;4;4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;BLOOD;CARDIOVASCULAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;2;1;1;1","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;3.4 VACCINES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;MYELOMA;OVARIAN CANCER;PROSTATE CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2015,65,14.6307692307692,1.86153846153846,0.2,0.138461538461538,0.292307692307692,1.3010752688172,1,0.9,1.05555555555556,0.523076923076923,0,33,11,10,7,0.51,0.17,0.15,0.11,15.86,0.425605076440872,4.59926470588235,0.353846153846154,0.953846153846154,0.381,0.344,0.207,0.315,"SALVATORE ANDREA MASTROLIA;VINCENZO MONTESARCHIO;A. BENEDETTI;DOMENICO SANSONNO;ANTONIO GASBARRINI;A.F. ATTILI;SALVATORE D’ANGELO;TERESA ZOLFINO;ANGELA BUONADONNA;C. ERMINERO;SANDRO BARNI;ERICA VILLA;PETROS GIOVANIS;UMBERTO CILLO;MAJDI IMTERAT;MARIO PIRISI;OFFER EREZ;FRANCESCO PAPADIA;G. PINOTTI;MARIA BOVA","6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;3","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;FLORENZO IANNONE;GIOVANNI LAPADULA;ANDREA RUBBOLI;FRANCESCO PAPADIA;MAJDI IMTERAT;MARTINO PEPE;VALERIA PARADIES;OFFER EREZ;MAURIZIO MARGAGLIONE;LUCA CIPRIAN;ROSSELLA TROCCOLI;MARIA FONTE PETRUZZELLI;LILIA BARDOSCIA ANGELA SARDARO;ROBERTO STRAMARE;BEATRICE DETTI MAURIZIO PORTALURI;GIOVANNI LUCA BOTTO;MARGHERITA GIANNINI;ANTONIO FURLAN","0.83;0.66;0.51;0.5;0.5;0.43;0.41;0.38;0.38;0.37;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","SALVATORE ANDREA MASTROLIA;DOMENICO SANSONNO;FRANCESCO PAPADIA;FLORENZO IANNONE;MARTINO PEPE;VINCENZO MONTINARO;VALERIA PARADIES;PAOLO COLONNA;FEDERICA ORTOLANI;FABRIZIO RESTA;FILIPPO CADEMARTIRI;ELVIRA PICCINNO;SIMONA VALLARELLI;RITA FISCHETTO;GIUSEPPE LOVERRO;STEFANO FAVALE;ERICA MAFFEI;MARCELLA VENDEMIALE;ALESSANDRO CAFARO;RUGGIERO FRANCAVILLA","6;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;FLORENZO IANNONE;FRANCESCO PAPADIA;MARTINO PEPE;VALERIA PARADIES;LUCA CIPRIAN;ROSSELLA TROCCOLI;MARIA FONTE PETRUZZELLI;LILIA BARDOSCIA ANGELA SARDARO;BEATRICE DETTI MAURIZIO PORTALURI;MARIO GIORDANO;VITTORIO SCIRUICCHIO;FABRIZIO RESTA;STEFANO FAVALE;ALESSANDRO CAFARO;MAURIZIO DELVECCHIO;FILIPPO MASI;GIUSEPPE LOVERRO;DOMENICO SANSONNO","0.83;0.66;0.51;0.43;0.38;0.38;0.33;0.33;0.33;0.33;0.33;0.31;0.27;0.25;0.25;0.25;0.25;0.25;0.23;0.22","FRANCESCO PAPADIA;ANDREA ZANICHELLI;CATERINA DE CAROLIS;ENRÌCO CILLARI;FRANCESCO ARCOLEO;ISABELLA DEL CORSO;MARCO CICARDI;MARIA BOVA;MARIA PINA BARCA;MASSIMO TRIGGIANI;MAURO CANCIAN;OLIVIERO ROSSI;PAOLA MINALE;PAOLINA QUATTROCCHI;PAOLO BORRELLI;ROBERTO PERRICONE;SERGIO NERI;STEFANO PUCCI;TIZIANA DE PASQUALE;VINCENZO MONTINARO","131;124;124;124;124;124;124;124;124;124;124;124;124;124;124;124;124;124;124;124","FRANCESCO PAPADIA;VINCENZO MONTINARO;SABINO PESCE;FEDERICA ORTOLANI;MARCELLA VENDEMIALE;RUGGIERO FRANCAVILLA;FERNANDA CRISTOFORI;MARICA OLIVA;RITA FISCHETTO;MARILINA TAMPOIA;ANTONIO GIACOMO RIZZO;GIROLAMO MATTIOLI;BALDO MARTIRE;DONATO F. ALTOMARE;E TRAVAGLIO;MARIA DI LENA;NORMA DEPALMA;RICCARDO MEMEO;V. FAVIA;SALVATORE ANDREA MASTROLIA","131;124;101;96;96;71;70;70;66;59;57;57;48;44;44;44;44;44;43;36","SALVATORE ANDREA MASTROLIA;DOMENICO SANSONNO;FRANCESCO PAPADIA;VINCENZO MONTINARO;FEDERICA ORTOLANI;FILIPPO CADEMARTIRI;FLORENZO IANNONE;GIUSEPPE LOVERRO;MARCELLA VENDEMIALE;MARILINA TAMPOIA;RITA FISCHETTO;RUGGIERO FRANCAVILLA;ALBINA TUMMOLO;ANDREA PIAZZOLLA;ANGELA LA NEVE;ANNA MARIA CARINGELLA;ANTONELLA RUSSO‐ROSSI;ANTONIO GIACOMO RIZZO;BALDO MARTIRE;BEATRICE DETTI MAURIZIO PORTALURI","6;5;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;ENGINEERING;BUSINESS;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;PHILOSOPHY","63;17;7;4;4;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PEDIATRICS;ENVIRONMENTAL HEALTH;IMMUNOLOGY;CARDIOLOGY;GASTROENTEROLOGY;PATHOLOGY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;OBSTETRICS;PSYCHIATRY;DERMATOLOGY;GYNECOLOGY;OPTICS;PHARMACOLOGY;ANATOMY;BIOCHEMISTRY;ONCOLOGY;RADIOLOGY","52;16;14;12;10;10;9;9;7;6;6;6;6;4;4;4;4;3;3;3;3","POPULATION;COHORT;PREGNANCY;ANTIBODY;DISEASE;GENE;MYOCARDIAL INFARCTION;ADVERSE EFFECT;HEPATOCELLULAR CARCINOMA;INCIDENCE (GEOMETRY);RETROSPECTIVE COHORT STUDY;ANGIOEDEMA;CANCER;CHEMOTHERAPY;DIABETES MELLITUS;HEART FAILURE;HEREDITARY ANGIOEDEMA;INTERVENTION (COUNSELING);OBESITY;ANTIGEN;COGNITION;CONCOMITANT;CORONARY ARTERY DISEASE;ENZYME;EPIDEMIOLOGY;ETIOLOGY;FAMILY HISTORY;HEPATITIS B;HEPATITIS C;KIDNEY;LIVER DISEASE;PERCUTANEOUS;PLATELET;PROSPECTIVE COHORT STUDY;RECEPTOR;TRANSPLANTATION","9;8;7;6;6;6;6;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FETUS;SORAFENIB;AUTOANTIBODY;GESTATION;PERCUTANEOUS CORONARY INTERVENTION;C1-INHIBITOR;ACUTE CORONARY SYNDROME;ALLELE;COLORECTAL CANCER;GESTATIONAL AGE;HUMAN GENETICS;MUTATION;OVERWEIGHT;SEROLOGY;SUBGROUP ANALYSIS;TOLERABILITY;AGE OF ONSET;ALEMTUZUMAB;ALKALINE PHOSPHATASE;ALLERGEN;ANGINA;ANTIEPILEPTIC DRUG;ATOPY;ATTENTIONAL CONTROL;AURA;AUTOIMMUNE DISEASE;AUTOIMMUNITY;BACTEREMIA;BEVACIZUMAB;BONE MORPHOGENETIC PROTEIN 2;BRAIN NATRIURETIC PEPTIDE;CAESAREAN SECTION;CANDIDATE GENE;CARDIOMYOPATHY;CELL ADHESION;CESAREAN DELIVERY;CHRONIC LYMPHOCYTIC LEUKEMIA;CHRONIC MIGRAINE;CLOPIDOGREL;COMPLEMENT SYSTEM;CORONARY ANGIOGRAPHY;CORONARY ARTERIES;CYCLOPHOSPHAMIDE;CYSTIC KIDNEY DISEASE;DEMENTIA;DILATED CARDIOMYOPATHY;EJECTION FRACTION;ENDOCRINE SYSTEM;ENDOTHELIN RECEPTOR;EPITHELIOID HEMANGIOENDOTHELIOMA;EPITOPE;FUNCTIONAL CONSTIPATION;GENE DUPLICATION;GENOME;GENOTYPE;HEMIPARESIS;HEPATITIS C VIRUS;IMATINIB;IMMUNOFLUORESCENCE;INDIRECT IMMUNOFLUORESCENCE;INFERIOR FRONTAL GYRUS;INJURY PREVENTION;INTRAVENOUS IMMUNOGLOBULINS;ISLET;KIDNEY TRANSPLANTATION;LEVETIRACETAM;LYMPHANGIOMATOSIS;MAINTENANCE THERAPY;MAJOR DEPRESSIVE DISORDER;MATERNAL MORBIDITY;METABOLIC SYNDROME;METASTASIS;MIXED CONNECTIVE TISSUE DISEASE;NATRIURETIC PEPTIDE;NEUTROPENIA;NOCICEPTION;OCTREOTIDE;OSTEOBLAST;PAIN MEDICINE;PARKINSON'S DISEASE;PATCH TEST;PERIPHERALLY INSERTED CENTRAL CATHETER;PHARMACODYNAMICS;PHENOTYPE;PHENYLALANINE;POLYCYSTIC KIDNEY;POLYCYSTIC KIDNEY DISEASE;PORTAL HYPERTENSION;PREECLAMPSIA;PSORIATIC ARTHRITIS;REVASCULARIZATION;RNA;SCLERODERMA (FUNGUS);SEROCONVERSION;SERUM FERRITIN;SOFT TISSUE SARCOMA;SOMATOSTATIN RECEPTOR;SPLENECTOMY;SUICIDE PREVENTION;TELEMEDICINE;TEMOZOLOMIDE;THROMBOCYTOPENIC PURPURA;TISSUE TRANSGLUTAMINASE;TITER;TRACHEOESOPHAGEAL FISTULA;TYPE 1 DIABETES;UNIVARIATE ANALYSIS;UNSTABLE ANGINA;VAGINAL DELIVERY;VASCULAR TUMORS;VON WILLEBRAND FACTOR","7;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PLACENTA;AMNIOTIC FLUID;ATYPICAL HEMOLYTIC UREMIC SYNDROME;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE;BETA CELL;BOSENTAN;CHILDHOOD OBESITY;COGNITIVE DECLINE;CONGENITAL HEPATIC FIBROSIS;COPY-NUMBER VARIATION;CYSTIC HYGROMA;DASATINIB;FLUDARABINE;FUNCTIONAL MITRAL REGURGITATION;GENOTYPE-PHENOTYPE DISTINCTION;GENOTYPING;HAPLOINSUFFICIENCY;HOUSE DUST MITE;HYPERALGESIA;IIF;INTRAUTERINE GROWTH RESTRICTION;KRAS;LEVODOPA;LYMPHATIC VESSEL;MACE;MISSENSE MUTATION;N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE;NEURAL CELL ADHESION MOLECULE;NILOTINIB;NO REFLOW PHENOMENON;OFATUMUMAB;OLIGOHYDRAMNIOS;P2Y12;PHENYLALANINE HYDROXYLASE;PRASUGREL;PRENATAL DIAGNOSIS;PRETERM LABOR;PRETERM LABOUR;PULSATILITY INDEX;RIBAVIRIN;RIBONUCLEOPROTEIN;THIENOPYRIDINE;TICAGRELOR;TIMI;TRABECTEDIN;UTERINE ARTERY;VON WILLEBRAND DISEASE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;ADULT;ITALY;MIDDLE AGED;ADOLESCENT;CHILD;AGED;PROSPECTIVE STUDIES;CHILD, PRESCHOOL;YOUNG ADULT;AUTOANTIBODIES;TREATMENT OUTCOME;ANTICOAGULANTS;FACTOR XA INHIBITORS;INFANT, NEWBORN;RETROSPECTIVE STUDIES;RISK FACTORS","36;29;28;26;19;15;15;12;12;11;10;8;8;7;7;6;6;6;6;6","HEREDITARY ANGIOEDEMA: MOLECULAR MECHANISMS AND CLINICAL MANAGEMENT;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;MATERNAL MORBIDITY ASSOCIATED WITH PREGNANCY AND CHILDBIRTH;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BREATH ANALYSIS TECHNOLOGY;BULLYING BEHAVIORS AND PSYCHOLOGICAL IMPACT;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;DEVELOPMENT AND EVALUATION OF CLINICAL GUIDELINES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;ECONOMICS OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","SORAFENIB;C1 INHIBITOR DEFICIENCY;C1-INHIBITOR;HEREDITARY ANGIOEDEMA;PRENATAL DIAGNOSIS;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CENTRAL VENOUS CATHETERIZATION;CONCOMITANT;DIABETES;ETIOLOGY;FETAL DNA ANALYSIS;HEPATITIS B;HEPATITIS C;HEPATOCELLULAR CARCINOMA;HUMAN GENETICS;LIVER DISEASE;MATERNAL PLASMA DNA SEQUENCING;PERIPHERALLY INSERTED CENTRAL CATHETERS;PLACENTA PREVIA","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FINAL RESULTS;GIDEON STUDY;HEPATOCELLULAR CARCINOMA;HEREDITARY ANGIOEDEMA;ITALIAN COHORT;ITALIAN EXPERIENCE;NATIONWIDE SURVEY;THERAPEUTIC DECISIONS;ANGIOEDEMA DUE;COHORT STUDY;CORONARY CT;CT ANGIOGRAPHY;ELDERLY PATIENTS;GIDEON GLOBAL;GLOBAL INVESTIGATIONAL;INHIBITOR DEFICIENCY;ITALIAN SURVEY;MATERNAL TOTAL;PATIENT ETIOLOGY;PATIENTS FINAL;SORAFENIB STUDY;ABNORMAL IMPLANTATION;ACUTE CORONARY;ADULT-ONSET SYSTEMIC;ADVANCED PARKINSON;AF-TIMI STUDY;AIEOP ASSOCIAZIONE;AINO ITALIAN;ANGIOGRAPHY EVALUATION;ANTI-DFS ANTIBODIES","4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MEDIAN AGE;MATERNAL SERUM;COGNITIVE SYMPTOMS;SERUM T-CFDNA;ATOPY PATCH;ELDERLY PTS;PATCH TEST;T-CFDNA CONCENTRATIONS;DIABETES ONSET;ISOLATED OLIGOHYDRAMNIOS;NGML NA;RO- RO-;SKIN PRICK;ADVERSE EVENTS;ATTENTIONAL CONTROL;C-INH-HAE TYPE;CLINICAL PRACTICE;PATIENTS DIAGNOSED;PRETERM PROM;PRICK TEST;ACTIVE MANAGEMENT;CLINICAL TRIALS;GIDEON STUDY;NATIONWIDE SURVEY;NORMAL PREGNANCY;SEVERELY OBESE;ANTI-TTG TITER;C-INH-HAE PATIENTS;CHL GENE;CHRONIC PAIN","14;11;9;9;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4",7,0.11,2.12,2.5,1,0,0,0,2,0,1,2.5,0,0,1.75,0,0,1,0,1,1,0,0,68.5,68.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,5.44,4009.56,10.34,5,0.56,198,1,0,0,0,2,0,0,6,0,4,5,0,0,0,0,0,0,8,1,0,9,0,0,0,0,0,0,0,0,0,"United States;Germany;Italy;Japan","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;3;3;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;BREAST CANCER;DIGESTIVE DISEASES;PATIENT SAFETY;RARE DISEASES;AGING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;COMPARATIVE EFFECTIVENESS RESEARCH;COMPLEMENTARY AND INTEGRATIVE HEALTH;CROHN'S DISEASE;ESTROGEN;HEART DISEASE;INFECTIOUS DISEASES;INFLAMMATORY BOWEL DISEASE;LIVER DISEASE;ORPHAN DRUG","9;5;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;CARDIOVASCULAR;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","3;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING","7;1;1;1","BREAST CANCER;LEUKEMIA / LEUKAEMIA","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3203 DENTISTRY;48 LAW AND LEGAL STUDIES;4806 PRIVATE LAW AND CIVIL OBLIGATIONS;49 MATHEMATICAL SCIENCES","4;2;1;1;1","NUTRITION;OBESITY;CLINICAL RESEARCH","2;2;1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2016,83,16.5542168674699,2.10843373493976,0.204819277108434,0.168674698795181,0.265060240963855,1.31578947368421,1,0.933333333333333,1.04761904761905,0.530120481927711,0,36,23,10,8,0.43,0.28,0.12,0.1,26.66,0.820818344715519,4.46229508196721,0.313253012048193,0.903614457831325,0.438,0.316,0.291,0.329,"PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;MAURIZIO DELVECCHIO;LORETO GESUALDO;MARIA FELICIA FAIENZA;GIORGINA SPECCHIA;MARIO GIORDANO;ELEONORA VECCHIO;ANNA MONTEMURNO;ALESSANDRA IURLO;ALESSIA TIEGHI;ROSSELLA CACCIOLA;LUCIANO CAVALLO;ANGELA RAGO;FRANCESCO DI RAIMONDO;MARIANNA DELUSSI;NICOLA VIANELLI;ALESSANDRO M. VANNUCCHI;MARIA LUIGIA RANDI;KATIA RICCI","5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;CHIARA GUASTADISEGNO;GIOVANNI MARIA FERRI;FABRIZIO AMMIRATI;ELEONORA VECCHIO;ANNA MONTEMURNO;MARIANNA DELUSSI;KATIA RICCI;MARINA DE TOMMASO;MAURIZIO DELVECCHIO;LORETO GESUALDO;VITO LEONARDO MINIELLO;MARIA FELICIA FAIENZA;MARIO GIORDANO;POLINA SCHWARZMAN;GIUSEPPE LOVERRO;ADI Y. WEINTRAUB;RELI HERSHKOVITZ;YAEL BAUMFELD","1.02;0.65;0.61;0.61;0.5;0.48;0.48;0.48;0.48;0.48;0.41;0.41;0.32;0.31;0.29;0.27;0.27;0.27;0.27;0.25","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;MAURIZIO DELVECCHIO;LORETO GESUALDO;MARIA FELICIA FAIENZA;GIORGINA SPECCHIA;MARIO GIORDANO;ELEONORA VECCHIO;ANNA MONTEMURNO;LUCIANO CAVALLO;MARIANNA DELUSSI;KATIA RICCI;MARINA DE TOMMASO;FRANCESCO PAPADIA;DANIELE ANDREINI;CHIARA GUASTADISEGNO;ANTONIO L. BARTORELLI;MARCO GUGLIELMO;ELVIRA PICCINNO;LAURA FUSINI","5;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;CHIARA GUASTADISEGNO;GIOVANNI MARIA FERRI;ELEONORA VECCHIO;ANNA MONTEMURNO;MARIANNA DELUSSI;KATIA RICCI;MARINA DE TOMMASO;MAURIZIO DELVECCHIO;LORETO GESUALDO;VITO LEONARDO MINIELLO;MARIA FELICIA FAIENZA;MARIO GIORDANO;GIUSEPPE LOVERRO;GIOVANNI MISCIAGNA;NICOLA CARDASCIA;FRANCO SILVESTRIS;LUCIANO CAVALLO;FRANCESCO PAPADIA","1.02;0.65;0.61;0.61;0.48;0.48;0.48;0.48;0.48;0.41;0.41;0.32;0.31;0.29;0.27;0.25;0.25;0.25;0.23;0.21","CARMINE SELLERI;ANDREAS VÖLP;ANGELO MICHELE CARELLA;ANTONIO M. RISITANO;ARNON NAGLER;CARLOS SOLANO;CHRISTELLE FERRÁ;CHRISTINE WOLSCHKE;DOMENICO PASTORE;DOMENICO RUSSO;ELISABETTA TERRUZZI;FABIO BENEDETTI;FRANCESCA BONIFAZI;FRANCESCA PATRIARCA;FRANCIS AYUK;FRANCO NARNI;GIUSEPPE BANDINI;GIUSEPPE MESSINA;GIUSEPPE MILONE;JAIME PÉREZ DE OTEYZA","505;478;478;478;478;478;478;478;478;478;478;478;478;478;478;478;478;478;478;478","DOMENICO PASTORE;MARIO GIORDANO;SALVATORE ANDREA MASTROLIA;GIUSEPPE LOVERRO;FRANCESCO PAPADIA;GIORGINA SPECCHIA;DI NARO EDOARDO;LEONARDO RESTA;MARIA ARCANGELA CASCARANO;MATTEO LOVERRO;MIRIAM DELLINO;ANDREA IGOREN GUARICCI;FABIO CARDINALE;ANNA MONTEMURNO;ELEONORA VECCHIO;KATIA RICCI;MARIANNA DELUSSI;MARINA DE TOMMASO;LUISA SANTANGELO;ANDREA BAGGIANO","478;144;134;113;104;102;87;87;87;87;87;86;84;77;77;77;77;77;70;68","PAOLO COLONNA;SALVATORE ANDREA MASTROLIA;GIORGINA SPECCHIA;MARIO GIORDANO;FRANCESCO PAPADIA;ANNA MONTEMURNO;ELEONORA VECCHIO;KATIA RICCI;MARIANNA DELUSSI;MARINA DE TOMMASO;LORETO GESUALDO;ANDREA IGOREN GUARICCI;CHIARA GUASTADISEGNO;ELVIRA PICCINNO;FABIO CARDINALE;GIANCARLO VECCHIO;GIOVANNI MARIA FERRI;GIUSEPPE LOVERRO;LUISA SANTANGELO;MARIA FELICIA FAIENZA","5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;PSYCHOLOGY;ENGINEERING;PHILOSOPHY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;POLITICAL SCIENCE;SOCIOLOGY","76;29;8;7;5;3;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;SURGERY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;GASTROENTEROLOGY;PEDIATRICS;CARDIOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;PATHOLOGY;OPTICS;PHARMACOLOGY;CANCER RESEARCH;OBSTETRICS;ONCOLOGY;FAMILY MEDICINE;GYNECOLOGY;PSYCHIATRY","60;18;15;15;13;12;12;12;10;10;9;9;7;7;6;5;5;4;4;4","GENE;POPULATION;RETROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;HEART FAILURE;INCIDENCE (GEOMETRY);PREGNANCY;ANTIBODY;CANCER;CHEMOTHERAPY;DIABETES MELLITUS;TRANSPLANTATION;DISEASE;EPIDEMIOLOGY;KIDNEY;ASTHMA;BONE MARROW;CLINICAL TRIAL;COHORT;IN VITRO;IN VIVO;MYOCARDIAL INFARCTION;PROSPECTIVE COHORT STUDY;PULMONARY EMBOLISM;THROMBOSIS","13;11;8;7;7;7;6;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3","MUTATION;EJECTION FRACTION;GENOTYPE;HAZARD RATIO;KIDNEY TRANSPLANTATION;TYPE 1 DIABETES;AUTOANTIBODY;BREAST CANCER;CLINICAL ENDPOINT;DEFERIPRONE;EXON;GESTATION;GESTATIONAL AGE;HOME HEMODIALYSIS;MYELOFIBROSIS;NEUTROPENIA;OSTEOBLAST;PERCUTANEOUS CORONARY INTERVENTION;POLYCYSTIC KIDNEY DISEASE;RITUXIMAB;VENOUS THROMBOSIS;WARFARIN;WNT SIGNALING PATHWAY","4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;ANTI-NUCLEAR ANTIBODY;FRAMESHIFT MUTATION;MACE;MYELOPROLIFERATIVE NEOPLASM;ABSOLUTE NEUTROPHIL COUNT;ACTIVE TUBERCULOSIS;ANAEROBIC GLYCOLYSIS;ANTHRACYCLINE;APGAR SCORE;AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE;BENDAMUSTINE;BIFIDOBACTERIUM;BK VIRUS;CERVICAL INSUFFICIENCY;CYP24A1;DIABETES MANAGEMENT;DKK1;DORSOLATERAL PREFRONTAL CORTEX;EPIRETINAL MEMBRANE;EPIRUBICIN;EUKARYOTE;EXOME SEQUENCING;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENE SIGNATURE;HAEMOLYTIC-URAEMIC SYNDROME;HBSAG;HERPESVIRIDAE;IGHV@;IIF;IMPAIRED GLUCOSE TOLERANCE;INSULIN PUMP;IPILIMUMAB;KARYOTYPE;LAMIVUDINE;LYMPHOVASCULAR INVASION;MICRODELETION SYNDROME;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NORMAL WEIGHT;OSTEOPROTEGERIN;PRIMARY MOTOR CORTEX;PULSED-FIELD GEL ELECTROPHORESIS;RANKL;RIVAROXABAN;RUNX2;SANGER SEQUENCING;SCLEROSTIN;SENTINEL LYMPH NODE;SENTINEL NODE;SHIGA TOXIN;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL FOR GESTATIONAL AGE;SPECKLE TRACKING ECHOCARDIOGRAPHY;STROKE VOLUME;TOBRAMYCIN;TRASTUZUMAB;TRIFLUOPERAZINE;TWIN PREGNANCY;VEILLONELLA;VITAMIN K ANTAGONIST","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ITALY;ADULT;;MIDDLE AGED;CHILD;AGED;RETROSPECTIVE STUDIES;YOUNG ADULT;ADOLESCENT;CHILD, PRESCHOOL;RISK FACTORS;BIOMARKERS;PULMONARY EMBOLISM;ANTICOAGULANTS;AGED, 80 AND OVER;IMMUNOSUPPRESSIVE AGENTS;INFANT, NEWBORN","61;50;45;25;23;22;22;18;15;13;13;12;12;12;10;10;9;8;8;8","MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;ATRIAL FIBRILLATION;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN TRANSPLANTATION PROCEDURES AND OUTCOMES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ASTHMA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CARDIOTOXICITY OF CANCER TREATMENTS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLINICAL IMPLICATIONS OF UTERINE ANOMALIES AND TREATMENT;COMPUTATIONAL METHODS IN DRUG DISCOVERY;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CONTINUOUS GLUCOSE MONITORING;DIABETES;TYPE 1 DIABETES;ANTIBODY ENGINEERING;ATRIAL FIBRILLATION;AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT;CLINICAL PRACTICE;DEFERIPRONE;DISCONTINUATION;ECHOCARDIOGRAPHY;ETIOLOGY;EXPOSURE ASSESSMENT;HEMODIALYSIS;HOME HEMODIALYSIS;LEFT VENTRICULAR FUNCTION;MACE;MIGRAINE PREVENTION","5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ITALIAN PATIENTS;RETROSPECTIVE ANALYSIS;ANMCO POSITION;ATRIAL FIBRILLATION;CLINICAL PRACTICE;COHORT STUDY;EUROPEAN EXPERIENCE;GROIN PAIN;GROWTH HORMONE;HEART FAILURE;HORMONE DEFICIENCY;ITALIAN STUDY;KIDNEY DISEASE;MULTICENTER ITALIAN;MYELOPROLIFERATIVE NEOPLASMS;NXSTAGE SYSTEM;ORAL ANTICOAGULANTS;PEDIATRIC TUBERCULOSIS;POPULATION BASED;POSITION PAPER;PULMONARY THROMBOEMBOLISM;REAL LIFE;SOUTHERN ITALY;THROMBOCYTHEMIC PATIENTS;TYPE DIABETES;ACID ENHANCES;ACL RECONSTRUCTION;ACUTE MYELOID;ADDON THERAPY;ADJUVANT TEMOZOLOMIDE","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","SEVERE ASTHMA;LEFT VENTRICLE;CANRENONE MG;CARGLUMIC ACID;CONFIDENCE INTERVAL;MG KG;TUNNEL WIDENING;ACTIVE TB;GROIN PAIN;INTER-LABORATORY VARIABILITY;MILD RENAL;NON-SEVERE PERSISTENT;PERSISTENT ASTHMA;PLASMA AMMONIA;PUBLIC HEALTH;RENAL IMPAIRMENT;BLOOD PRESSURE;BONE CELL;BONE TUNNEL;CONSENSUS CONFERENCE;GADOLINIUM ENHANCEMENT;GUT MICROBIOTA;INTERVAL CI;LAPAROSCOPIC ADRENALECTOMY;LATE GADOLINIUM;LATENCY PERIOD;MULTICENTER STUDY;PATIENTS RECEIVING;PRETERM DELIVERY;ACL RECONSTRUCTION","9;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3",12,0.14,3.62,7,7.5,2,0,8,0,0,1,8,0,1,6.25,1,0,4.75,1,3.5,3,0,0,67,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,5.25,319.5,3.12,2,0.5,93.25,0,0,0,0,3,0,1,0,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Belgium;Czechia;Estonia;Germany;Japan;Netherlands;Spain;Sweden;United Kingdom","1;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES","4;4;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;PEDIATRIC;RARE DISEASES;CHILDHOOD LEUKEMIA;LUNG;LUNG CANCER;ORPHAN DRUG;PATIENT SAFETY;PEDIATRIC CANCER;PREVENTION","4;4;3;2;2;2;1;1;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS","4","LEUKEMIA / LEUKAEMIA;LUNG CANCER","2;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1",1,15085937,419053.81,8,36,11,1,163,219435.155764375,0.378243858468713,"ABBVIE (UNITED STATES);ANTAROS MEDICAL (SWEDEN);ASTELLAS PHARMA (NETHERLANDS);AZIENDA UNIVERSITARIA OSPEDALIERA CONSORZIALE - POLICLINICO BARI;BAYER (GERMANY);BOEHRINGER INGELHEIM (GERMANY);CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX;ELI LILLY (UNITED KINGDOM);INNSBRUCK MEDICAL UNIVERSITY;JUVENILE DIABETES RESEARCH FOUNDATION;LEEDS TEACHING HOSPITALS NHS TRUST;LIPOTYPE (GERMANY);LUND UNIVERSITY;MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH;MEDICAL UNIVERSITY OF VIENNA;NOVO NORDISK (DENMARK);SANOFI (GERMANY);SWISS INSTITUTE OF BIOINFORMATICS;UNIVERSITY HOSPITAL REGENSBURG;UNIVERSITY MEDICAL CENTER FREIBURG","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-JTI-IMI2-2015-05-TWO-STAGE (CALL FOR PROPOSAL);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","DIABETES;KIDNEY DISEASE","1;1","METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1","3 GOOD HEALTH AND WELL BEING","1",2,"PUBLIC LIBRARY OF SCIENCE","2","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","2;2;1;1;1","DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;FOODBORNE ILLNESS;HEPATITIS;INFECTIOUS DISEASES;LIVER DISEASE","1;1;1;1;1;1","INFECTION","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,"PUBLIC HEALTH","1",NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2017,87,15.6206896551724,1.93103448275862,0.28735632183908,0.229885057471264,0.32183908045977,1.27272727272727,1.13636363636364,1.05263157894737,1.12,0.448275862068966,2,43,18,9,13,0.49,0.21,0.1,0.15,21.49,0.729236068257587,4.15697674418605,0.333333333333333,0.931034482758621,0.442,0.286,0.329,0.285,"GIORGINA SPECCHIA;FRANCESCO PAPADIA;LORETO GESUALDO;G. MIRAGLIOTTA;FLAVIA INDRIO;SUSANNA ESPOSITO;S. CALANDRA;GIUSEPPE GIUDICE;GIOACCHINO ANGARANO;LIVIA PISCIOTTA;GRAZIA ADDATI;RAFFAELE DEL PRETE;SALVATORE ANDREA MASTROLIA;LUIGI RONGA;STEFANO FAVALE;MAURIZIO DELVECCHIO;FABRIZIO PANE;LAURA LANCELLA;LORENZO IUGHETTI;MARIO GIORDANO","7;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","C LAMESTA;L MILELLA;LORETO GESUALDO;G. MIRAGLIOTTA;GRAZIA ADDATI;RAFFAELE DEL PRETE;LUIGI RONGA;GIOVANNI PISCOPO;LUIGI ROSSI;LUIGI MORRONE;ROBERTO CORCIULO;SIMONE CORCIULO;SALVATORE ANDREA MASTROLIA;ANNALISA SARACINO;ANNAMARIA DACHILLE;FLAVIA INDRIO;GIUSEPPE GIUDICE;RAFFAELLA MAGRONE;FRANCESCO PAPADIA;SYED SHAKIL UR REHMAN","1;1;0.92;0.71;0.51;0.51;0.51;0.5;0.5;0.5;0.5;0.5;0.47;0.45;0.44;0.43;0.42;0.37;0.37;0.33","GIORGINA SPECCHIA;FRANCESCO PAPADIA;LORETO GESUALDO;G. MIRAGLIOTTA;FLAVIA INDRIO;GIUSEPPE GIUDICE;GIOACCHINO ANGARANO;GRAZIA ADDATI;RAFFAELE DEL PRETE;SALVATORE ANDREA MASTROLIA;LUIGI RONGA;STEFANO FAVALE;MAURIZIO DELVECCHIO;MARIO GIORDANO;ELEONORA VECCHIO;PAOLO COLONNA;ANNAMARIA DACHILLE;MARIA RENDINA;RITA FISCHETTO;FRANCO SILVESTRIS","7;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","C LAMESTA;L MILELLA;LORETO GESUALDO;G. MIRAGLIOTTA;GRAZIA ADDATI;RAFFAELE DEL PRETE;LUIGI RONGA;GIOVANNI PISCOPO;ROBERTO CORCIULO;SIMONE CORCIULO;SALVATORE ANDREA MASTROLIA;ANNAMARIA DACHILLE;FLAVIA INDRIO;GIUSEPPE GIUDICE;FRANCESCO PAPADIA;GIORGINA SPECCHIA;ELEONORA VECCHIO;MARINA DE TOMMASO;STEFANO FAVALE;GIOACCHINO ANGARANO","1;1;0.92;0.71;0.51;0.51;0.51;0.5;0.5;0.5;0.47;0.44;0.43;0.42;0.37;0.33;0.31;0.31;0.28;0.27","FLAVIA INDRIO;HANIA SZAJEWSKA;ALFREDO GUARINO;BRUNO POT;IVA HOJSAK;JOHANNES B. VAN GOUDOEVER;RAANAN SHAMIR;ROBERTO BERNI CANANI;ROK OREL;SANJA KOLAČEK;YVAN VANDENPLAS;ZVI WEIZMAN;SABRINA GIGLIO;LORENZO IUGHETTI;GIULIO MALTONI;MAURIZIO DELVECCHIO;PAOLA GIORDANO;LORETO GESUALDO;MARIO GIORDANO;LUISA MURER","280;220;191;191;191;191;191;191;191;191;191;191;186;144;122;122;119;115;110;104","FLAVIA INDRIO;ZVI WEIZMAN;LORETO GESUALDO;MARIO GIORDANO;RITA FISCHETTO;MAURIZIO DELVECCHIO;SALVATORE ANDREA MASTROLIA;GIORGINA SPECCHIA;ELEONORA VECCHIO;MARINA DE TOMMASO;PAOLA GIORDANO;GIANCARLO VECCHIO;FRANCESCO PAPADIA;O MONTAGNA;MARIO ROMANDINI;MICHELE ROSSINI;MARIA FICARELLA;RUGGIERO FRANCAVILLA;MARIANNA DELUSSI;SABINO PESCE","280;191;115;110;101;90;87;82;80;80;76;75;74;69;62;58;47;47;42;40","GIORGINA SPECCHIA;FRANCESCO PAPADIA;FLAVIA INDRIO;G. MIRAGLIOTTA;LORETO GESUALDO;MARIO GIORDANO;LUIGI RONGA;RAFFAELE DEL PRETE;ELEONORA VECCHIO;FRANCO SILVESTRIS;GIANCARLO VECCHIO;MARIA RENDINA;MARINA DE TOMMASO;PAOLO COLONNA;RITA FISCHETTO;RUGGIERO FRANCAVILLA;SABINO PESCE;SALVATORE ANDREA MASTROLIA;STEFANO FAVALE;A. BASSO","7;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;CHEMISTRY;SOCIOLOGY;ECONOMICS;MATHEMATICS;PHILOSOPHY;COMPUTER SCIENCE;ENGINEERING;GEOGRAPHY;MATERIALS SCIENCE;POLITICAL SCIENCE","83;27;8;6;4;4;3;3;3;2;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;SURGERY;GENETICS;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PATHOLOGY;CARDIOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;ONCOLOGY;RADIOLOGY;OPTICS;VIROLOGY;ANESTHESIA;FAMILY MEDICINE;GYNECOLOGY;MICROBIOLOGY;OBSTETRICS","63;19;19;17;15;14;12;12;12;10;8;7;7;7;6;6;5;5;5;4;4","DISEASE;POPULATION;GENE;COHORT;CANCER;ADVERSE EFFECT;DIABETES MELLITUS;INCIDENCE (GEOMETRY);KIDNEY DISEASE;CHEMOTHERAPY;HEART FAILURE;PREGNANCY;RETROSPECTIVE COHORT STUDY;TRANSPLANTATION;ANTIBODY;VIRUS;ALTERNATIVE MEDICINE;ANTIBIOTICS;BLOOD PRESSURE;CHOLESTEROL;COMPLICATION;CONFIDENCE INTERVAL;DIALYSIS;EPIDEMIOLOGY;HEPATITIS C;KIDNEY;LOGISTIC REGRESSION;LYMPHOMA;MIGRAINE;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;ODDS RATIO;PROPORTIONAL HAZARDS MODEL","15;13;10;9;8;7;7;6;6;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HEPATITIS C VIRUS;TOLERABILITY;ANGIOTENSIN II;APOLIPOPROTEIN B;AUTOANTIBODY;BREAST CANCER;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;CUMULATIVE INCIDENCE;FETUS;GENOTYPE;GESTATION;GESTATIONAL AGE;GLOMERULONEPHRITIS;HAEMATOPOIESIS;HAZARD RATIO;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMATINIB;IMMUNOTHERAPY;MICRORNA;MUTATION;NEUTROPENIA;OVERWEIGHT;PHENOTYPE;PLACEBO;POLYMERASE CHAIN REACTION;PROBIOTIC;SEROLOGY;VIRAL LOAD;WARFARIN","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ANTIRETROVIRAL THERAPY;COMPOUND HETEROZYGOSITY;DASATINIB;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;MULTIPLEX POLYMERASE CHAIN REACTION;NIVOLUMAB;RIBAVIRIN;ABSOLUTE NEUTROPHIL COUNT;ACE INHIBITOR;ACUTE CHEST SYNDROME;AEDES ALBOPICTUS;ANAGRELIDE;ANGIOTENSIN RECEPTOR;ANGIOTENSIN RECEPTOR BLOCKERS;ANTHRACYCLINE;ANTI-NUCLEAR ANTIBODY;ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;BRENTUXIMAB VEDOTIN;CARDIAC RESYNCHRONIZATION THERAPY;CHOLESTERYL ESTER;CONCENTRIC HYPERTROPHY;CONGENITAL NEUTROPENIA;CONTROL OF CHROMOSOME DUPLICATION;CXCR4;DABIGATRAN;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DNA MICROARRAY;DOUBLE BLIND;ELECTRICAL CARDIOVERSION;ELTROMBOPAG;EUKARYOTIC DNA REPLICATION;EXCESS WEIGHT;GENITAL HERPES;GENOME INSTABILITY;GENOTYPING;GESTATIONAL DIABETES;GLOBOTRIAOSYLCERAMIDE;GROWTH HORMONE TREATMENT;HMGA2;HPV INFECTION;HYPERALGESIA;IIF;IMATINIB MESYLATE;IN UTERO;LACTOBACILLUS REUTERI;MATURITY ONSET DIABETES OF THE YOUNG;METASTATIC BREAST CANCER;MICRODELETION SYNDROME;MIGRAINE WITH AURA;NILOTINIB;PARS PLANA;PEER VICTIMIZATION;PHOTIC STIMULATION;PLACENTA;PLACENTAL ABRUPTION;PLEXIFORM NEUROFIBROMA;POLYCYSTIC OVARY;RIVAROXABAN;RUXOLITINIB;SACUBITRIL;SENTINEL LYMPH NODE;SEXUALLY TRANSMITTED DISEASE;TAXANE;THROMBOPOIETIN;VITAMIN K ANTAGONIST;WATCHFUL WAITING","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;ITALY;ADULT;MIDDLE AGED;ADOLESCENT;AGED;CHILD;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;RENAL INSUFFICIENCY, CHRONIC;HEART FAILURE;HYPERCHOLESTEROLEMIA;INFANT;ANTIVIRAL AGENTS;BRAIN ABSCESS;CARDIOVASCULAR DISEASES;CHILD, PRESCHOOL","55;49;43;32;26;23;22;17;17;15;15;14;12;10;10;10;9;9;9;9","CANCER IMMUNOTHERAPY;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATITIS C INFECTION AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;EFFECTS OF MEDICATION ON PREGNANCY OUTCOMES;EFFICACY AND RESISTANCE IN CML TREATMENT;GENETIC BASIS OF NEUTROPENIA DISORDERS;INFANT CRYING AND COLIC STUDIES;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MANAGEMENT OF VALVULAR HEART DISEASE;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;ACUTE MYELOID LEUKEMIA;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;ATRIAL FIBRILLATION;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","TREATMENT;HEPATITIS C;TOLERABILITY;CARDIAC ELECTROPHYSIOLOGY;CARDIAC IMAGING;CARDIAC RESYNCHRONIZATION THERAPY;CLONAL HEMATOPOIESIS;COLIC;COMPOUND HETEROZYGOSITY;CONCOMITANT;CUMULATIVE INCIDENCE;DISCONTINUATION;HYPERTENSION;LYMPHOMA;LYSOSOMAL STORAGE DISORDERS;MIGRAINE;MIGRAINE PREVENTION;NEUROIMAGING DATA ANALYSIS;NEUTROPENIA;PROBIOTICS","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SOUTHERN ITALY;HEART FAILURE;OBSERVATIONAL STUDY;ACCESS PROGRAMME;AORTIC VALVE;CARDIOVASCULAR RISK;CHRONIC KIDNEY;EXPANDED ACCESS;FOCAL SEGMENTAL;HODGKIN LYMPHOMA;HYPERTENSIVE PATIENTS;KIDNEY DISEASE;LONG-TERM SAFETY;MULTIPLE SCLEROSIS;OCCUPATIONAL EXPOSURE;PRIMARY FOCAL;SEGMENTAL GLOMERULOSCLEROSIS;STEM CELL;SYSTEMATIC REVIEW;ABDOMINAL PAIN;ACID LIPASE;ACTING ANTIVIRALS;ACUTE ABDOMINAL;ACUTE AORTIC;ACUTE MYELOID;ADOLESCENT FEMALE;ADULT PRIMARY;ADVANCED HEPATITIS;ADVANCED NAÏVE;ADVANCED SQ-NSCLC","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","BMI Z-SCORE;PEER VICTIMIZATION;HCV GENOTYPE;FOREIGN BODY;PLACENTA PREVIA;INTENSIVE CARE;SEVERE INFECTIONS;ADVERSE EVENTS;CARE UNIT;GAUGE VITRECTOMY;INCREASED RISK;MEDIAN AGE;PERICRANIAL TENDERNESS;REUTERI DSM;TB PATIENTS;ACE INHIBITORS;CKD STAGE;CLINICAL FEATURES;DISTAL RENAL;FRESOLIMUMAB MGKG;GENOTYPE INFECTION;GESTATIONAL AGE;INFANTILE COLIC;KIDNEY DISEASE;MATERIAL DEPRIVATION;MIR-P MIR-P;NON- ALBICANS;OMBITASVIR PARITAPREVIR;ORAL ANTICOAGULANTS;RENAL TUBULAR","9;9;8;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",13,0.15,6,3,2,1,0,0,2,0,1,3,0,1,5,0,1,2.5,1,4.5,2,0,0,68,68,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,4.17,616.06,14.29,6,0.33,73.72,0,1,3,0,5,0,0,9,0,10,8,0,0,0,0,0,0,18,0,0,17,0,0,1,0,0,0,0,0,0,"Italy;United States;Japan;Denmark","4;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","17;8;5;3;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;CANCER;HEMATOLOGY;RARE DISEASES;AGING;BIOENGINEERING;PREVENTION;TRANSPLANTATION;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;COMPARATIVE EFFECTIVENESS RESEARCH;COMPLEMENTARY AND INTEGRATIVE HEALTH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES","16;8;6;5;4;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INJURIES AND ACCIDENTS;MUSCULOSKELETAL","3;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","10;1;1","MYELOMA;NON-HODGKIN'S LYMPHOMA;LEUKEMIA / LEUKAEMIA;BLOOD CANCER;HODGKIN'S DISEASE;MELANOMA","3;3;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","5;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;4905 STATISTICS;31 BIOLOGICAL SCIENCES;3103 ECOLOGY;3202 CLINICAL SCIENCES;38 ECONOMICS;3801 APPLIED ECONOMICS;50 PHILOSOPHY AND RELIGIOUS STUDIES","5;4;2;2;1;1;1;1;1;1","HIV/AIDS;CLINICAL RESEARCH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE","2;1;1;1;1;1;1;1","INFECTION","1","6.1 PHARMACEUTICALS","1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","2","LIVER CANCER","1",NA,NA
"AOUSSN_POLICLINICOBARI",2018,116,13.2844827586207,2.43965517241379,0.301724137931034,0.28448275862069,0.560344827586207,1.42929292929293,1.16666666666667,1.13793103448276,1.14035087719298,0.577586206896552,7,48,27,10,17,0.41,0.23,0.09,0.15,14.89,0.48799681881283,4.05896805896806,0.258620689655172,0.836206896551724,0.437,0.331,0.333,0.339,"LORETO GESUALDO;LEONARDO MILELLA;VINCENZO MONTINARO;GIOVANNI MISCIAGNA;GIANCARLO CASTAMAN;ROBERTO MINUTOLO;MASSIMO PUOTI;NICOLA DI RENZO;FRANCESCO PERTICONE;EDOARDO G. GIANNINI;NICOLA CASCAVILLA;MARIA RENDINA;PAOLO MAGGI;ANNA LINDA ZIGNEGO;NICOLA VERONESE;MARCELLO PERSICO;ALESSANDRO SANTO BORTONE;ALBERTO TOSETTO;ALBERTO R. OSELLA;ALESSIO AGHEMO","9;7;6;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","LEONARDO MILELLA;LEONARDO MILELLA;L MILELLA;GAETANO BRINDICCI;LORETO GESUALDO;RENATA BECK;C LABELLARTE;VINCENZO MONTINARO;GIOVANNI MISCIAGNA;CLAUDIO VILLANI;MARIANNA DELUSSI;MARINA DE TOMMASO;PIETRO FIORE;UGO VAIRO;LUCIA MARGARI;FRANCESCO CRAIG;GIOVANNI ALESSIO;ALFREDO NIRO;BIAGIO MORETTI;A M MONTINARO","4.73;1;1;1;0.68;0.67;0.67;0.59;0.54;0.51;0.5;0.5;0.48;0.45;0.39;0.39;0.38;0.38;0.36;0.34","LORETO GESUALDO;LEONARDO MILELLA;VINCENZO MONTINARO;GIOVANNI MISCIAGNA;LUCIA MARGARI;MARIABEATRICE PRINCIPI;FEDERICA ORTOLANI;C. ETTORRE;GRAZIANA INTRANUOVO;FRANCESCO BIRTOLO;DOMENICA CAVONE;ALBINA TUMMOLO;CLAUDIO VILLANI;BIAGIO MORETTI;ANGELO OSTUNI;EMANUELA DE CILLIS;UGO VAIRO;LUIGI VIMERCATI;PAOLA GIORDANO;FRANCESCO PAPADIA","9;7;6;5;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","LEONARDO MILELLA;LEONARDO MILELLA;L MILELLA;GAETANO BRINDICCI;LORETO GESUALDO;VINCENZO MONTINARO;GIOVANNI MISCIAGNA;CLAUDIO VILLANI;MARIANNA DELUSSI;MARINA DE TOMMASO;PIETRO FIORE;UGO VAIRO;LUCIA MARGARI;GIOVANNI ALESSIO;ALFREDO NIRO;BIAGIO MORETTI;A M MONTINARO;GRAZIANA INTRANUOVO;FRANCESCO BIRTOLO;DOMENICA CAVONE","4.73;1;1;1;0.68;0.59;0.54;0.51;0.5;0.5;0.48;0.45;0.39;0.38;0.38;0.36;0.34;0.33;0.33;0.33","ADINA CROITORU;AGRIN MOEINI;AUGUSTO VILLANUEVA;CAROL PEÑA;CHRIS VERSLYPE;DANIELA SIA;EDWARD GANE;GAR-YANG CHAU;GEROLD MEINHARDT;HAN CHU LEE;JOONG‐WON PARK;JORDI BRUIX;JORDI CAMPS;JOSEP M. LLOVET;L. LUPO;LAIA BASSAGANYAS;LEONARDO RODRÍGUEZ‐CARUNCHIO;MANEL SOLÉ;MANUEL DE LA MATA;NORIHIRO KOKUDO","239;239;239;239;239;239;239;239;239;239;239;239;239;239;239;239;239;239;239;239","L. LUPO;LORETO GESUALDO;MARIABEATRICE PRINCIPI;ALBINA TUMMOLO;FRANCESCO PAPADIA;MARCELLA VENDEMIALE;GIOVANNI MISCIAGNA;BALDASSARRE MARTIRE;RUGGIERO FRANCAVILLA;PAOLA MUGGEO;DILETTA DOMENICA TORRES;LUISA SANTANGELO;MARIDA MARTINO;MARIO GIORDANO;PAOLO GIORDANO;VINCENZA CARBONE;FEDERICA ORTOLANI;ALBERTO GAETA;LEONARDO MILELLA;FABIO CARDINALE","239;196;147;126;126;103;87;71;71;66;61;61;61;61;61;61;56;51;42;41","LEONARDO MILELLA;LORETO GESUALDO;VINCENZO MONTINARO;GIOVANNI MISCIAGNA;ALBINA TUMMOLO;BIAGIO MORETTI;C. ETTORRE;FRANCESCO PAPADIA;CLAUDIO VILLANI;DOMENICA CAVONE;FEDERICA ORTOLANI;FRANCESCO BIRTOLO;GRAZIANA INTRANUOVO;LUCIA MARGARI;LUIGI VIMERCATI;ANGELO OSTUNI;UGO VAIRO;A M MONTINARO;ALBERTO GAETA;ALFREDO NIRO","8;8;6;5;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;CHEMISTRY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;MATERIALS SCIENCE;MATHEMATICS;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;HISTORY;BUSINESS;GEOLOGY","112;23;14;9;9;4;4;4;4;3;3;2;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;PEDIATRICS;PATHOLOGY;ENVIRONMENTAL HEALTH;GENETICS;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;CARDIOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;PSYCHIATRY;ANESTHESIA;ONCOLOGY;OPTICS;RADIOLOGY;BIOCHEMISTRY;FAMILY MEDICINE;NUCLEAR MEDICINE;PHYSICAL THERAPY","86;27;24;19;18;15;14;14;13;11;11;8;7;7;7;7;6;6;5;5","DISEASE;POPULATION;COHORT;CANCER;RETROSPECTIVE COHORT STUDY;GENE;OBSERVATIONAL STUDY;ALTERNATIVE MEDICINE;EPIDEMIOLOGY;NEPHROLOGY;PROSPECTIVE COHORT STUDY;CHEMOTHERAPY;DIALYSIS;HEPATITIS C;INCIDENCE (GEOMETRY);PREGNANCY;RANDOMIZED CONTROLLED TRIAL;TRANSPLANTATION;COHORT STUDY;DIABETES MELLITUS;KIDNEY DISEASE;RECEPTOR;RENAL REPLACEMENT THERAPY","20;14;12;9;9;8;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5","PROTOCOL (SCIENCE);CHRONIC LIVER DISEASE;LIVER TRANSPLANTATION;CLINICAL ENDPOINT;COLORECTAL CANCER;FATTY LIVER;FETUS;GENOTYPE;INFLAMMATORY BOWEL DISEASE;MULTICENTER STUDY;PLACEBO;PRIMARY IMMUNODEFICIENCY;VON WILLEBRAND FACTOR;BREAST CANCER;CARDIAC OUTPUT;CHRONIC LYMPHOCYTIC LEUKEMIA;CLOPIDOGREL;HAZARD RATIO;HEART RATE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNIZATION;IMMUNODEFICIENCY;INTERNATIONAL AGENCY;MUTATION;NEUTROPENIA;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;PROGRESSION-FREE SURVIVAL;RITUXIMAB;ULCERATIVE COLITIS;VALVE REPLACEMENT;VIRAL LOAD","5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","VON WILLEBRAND DISEASE;ANTIRETROVIRAL THERAPY;CARDIAC INDEX;COMPOUND HETEROZYGOSITY;P2Y12;PRASUGREL;SANGER SEQUENCING;STROKE VOLUME;TICAGRELOR;ANAPHYLACTIC REACTIONS;ANGIOTENSIN RECEPTOR;BENDAMUSTINE;BLOOD PLATELET DISORDERS;BREAST RECONSTRUCTION;BREAST TISSUE;BROMOCRIPTINE;BRUTON'S TYROSINE KINASE;CD18;CERVICAL INSUFFICIENCY;CETUXIMAB;CHILDHOOD LEUKEMIA;COLECTOMY;CROSSOVER STUDY;CYANOACRYLATE;CYCLIC NEUTROPENIA;DEEP BRAIN STIMULATION;DIABETIC MACULAR EDEMA;DIFFUSING CAPACITY;DOUBLE BLIND;DRUJ;ECULIZUMAB;ENDOTHELIN RECEPTOR ANTAGONIST;FEBRILE NEUTROPENIA;FETAL GROWTH;FIBROBLAST GROWTH FACTOR RECEPTOR;FIBROBLAST GROWTH FACTOR RECEPTOR 3;GANCICLOVIR;GASTRIC BYPASS;GENE SIGNATURE;GLOMERULOSCLEROSIS;HEMATOPOIETIC STEM CELL;HEPACIVIRUS;HETEROZYGOTE ADVANTAGE;IBRUTINIB;IIF;INTRAUTERINE GROWTH RESTRICTION;IRINOTECAN;LAMIVUDINE;LIVER STEATOSIS;LOWER RESPIRATORY TRACT INFECTION;MULTICENTER TRIAL;NEOADJUVANT THERAPY;NEPHRONOPHTHISIS;OSTEOCALCIN;OSTEOPROTEGERIN;PHENYLKETONURIAS;PRENATAL DIAGNOSIS;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;TIMI;TOTAL MESORECTAL EXCISION;UREA CYCLE;VENETOCLAX;WHEAT ALLERGY","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;ITALY;ADOLESCENT;CHILD;RENAL INSUFFICIENCY, CHRONIC;RISK FACTORS;CHILD, PRESCHOOL;YOUNG ADULT;RETROSPECTIVE STUDIES;ANTIVIRAL AGENTS;INFANT;NON-ALCOHOLIC FATTY LIVER DISEASE;TREATMENT OUTCOME;BIOMARKERS","59;56;42;39;27;24;23;23;15;15;14;13;12;12;11;9;9;9;9;7","HEPATITIS C INFECTION AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;OPTIMIZATION OF PERIOPERATIVE FLUID THERAPY;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;SHARED DECISION MAKING IN HEALTHCARE;SOURCES AND EFFECTS OF IONIZING RADIATION ON HUMAN HEALTH","6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","NEPHROLOGY;HEPATITIS C;RENAL REPLACEMENT THERAPY;CHRONIC LIVER DISEASE;ETIOLOGY;HEPATITIS C VIRUS;LIVER DISEASE;STEATOSIS;CARDIAC OUTPUT;CLINICAL ENDPOINT;FETAL CARDIAC DISEASE;GOLD STANDARD (TEST);NONCARDIAC SURGERY;PRIMARY IMMUNODEFICIENCY;TREATMENT;VON WILLEBRAND DISEASE;ADAMTS13;ANESTHESIA;BODY SURFACE AREA;CANCER COMMUNICATION","7;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2","ITALIAN SOCIETY;KIDNEY DISEASE;VON WILLEBRAND;AISF ITALIAN;ANESTHESIA PROTOCOL;CHRONIC KIDNEY;DISEASE POSITION;DISEASE SIMIT;INTERNAL MEDICINE;ITALIAN ASSOCIATION;JOINT COMMITTEE;LIVER AISF;MEDICINE SIMI;NEPHROLOGY SIN;POSITION STATEMENT;SIMI ITALIAN;TROPICAL DISEASE;TYPE VON;VIRUS INFECTION;WILLEBRAND DISEASE;COHORT STUDY;PATIENTS TREATED;RISK FACTORS;SOUTHERN ITALY;WINTERS-IPS PROJECT;AORTIC VALVE;BIO-MEDICO UNIVERSITY;BOWEL DISEASE;CAMPUS BIO-MEDICO;CARDIAC INDEX","12;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2","SPEAKERS BUREAU;PUBMED SCOPUS;CROSSREF PUBMED;AKU PATIENTS;RISK FACTORS;ADVISORY COMMITTEES;ENTITYS BOARD;HONORARIA MEMBERSHIP;LUNG CANCER;ADULT AKU;PLASMIC SCORE;NOVO NORDISK;RESEARCH FUNDING;SERUM LEVELS;BLOOD DONORS;MATERNAL SERUM;NORMAL RANGE;AKU CHILDREN;ANTERIOR ISCHEMIC;BUREAU GRIFOLS;COMMITTEES RESEARCH;CONSULTANCY SPEAKERS;FATTY LIVER;GRIFOLS SPEAKERS;HCV INFECTION;ISCHEMIC OPTIC;MED -CROSSREF;MULTIVARIATE ANALYSIS;NORDISK SPEAKERS;OPTIC NEUROPATHY","43;24;22;19;18;14;14;12;12;9;9;8;8;8;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6",16,0.14,20.99,19.75,1,1.5,1,7.5,2,0,1,22,0,1,18,0,0,4,8.5,17,10.25,0,0,85.75,85.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,3.5,651.06,9.9,5,0.26,47.47,0,0,3,0,5,0,1,10,0,9,9,0,0,0,0,0,0,19,0,0,18,1,0,0,0,0,0,0,0,0,"United States;Italy;Germany;Japan","5;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;42 HEALTH SCIENCES;44 HUMAN SOCIETY","19;9;5;4;4;3;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;RARE DISEASES;AGING;BRAIN DISORDERS;CARDIOVASCULAR;GENETICS;HEART DISEASE;MENTAL HEALTH;PEDIATRIC;PEDIATRIC CANCER;STEM CELL RESEARCH;ARTHRITIS;CHILDHOOD LEUKEMIA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;DEPRESSION;EYE DISEASE AND DISORDERS OF VISION;KIDNEY DISEASE","14;7;5;5;4;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;INFECTION;BLOOD;CARDIOVASCULAR;EYE;INFLAMMATORY AND IMMUNE SYSTEM;INJURIES AND ACCIDENTS;MUSCULOSKELETAL;RENAL AND UROGENITAL;RESPIRATORY","3;2;1;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.4 SURVEILLANCE AND DISTRIBUTION;5.1 PHARMACEUTICALS;6.4 SURGERY","10;4;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;KIDNEY CANCER;MELANOMA;MYELOMA","5;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","7;2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","49 MATHEMATICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;4905 STATISTICS;3202 CLINICAL SCIENCES","4;2;2;1","ATHEROSCLEROSIS;BIOMEDICAL IMAGING;CARDIOVASCULAR;CLINICAL RESEARCH;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","1;1;1;1;1;1","CARDIOVASCULAR","1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2019,106,15.4811320754717,2.22641509433962,0.235849056603774,0.320754716981132,0.273584905660377,1.4390243902439,1.13636363636364,1.21428571428571,1.16,0.622641509433962,1,35,27,15,15,0.33,0.25,0.14,0.14,15.43,0.63470139501353,4.07096774193548,0.320754716981132,0.905660377358491,0.41,0.333,0.36,0.389,"PAOLA GIORDANO;ALESSANDRO BERTOLINO;GIUSEPPE BLASI;GIULIO PERGOLA;FABIO CARDINALE;CLAUDIO PIGNATA;CATERINA CANCRINI;ANTONIO RAMPINO;SARA GALIMBERTI;MARIA CATERINA PUTTI;ANTONELLA GOZZINI;ALESSANDRA IURLO;PASQUALE DI CARLO;ANGELA ABBASCIANO;RAFFAELE DEL PRETE;RITA FISCHETTO;LUIGI RONGA;BALDASSARRE MARTIRE;PAOLO COLONNA;MONICA CRUGNOLA","9;7;7;7;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3","LEONARDO MILELLA;PAOLA GIORDANO;GABRIELE SCALZO;UGO VAIRO;GIOVANNI MELIOTA;ALESSANDRO BERTOLINO;GIUSEPPE BLASI;GIULIO PERGOLA;ANGELA ABBASCIANO;RAFFAELE DEL PRETE;LUIGI RONGA;ANTONIO RAMPINO;GRAZIA ADDATI;RAFFAELLA MAGRONE;GENNARO MARTINES;LUIGÌ SANTACROCE;G. MIRAGLIOTTA;MARCO MATTEO CICCONE;PIERLUIGI ZAZA;M. LOMBARDI","1;0.81;0.73;0.68;0.68;0.63;0.63;0.63;0.52;0.52;0.52;0.51;0.41;0.41;0.4;0.39;0.38;0.35;0.34;0.34","PAOLA GIORDANO;ALESSANDRO BERTOLINO;GIUSEPPE BLASI;FABIO CARDINALE;ANTONIO RAMPINO;RAFFAELE DEL PRETE;RITA FISCHETTO;LUIGI RONGA;BALDASSARRE MARTIRE;PAOLO COLONNA;G. MIRAGLIOTTA;ALBINA TUMMOLO;LUCREZIA DE MICHELE;MAURIZIO DELVECCHIO;GIORGINA SPECCHIA;RUGGIERO FRANCAVILLA;GABRIELE SCALZO;MARIO GIORDANO;UGO VAIRO;GIOVANNI MELIOTA","9;7;7;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","LEONARDO MILELLA;PAOLA GIORDANO;GABRIELE SCALZO;UGO VAIRO;GIOVANNI MELIOTA;ALESSANDRO BERTOLINO;GIUSEPPE BLASI;RAFFAELE DEL PRETE;LUIGI RONGA;ANTONIO RAMPINO;GENNARO MARTINES;LUIGÌ SANTACROCE;G. MIRAGLIOTTA;PIERLUIGI ZAZA;M. LOMBARDI;MARIAROSARIA TAGLIENTE;GIUSEPPE IODICE;ALFREDO DI LEO;M. BARONE;MARIA TERESA VIGGIANI","1;0.81;0.73;0.68;0.68;0.63;0.63;0.52;0.52;0.51;0.4;0.39;0.38;0.34;0.34;0.34;0.33;0.33;0.33;0.33","CATERINA CANCRINI;FABIO CARDINALE;ANDREA DIOCIAIUTI;ALESSANDRO BERTOLINO;GIULIO PERGOLA;GIUSEPPE BLASI;MARCO GATTORNO;CLAUDIO PIGNATA;ELVIRA VERDUCI;STEFANO VOLPI;ALESSIA SCARSELLI;MARZIA DUSE;ANTONELLA INSALACO;FABRIZIO DE BENEDETTI;PASQUALE DI CARLO;ALBINA TUMMOLO;ALEXANDRE LAPILLONNE;CHRISTIAN MØLGAARD;CRISTINA CAMPOY;FLAVIA INDRIO","229;208;172;167;167;167;143;141;133;128;124;124;117;117;113;111;111;111;111;111","FABIO CARDINALE;ALESSANDRO BERTOLINO;GIUSEPPE BLASI;ALBINA TUMMOLO;FLAVIA INDRIO;ANTONIO RAMPINO;BALDASSARRE MARTIRE;CARLA MASTRORILLI;GIORGINA SPECCHIA;FRANCESCO PESCE;L. LUPO;LORETO GESUALDO;RUGGIERO FRANCAVILLA;DOMENICO PASTORE;RITA FISCHETTO;BALDASSARE MARTIRE;ROSA ANGARANO;FRANCESCA FELICIA OPERTO;LUIGI RONGA;RAFFAELE DEL PRETE","208;167;167;111;111;96;91;84;75;62;62;62;55;49;49;47;47;41;41;41","GIUSEPPE BLASI;ALESSANDRO BERTOLINO;FABIO CARDINALE;ANTONIO RAMPINO;RITA FISCHETTO;LUIGI RONGA;RAFFAELE DEL PRETE;PAOLA GIORDANO;ALBINA TUMMOLO;BALDASSARRE MARTIRE;G. MIRAGLIOTTA;GABRIELE SCALZO;GIORGINA SPECCHIA;GIOVANNI MELIOTA;GIUSEPPE ESPOSITO;MARIO GIORDANO;PAOLO COLONNA;UGO VAIRO;LUCREZIA DE MICHELE;A MANNARINI","7;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;SOCIOLOGY;PHYSICS;MATHEMATICS;PHILOSOPHY;ART;ENGINEERING;GEOLOGY;POLITICAL SCIENCE;ECONOMICS;HISTORY;MATERIALS SCIENCE","96;34;9;6;6;6;5;4;4;3;3;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;PEDIATRICS;GENETICS;IMMUNOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PATHOLOGY;PSYCHIATRY;GASTROENTEROLOGY;NEUROSCIENCE;ENDOCRINOLOGY;ONCOLOGY;BIOCHEMISTRY;FAMILY MEDICINE;PALEONTOLOGY;OBSTETRICS;MICROBIOLOGY;RADIOLOGY","70;30;27;24;19;15;12;11;11;11;10;10;9;7;6;6;6;5;4;4","GENE;DISEASE;POPULATION;COGNITION;CANCER;RETROSPECTIVE COHORT STUDY;ANTIBODY;COHORT;HEART FAILURE;PROSPECTIVE COHORT STUDY;BONE MARROW;IMMUNE SYSTEM;MYOCARDIAL INFARCTION;OBESITY;PREGNANCY;ADVERSE EFFECT;CLINICAL TRIAL;COMPLICATION;EPIDEMIOLOGY;MYELOID LEUKEMIA;PERCUTANEOUS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TRANSPLANTATION","18;11;11;9;8;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4","GENOTYPE;MUTATION;PHENOTYPE;PRIMARY IMMUNODEFICIENCY;CLINICAL ENDPOINT;EJECTION FRACTION;FETUS;GENE EXPRESSION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMATINIB;IMMUNODEFICIENCY;MICRORNA;PREFRONTAL CORTEX;WEIGHT LOSS;BREAST CANCER;CYSTATIN C;CYTOPENIA;DRUG ALLERGY;ESCHERICHIA COLI;FIXATION (POPULATION GENETICS);GREAT ARTERIES;HAZARD RATIO;IMMUNOPHENOTYPING;LYMPHOBLASTIC LEUKEMIA;POLYMERASE CHAIN REACTION;SALVAGE THERAPY;TRANSCRIPTION FACTOR;TYROSINE-KINASE INHIBITOR;VENOUS THROMBOSIS","6;6;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NILOTINIB;AMNIOTIC FLUID;APGAR SCORE;CARDIAC RESYNCHRONIZATION THERAPY;DASATINIB;GASTRIC BYPASS;MULTIPLEX POLYMERASE CHAIN REACTION;NESTED POLYMERASE CHAIN REACTION;PENETRANCE;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME;ANTIRETROVIRAL THERAPY;BIOPHYSICAL PROFILE;BONE MARROW FAILURE;BREAST CARCINOMA;CERVICAL DILATATION;CHILDHOOD OBESITY;CLOFARABINE;COLECTOMY;COMPOUND HETEROZYGOSITY;CONCENTRIC HYPERTROPHY;CONGENITAL TOXOPLASMOSIS;DIASTOLIC HEART FAILURE;DNA EXTRACTION;DORSOLATERAL PREFRONTAL CORTEX;FETAL HEAD;FETAL POSITION;FIBROBLAST GROWTH FACTOR RECEPTOR;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;FRAMESHIFT MUTATION;GENE EXPRESSION PROFILING;GENE MUTATION;GENE REGULATORY NETWORK;GENOTYPE-PHENOTYPE DISTINCTION;GERD;GLOMERULOPATHY;GREY MATTER;HAPLOINSUFFICIENCY;HETEROZYGOTE ADVANTAGE;HISTONE METHYLTRANSFERASE;HPV INFECTION;IMATINIB MESYLATE;JAG1;KARYOTYPE;KLEBSIELLA PNEUMONIAE;LUXOL FAST BLUE STAIN;LYMPHOBLASTIC LYMPHOMA;MECONIUM;MEMBRANOUS NEPHROPATHY;METASTATIC BREAST CANCER;MISSENSE MUTATION;MYXOID LIPOSARCOMA;NATIONAL DEATH INDEX;NUCLEAR RECEPTOR;OSWESTRY DISABILITY INDEX;PITTSBURGH SLEEP QUALITY INDEX;PLASMODIUM VIVAX;RNA SPLICING;RUXOLITINIB;SELECTED REACTION MONITORING;SHIGA TOXIN;SLEEP STAGES;TRANSPOSITION OF THE GREAT VESSELS;UMBILICAL ARTERY;VANCOMYCIN","3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;ITALY;CHILD;ADULT;MIDDLE AGED;ADOLESCENT;RETROSPECTIVE STUDIES;CHILD, PRESCHOOL;YOUNG ADULT;HEART FAILURE;AGED;SCHIZOPHRENIA;INFANT;TREATMENT OUTCOME;RISK FACTORS;HIV INFECTIONS;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA","61;45;45;41;27;22;21;21;20;17;16;16;14;13;13;10;10;9;8;8","GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ANALYSIS OF GENE INTERACTION NETWORKS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MANAGEMENT AND TREATMENT OF HEMOPHILIA;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ACUTE MYELOID LEUKEMIA;ATOMIC MAGNETOMETRY TECHNIQUES;BLOOD RHEOLOGY AND COAGULATION MECHANISMS","4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","NEUROIMAGING DATA ANALYSIS;PRIMARY IMMUNODEFICIENCY;CLINICAL ENDPOINT;DIAGNOSIS;DISCONTINUATION;INTERQUARTILE RANGE;PULMONARY VALVE REPLACEMENT;APGAR SCORE;CARDIAC IMAGING;CARDIAC RESYNCHRONIZATION THERAPY;CIRCULATION (FLUID DYNAMICS);CO-EXPRESSION NETWORKS;CONCOMITANT;CYTOPENIA;DIET QUALITY;DRUG ALLERGY;DRUG HYPERSENSITIVITY;HEALTHY EATING INDEX;HEMATOLOGY;HIV","4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","ACUTE LYMPHOBLASTIC;CHRONIC MYELOID;HEART FAILURE;LEAD EXTRACTION;LYMPHOBLASTIC LEUKEMIA;MYELOID LEUKEMIA;PEDIATRIC PATIENTS;RETROSPECTIVE STUDY;AUTOIMMUNE CYTOPENIA;CLINICAL PRACTICE;HUMAN PAPILLOMAVIRUS;LAPAROSCOPIC SLEEVE;LEUKEMIA RESULTS;MULTICENTER EXPERIENCE;OBSERVATIONAL STUDY;PRIMARY IMMUNODEFICIENCY;PULMONARY CIRCULATION;PULMONARY VENOUS;SCHIZOPHRENIA RISK;SLEEVE GASTRECTOMY;SOUTHERN ITALY;SYMPTOM ONSET;TEACHING HOSPITAL;ACL RECONSTRUCTION;ACQUIRED HYPOFIBRINOGENEMIA;ACTIVE FIXATION;ACUTE BLEEDING;ACUTE CORONARY;ACUTE HEART;ACUTE LEUKAEMIA","3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","BARI BARI;ALDO MORO;MEDICAL SCHOOL;SCHOOL ALDO;BARI ITALY;BARI ITALYSEARCH;UNIVERSITY MEDICAL;SCZ RISK;BIOMEDICAL SCIENCES;HUMAN ONCOLOGY;MD DEPARTMENT;ONCOLOGY UNIVERSITY;POLICLINIC HOSPITAL;RISK GENES;BREAST UNIT;HONORARIA NOVARTIS;ITALY BREAST;UNIT POLICLINIC;PAIN CATASTROPHIZING;PATIENTS TREATED;PEDIATRIC PATIENTS;ADVERSE EVENTS;GM GANGLIOSIDE;HONORARIA PFIZER;NOVARTIS HONORARIA;PFIZER HONORARIA;PROSPECTIVE STUDY;SAFETY PROFILE;SPEAKER HONORARIA;TUNNEL WIDENING","27;22;20;20;18;16;16;13;12;12;12;12;10;9;8;8;8;8;7;7;7;6;6;6;6;6;6;6;6;6",21,0.2,6.25,5,1,0,0,1.75,0,0,1,7,0,0,5.5,0,2,1.5,2.5,4,2.5,0,0,45,45,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27,4.63,656.26,16.98,9,0.33,41.19,0,0,3,0,6,0,3,15,0,14,13,0,0,0,0,0,0,26,1,0,27,0,0,0,0,0,0,0,0,0,"Italy;United States;Belgium;France;Germany","5;3;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3207 MEDICAL MICROBIOLOGY;3208 MEDICAL PHYSIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","27;15;6;5;3;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;HEMATOLOGY;CANCER;PATIENT SAFETY;ORPHAN DRUG;PEDIATRIC;TRANSPLANTATION;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;AGING;KIDNEY DISEASE;NEUROSCIENCES;PEDIATRIC CANCER;STEM CELL RESEARCH;CHILDHOOD LEUKEMIA;CHRONIC LIVER DISEASE AND CIRRHOSIS;GENETICS;LIVER DISEASE","27;16;12;11;10;9;6;5;5;4;4;3;3;3;3;3;2;2;2;2","CANCER;RENAL AND UROGENITAL;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;BLOOD;CARDIOVASCULAR;CONGENITAL;EYE;INFECTION;MUSCULOSKELETAL;NEUROLOGICAL;REPRODUCTIVE HEALTH AND CHILDBIRTH;SKIN","9;3;2;2;1;1;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","16;3;2;2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;MYELOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;BLOOD CANCER;BREAST CANCER;HODGKIN'S DISEASE;LIVER CANCER;NEUROBLASTOMA;SKIN CANCER","7;4;2;2;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","10;8;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","2;2;1;1;1","INFECTIOUS DISEASES","1","INFECTION","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","1;1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2020,163,18.3435582822086,1.79141104294479,0.134969325153374,0.171779141104294,0.141104294478528,1.61325966850829,1.04761904761905,1.33333333333333,1.0952380952381,0.595092024539877,0,71,42,11,15,0.44,0.26,0.07,0.09,27.71,1.09948799771818,5.36131386861314,0.325153374233129,0.969325153374233,0.417,0.298,0.334,0.35,"FABIO CARDINALE;GIAN LUIGI MARSEGLIA;LORETO GESUALDO;MARZIA DUSE;MARIO GIORDANO;CARLOS MACAYA;SERGIO RAPOSEIRAS‐ROUBÍN;MARTINO PEPE;ENRICO CERRATO;IVÁN J. NÚÑEZ‐GIL;VÍCTOR MANUEL BECERRA‐MUÑOZ;MICHELE MIRAGLIA DEL GIUDICE;GISELA FELTES;RODOLFO ROMERO;PAOLA GIORDANO;MARIA CATERINA PUTTI;VICENTE ESTRADA;INMACULADA FERNÁNDEZ‐ROZAS;CARLO CAFFARELLI;LUIGÌ SANTACROCE","11;8;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5","DESIRÉE CASELLI;MAURIZIO ARICÒ;FABIO CARDINALE;LORETO GESUALDO;LUCIA DIAFERIO;MARIO GIORDANO;MASSIMILIANO CHETTA;NENAD BUKVIĆ;GIAN LUIGI MARSEGLIA;MICHELE MIRAGLIA DEL GIUDICE;GIOVANNI MIGLIORE;LUIGÌ SANTACROCE;LIDIA DALFINO;ELVIRA GRANDONE;ANGELO OSTUNI;MARIA CHIRONNA;MAURIZIO DELVECCHIO;LUCIA FEDERICA CARPAGNANO;MATILDE CARLUCCI;CARLO CAFFARELLI","0.89;0.82;0.63;0.62;0.56;0.56;0.53;0.53;0.52;0.51;0.51;0.51;0.49;0.48;0.48;0.43;0.43;0.4;0.4;0.38","FABIO CARDINALE;LORETO GESUALDO;MARIO GIORDANO;MARTINO PEPE;PAOLA GIORDANO;LUIGÌ SANTACROCE;MAURIZIO DELVECCHIO;CARLO D’AGOSTINO;LUCIA DIAFERIO;FRANCESCO LA TORRE;MAURIZIO ARICÒ;FLAVIA INDRIO;RITA DARIO;PAOLA CARLUCCIO;CLAUDIO FURINO;VINCENZA CARBONE;GIOVANNI ALESSIO;VITO PROCACCI;LIDIA DALFINO;RITA FISCHETTO","11;7;7;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3","DESIRÉE CASELLI;MAURIZIO ARICÒ;FABIO CARDINALE;LORETO GESUALDO;LUCIA DIAFERIO;MARIO GIORDANO;NENAD BUKVIĆ;GIOVANNI MIGLIORE;LUIGÌ SANTACROCE;LIDIA DALFINO;ANGELO OSTUNI;MAURIZIO DELVECCHIO;LUCIA FEDERICA CARPAGNANO;MATILDE CARLUCCI;CARLO D’AGOSTINO;GIOVANNI MELIOTA;PELLEGRINO MUSTO;RITA DARIO;SALVATORE GRASSO;CLAUDIO FURINO","0.89;0.82;0.63;0.62;0.56;0.56;0.53;0.51;0.51;0.49;0.48;0.43;0.4;0.4;0.36;0.36;0.36;0.35;0.34;0.33","FABIO CARDINALE;ANDREA APICELLA;EGIDIO BARBI;FEDERICO MARCHETTI;GIANLUCA TROBIA;MARZIA LAZZERINI;CARLOS MACAYA;ENRICO CERRATO;GISELA FELTES;IVÁN J. NÚÑEZ‐GIL;MARTINO PEPE;RODOLFO ROMERO;SERGIO RAPOSEIRAS‐ROUBÍN;VÍCTOR MANUEL BECERRA‐MUÑOZ;INMACULADA FERNÁNDEZ‐ROZAS;VICENTE ESTRADA;AITOR URIBARRI;ANTONIO FERNÁNDEZ-ORTÍZ;MARÍA C. VIANA‐LLAMAS;CRISTINA FERNÁNDEZ","1436;1252;1252;1252;1252;1252;437;437;437;437;437;437;437;437;339;339;315;305;305;291","FABIO CARDINALE;MARTINO PEPE;FLAVIA INDRIO;VITO PROCACCI;ANNALISA SCHIRINZI;FRANCESCA DI SERIO;PIETRO POZZESSERE;ROBERTO LOVERO;MARIA PEPE;BIAGIO MORETTI;LORENZO MORETTI;LUIGI CHIUMARULO;MARIO GIORDANO;MARCO PETRUZZELLIS;MAURIZIO ARICÒ;LUCIA DIAFERIO;SERGIO CARBONARA;MAURIZIO DELVECCHIO;GIORGINA SPECCHIA;ALBINA TUMMOLO","1436;437;286;206;203;203;203;203;165;143;143;104;98;88;88;83;83;80;79;76","FABIO CARDINALE;MARIO GIORDANO;MARTINO PEPE;LORETO GESUALDO;MAURIZIO DELVECCHIO;CARLO D’AGOSTINO;FLAVIA INDRIO;FRANCESCO LA TORRE;LUCIA DIAFERIO;MAURIZIO ARICÒ;MARIO DELIA;VINCENZA CARBONE;VITO PROCACCI;ANGELANTONIO VITUCCI;ANGELO OSTUNI;CLAUDIO FURINO;DILETTA DOMENICA TORRES;GIOVANNI ALESSIO;GIOVANNI MELIOTA;GIOVANNI MIGLIORE","11;7;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;CHEMISTRY;POLITICAL SCIENCE;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;MATHEMATICS;PHILOSOPHY;SOCIOLOGY;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;ART;ENVIRONMENTAL SCIENCE;HISTORY","151;35;16;12;11;11;10;8;7;5;5;5;3;3;2;1;1;1","INTERNAL MEDICINE;PEDIATRICS;SURGERY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;PATHOLOGY;GENETICS;VIROLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;GASTROENTEROLOGY;CARDIOLOGY;FAMILY MEDICINE;BIOCHEMISTRY;LAW;MEDICAL EMERGENCY;MICROBIOLOGY;DERMATOLOGY;MECHANICAL ENGINEERING;NURSING;OPTICS;PHYSICAL THERAPY;PSYCHIATRY","116;40;33;32;31;27;20;17;14;13;13;12;11;10;10;9;9;8;8;8;8;8;8","DISEASE;GENE;OUTBREAK;POPULATION;RETROSPECTIVE COHORT STUDY;COHORT;CANCER;ALLERGY;OBSERVATIONAL STUDY;TRANSPLANTATION;CLINICAL TRIAL;COHORT STUDY;DIABETES MELLITUS;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);ANTIBODY;CHEMOTHERAPY;EPIDEMIOLOGY;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;HEALTH CARE;PROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE)","46;16;14;13;13;12;11;10;10;10;9;8;8;8;8;7;7;7;7;6;6;6;6","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CLINICAL ENDPOINT;GENE EXPRESSION;MUTATION;ANAPHYLAXIS;CHROMATIN;IMMUNOTHERAPY;KIDNEY TRANSPLANTATION;ADALIMUMAB;ALLELE;ALLERGEN;ARDS;ARTERIAL STIFFNESS;BACTEREMIA;BREAST CANCER;CARBAPENEM;COLORECTAL SURGERY;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;DEFERASIROX;DEFERIPRONE;DOSIMETER;DYSLIPIDEMIA;EPIGENETICS;FOOD ALLERGY;GENE DUPLICATION;GENOME;GLOMERULONEPHRITIS;GROWTH HORMONE;HAZARD RATIO;IMMUNODEFICIENCY;IN SILICO;INSULIN RESISTANCE;ISCHEMIC STROKE;LOCUS (GENETICS);MACULAR EDEMA;PEDIATRIC GASTROENTEROLOGY;PHENOTYPE;PI3K/AKT/MTOR PATHWAY;PROBIOTIC;PSEUDOMONAS AERUGINOSA;SEROLOGY;TYPE 1 DIABETES;TYPE 2 DIABETES;VON WILLEBRAND FACTOR","26;13;6;6;5;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);COLONOSCOPY;EXOME SEQUENCING;ALLERGEN IMMUNOTHERAPY;CEFTAZIDIME;CHROMATIN REMODELING;DNA METHYLATION;LACTOBACILLUS RHAMNOSUS;MEMBRANOUS NEPHROPATHY;MODIFIED RANKIN SCALE;7-DEHYDROCHOLESTEROL REDUCTASE;ADAMTS13;AEROALLERGEN;AFLIBERCEPT;ANAPHYLACTIC REACTIONS;ANTIRETROVIRAL THERAPY;APOLIPOPROTEIN A1;BIFIDOBACTERIUM;BRANCH RETINAL VEIN OCCLUSION;BRUTON'S TYROSINE KINASE;CANNABINOID RECEPTOR;CERTOLIZUMAB PEGOL;CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS;CIRCULATING TUMOR CELL;COLECTOMY;CONTINUOUS GLUCOSE MONITORING;COPY-NUMBER VARIATION;CYANOACRYLATE;DIGITAL POLYMERASE CHAIN REACTION;DORSOLATERAL PREFRONTAL CORTEX;DYSKINESIA;ECULIZUMAB;EFFECTS OF CANNABIS;ELIMINATION DIET;ESTROGEN RECEPTOR;FOOD ALLERGENS;GENE REGULATORY NETWORK;GENE SIGNATURE;GLUCOSE HOMEOSTASIS;GLYCATED HEMOGLOBIN;GOLIMUMAB;HISTONE METHYLTRANSFERASE;HOMICIDE;HUMAN GROWTH HORMONE;IDARUBICIN;INTERFACE (MATTER);IPILIMUMAB;JAK2 V617F;KETOACIDOSIS;KIDNEY TRANSPLANT;KLEBSIELLA PNEUMONIA;KLEBSIELLA PNEUMONIAE;KRAS;LACTOBACILLUS REUTERI;LAMIVUDINE;LATENT TUBERCULOSIS;LIVE ATTENUATED INFLUENZA VACCINE;LYMPHOBLASTIC LYMPHOMA;MAMMOGRAPHY;MANIA;METASTATIC BREAST CANCER;MICROKERATOME;MIGRAINE WITH AURA;MILK ALLERGY;MONOCLONAL;NILOTINIB;PROBAND;RANIBIZUMAB;RUBELLA;SACCHAROMYCES BOULARDII;SANGER SEQUENCING;SECUKINUMAB;SHIGA TOXIN;SOLID-PHASE MICROEXTRACTION;SOMATROPIN;SUBSTRATE REDUCTION THERAPY;TOCOPHEROL;TRANSCRIPTOME;TRANSLATION (BIOLOGY);TRANSPOSABLE ELEMENT;USTEKINUMAB;VON WILLEBRAND DISEASE","26;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ITALY;MIDDLE AGED;COVID-19;ADULT;CHILD;AGED;ADOLESCENT;CORONAVIRUS INFECTIONS;PNEUMONIA, VIRAL;SARS-COV-2;REGISTRIES;BIOMARKERS;PANDEMICS;RETROSPECTIVE STUDIES;INFANT;CHILD, PRESCHOOL","82;80;43;43;37;28;26;24;24;23;20;18;18;12;11;10;10;10;9;8","CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;IMPACT OF COVID-19 ON MENTAL HEALTH;KIDNEY TRANSPLANTATION;ACUTE MYELOID LEUKEMIA;ASTHMA;AUTOINFLAMMATORY BONE DISORDERS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMMUNOGENICITY OF BIOSIMILAR THERAPEUTICS IN DRUG DEVELOPMENT;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM","7;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TREATMENT;NEPHROLOGY;CLINICAL ENDPOINT;STROKE (ENGINE);CROSS-SECTIONAL STUDY;DIABETES;INFARCTION TREATMENT;ASTHMA;BETACORONAVIRUS;CLINICAL PRACTICE;CORONAVIRUS;DEEP VEIN THROMBOSIS;EXPERT OPINION;EXTRACORPOREAL;HYDROXYCHLOROQUINE;INTRAVITREAL INJECTION;ISOLATION (MICROBIOLOGY);PEDIATRIC GASTROENTEROLOGY","14;12;8;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","COVID- PATIENTS;ITALIAN COHORT;STEM CELL;ACUTE ISCHEMIC;CELL TRANSPLANTATION;COVID- PANDEMIC;GASTROINTESTINAL BLEEDING;ISCHEMIC STROKE;LOWER GASTROINTESTINAL;PULMONARY EMBOLISM;RETROSPECTIVE STUDY;RISK FACTORS;SOUTHERN ITALY;TYPE DIABETES;ACUTE LOWER;ACUTE LYMPHOBLASTIC;ACUTE MYELOID;ACUTE PULMONARY;ALLERGEN IMMUNOTHERAPY;BREAST CANCER;CARDIOVASCULAR RISK;CHRONIC KIDNEY;CHRONIC NON-BACTERIAL;CLINICAL TRIAL;COHORT STUDY;CONGENITAL CARDIAC;COVID- REGISTRY;CRITICALLY ILL;EXPERT OPINION;GLUCOSE METABOLISM","4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GA VERSUS;INFLUENZA VACCINATION;INTENSIVE CARE;MULTIPLE MYELOMA;SPEAKERS BUREAU;ADVERSE EVENTS;AOR CI;SIGNIFICANTLY LOWER;COVID- PATIENTS;CV RISK;EMERGENCY DEPARTMENT;MEDIAN AGE;PATIENTS TREATED;CLINICAL PRACTICE;COLORECTAL CANCER;MODIFIED RANKIN;RANKIN SCALE;ACUTE RESPIRATORY;ADVISORY COMMITTEES;CORONAVIRUS DISEASE;COVID- PANDEMIC;ENTITYS BOARD;GLUCOSE METABOLISM;HEART DISEASE;PATIENTS AGED;PERIODONTAL TREATMENT;REPLACEMENT THERAPY;SARS-COV- INFECTION;SCALE SCORE;AFFECTED PATIENTS","11;11;11;11;11;10;10;10;9;9;9;9;9;8;8;8;8;7;7;7;7;7;7;7;7;7;7;7;7;6",38,0.23,7.49,11.75,1,1,0,1.5,0,0,0,13,0,0,11,0,1,1.5,2,7,2,0,0,73.25,63.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,3.53,1598.65,20.11,16,0.46,70.89,0,0,4,0,11,0,2,18,0,19,15,0,0,0,0,0,0,33,1,1,34,1,0,0,0,0,0,0,0,0,"United States;Italy;Denmark;Japan;Switzerland","6;3;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;4203 HEALTH SERVICES AND SYSTEMS;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;36 CREATIVE ARTS AND WRITING;3603 MUSIC;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3207 MEDICAL MICROBIOLOGY;3210 NUTRITION AND DIETETICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","35;19;8;6;3;3;2;2;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PATIENT SAFETY;RARE DISEASES;PREVENTION;INFECTIOUS DISEASES;AUTOIMMUNE DISEASE;CARDIOVASCULAR;COMPLEMENTARY AND INTEGRATIVE HEALTH;PAIN RESEARCH;CHRONIC PAIN;DIGESTIVE DISEASES;GENETICS;KIDNEY DISEASE;LYMPHOMA;MENTAL HEALTH;NEUROSCIENCES;PEDIATRIC","32;16;16;9;9;9;8;5;4;4;4;4;3;3;3;3;3;3;3;3","CANCER;CARDIOVASCULAR;INFECTION;METABOLIC AND ENDOCRINE;INFLAMMATORY AND IMMUNE SYSTEM;EYE;GENERIC HEALTH RELEVANCE;INJURIES AND ACCIDENTS;MENTAL HEALTH;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;SKIN","9;4;3;3;2;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY;3.4 VACCINES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING;8.1 ORGANISATION AND DELIVERY OF SERVICES","18;3;2;2;1;1;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;KIDNEY CANCER;MYELOMA;BLADDER CANCER;BLOOD CANCER;BRAIN TUMOR;BREAST CANCER;COLON AND RECTAL CANCER;HODGKIN'S DISEASE;NOT SITE-SPECIFIC CANCER","7;3;2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.2 SURVEILLANCE","7;3;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE","4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4206 PUBLIC HEALTH;52 PSYCHOLOGY;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY","6;4;2;2;1;1;1","PEDIATRIC;PREVENTION;CARDIOVASCULAR;CLINICAL RESEARCH;NUTRITION;OBESITY;BRAIN DISORDERS;DIABETES;HEMATOLOGY;INFECTIOUS DISEASES;LUNG;MENTAL HEALTH;PNEUMONIA;PNEUMONIA & INFLUENZA;SCHIZOPHRENIA;SEPSIS;SERIOUS MENTAL ILLNESS","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;STROKE;INFECTION;MENTAL HEALTH;METABOLIC AND ENDOCRINE","2;2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","3","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE","4",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"AOUSSN_POLICLINICOBARI",2021,191,16.5811518324607,1.68586387434555,0.162303664921466,0.18848167539267,0.172774869109948,1.73118279569892,1.29166666666667,1.28571428571429,1.17857142857143,0.638743455497382,3,83,41,11,28,0.43,0.21,0.06,0.15,12.91,0.836910747842562,6.04654654654654,0.272251308900524,0.952879581151832,0.501,0.426,0.472,0.407,"MICHELE MIRAGLIA DEL GIUDICE;FABIO CARDINALE;GIAN LUIGI MARSEGLIA;AMELIA LICARI;MAURIZIO DELVECCHIO;VICENTE ESTRADA;CAMILLO PORTA;MARTINO PEPE;IVÁN J. NÚÑEZ‐GIL;VÍCTOR MANUEL BECERRA‐MUÑOZ;RODOLFO ROMERO;CARLO CAFFARELLI;INMACULADA FERNÁNDEZ‐ROZAS;GISELA FELTES;AITOR URIBARRI;MARIA CHIRONNA;MARZIA DUSE;SERGIO RAPOSEIRAS‐ROUBÍN;DANIELA LOCONSOLE;ENRICO CERRATO","16;15;14;12;12;11;11;11;11;11;11;10;9;9;9;9;8;8;8;8","ALESSIA TODESCHINI;DESIRÉE CASELLI;MAURIZIO ARICÒ;MICHELE MIRAGLIA DEL GIUDICE;CAMILLO PORTA;MARIA CHIRONNA;GIAN LUIGI MARSEGLIA;MAURIZIO DELVECCHIO;FABIO CARDINALE;DANIELA LOCONSOLE;AMELIA LICARI;BIAGIO MORETTI;MARISA ACCOGLI;ANNA SALLUSTIO;UGO VAIRO;CARLO CAFFARELLI;PASQUALE STEFANIZZI;FRANCESCA CENTRONE;GIOVANNI MELIOTA;SILVIO TAFURI","2;1.7;1.24;1.21;1.09;1.08;1.06;1.05;1.04;1.02;0.91;0.83;0.82;0.82;0.77;0.74;0.7;0.67;0.65;0.63","FABIO CARDINALE;MAURIZIO DELVECCHIO;CAMILLO PORTA;MARTINO PEPE;PELLEGRINO MUSTO;ANNA SALLUSTIO;ANNA MARIA ZICARI;BIAGIO MORETTI;MAURIZIO ARICÒ;ELVIRA PICCINNO;ETTORE CICINELLI;FRANCESCA AREZZO;ANGELANTONIO VITUCCI;FRANCESCO ALBANO;UGO VAIRO;GENNARO CORMIO;PAOLA GIORDANO;VERA LOIZZI;DANIELA DIBELLO;FRANCESCO LA TORRE","15;12;11;11;7;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4","ALESSIA TODESCHINI;DESIRÉE CASELLI;MAURIZIO ARICÒ;CAMILLO PORTA;MAURIZIO DELVECCHIO;FABIO CARDINALE;BIAGIO MORETTI;ANNA SALLUSTIO;UGO VAIRO;GIOVANNI MELIOTA;ETTORE CICINELLI;FRANCESCA AREZZO;GENNARO CORMIO;RUGGIERO FRANCAVILLA;FERNANDA CRISTOFORI;MARIA GRAZIA FOSCHINO BARBARO;MICHELE PELLEGRINI;DANIELA DIBELLO;VERA LOIZZI;ANNA MARIA ZICARI","2;1.7;1.24;1.09;1.05;1.04;0.83;0.82;0.77;0.65;0.56;0.56;0.56;0.52;0.52;0.5;0.5;0.49;0.48;0.45","BERNHARD LUDVIK;ESTEBAN JÓDAR;FRANCESCO GIORGINO;JUAN P. FRÍAS;KATELYN BROWN;LAURA FERNÁNDEZ LANDÓ;ROSS BRAY;ÁNGEL RODRÍGUEZ;ALBERTO VILLANI;FRANCESCO LA TORRE;CLAUDIA BRACAGLIA;GABRIELE SIMONINI;ROLANDO CIMAZ;ALESSANDRA MARCHESI;ANDREA TADDIO;FIAMMETTA ZUNICA;GIAN VINCENZO ZUCCOTTI;MARCO CATTALINI;SARA DELLA PAOLERA;MICHELE MIRAGLIA DEL GIUDICE","374;374;374;374;374;374;374;374;256;212;197;197;197;189;189;189;189;189;189;182","FRANCESCO GIORGINO;FRANCESCO LA TORRE;MARTINO PEPE;FABIO CARDINALE;ALESSANDRA RICCO;MAURIZIO DELVECCHIO;ANNA SALLUSTIO;GIOVANNI MIGLIORE;MARCO PETRUZZELLIS;MARIA DELL’AERA;VITO LEONARDO MINIELLO;ELVIRA PICCINNO;CAMILLO PORTA;GIOVANNA ELISIANA CARPAGNANO;PAOLA PIERUCCI;PELLEGRINO MUSTO;GIUSEPPINA LEONETTI;D CARRETTA;LUCIA DIAFERIO;GIUSEPPINA FRASCA","374;197;179;170;125;121;115;115;102;69;67;65;58;58;58;55;45;44;41;40","FABIO CARDINALE;MAURIZIO DELVECCHIO;MARTINO PEPE;CAMILLO PORTA;ANNA SALLUSTIO;PELLEGRINO MUSTO;ELVIRA PICCINNO;FRANCESCA AREZZO;UGO VAIRO;ANGELANTONIO VITUCCI;D CARRETTA;DANIELA DIBELLO;GIOVANNI MELIOTA;GIOVANNI MIGLIORE;MAURIZIO ARICÒ;DESIRÉE CASELLI;FERNANDA CRISTOFORI;LEONARDO VINCENTI;MARIO DELIA;MARIO GIORDANO","15;12;11;10;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;ECONOMICS;CHEMISTRY;ENGINEERING;PSYCHOLOGY;POLITICAL SCIENCE;MATHEMATICS;SOCIOLOGY;MATERIALS SCIENCE;BUSINESS;ART;PHILOSOPHY;ENVIRONMENTAL SCIENCE;HISTORY","183;44;15;13;12;8;8;8;7;6;5;4;3;2;2;1;1","INTERNAL MEDICINE;PEDIATRICS;SURGERY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PATHOLOGY;GENETICS;ENVIRONMENTAL HEALTH;ONCOLOGY;ENDOCRINOLOGY;VIROLOGY;EMERGENCY MEDICINE;GASTROENTEROLOGY;PSYCHIATRY;CARDIOLOGY;FAMILY MEDICINE;NURSING;OPTICS;ECONOMIC GROWTH;MEDICAL EMERGENCY;RADIOLOGY","142;50;37;33;31;31;28;22;21;20;20;15;15;14;13;11;11;10;9;9;9","DISEASE;OUTBREAK;POPULATION;COHORT;GENE;CANCER;DIABETES MELLITUS;RETROSPECTIVE COHORT STUDY;HEALTH CARE;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;ANTIBODY;CONFIDENCE INTERVAL;ODDS RATIO;VACCINATION;INSULIN;TRANSPLANTATION;ADVERSE EFFECT;COHORT STUDY;EMERGENCY DEPARTMENT;INCIDENCE (GEOMETRY);LOGISTIC REGRESSION","64;22;21;20;18;17;17;15;11;10;10;9;9;9;9;8;8;7;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;TYPE 2 DIABETES;TYPE 1 DIABETES;CLINICAL ENDPOINT;GLYCEMIC;HAZARD RATIO;MUTATION;PHENOTYPE;PROGRESSION-FREE SURVIVAL;SORAFENIB;TELEMEDICINE;TOLERABILITY;COLORECTAL CANCER;GENOME;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEPHROPATHY;OVARIAN CANCER;PROTEINURIA;RENAL BIOPSY;SALVAGE THERAPY","40;19;7;6;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);INSULIN PUMP;CONTINUOUS GLUCOSE MONITORING;DASATINIB;GENOME INSTABILITY;MONOCLONAL;SEROUS CARCINOMA;WHOLE GENOME SEQUENCING;ABSOLUTE NEUTROPHIL COUNT;ACINETOBACTER BAUMANNII;ACUTE BRONCHIOLITIS;ACUTE LYMPHOCYTIC LEUKEMIA;ALCOHOL INTOXICATION;ALPHA (FINANCE);ANTIBIOTIC STEWARDSHIP;ANTIMICROBIAL STEWARDSHIP;ANTIRETROVIRAL THERAPY;AXITINIB;BASDAI;BRCA MUTATION;CANAKINUMAB;CARDIAC RESYNCHRONIZATION THERAPY;CD3;CEFTAZIDIME;CENTRAL PRECOCIOUS PUBERTY;CERTOLIZUMAB PEGOL;CHIMERIC ANTIGEN RECEPTOR;COLONOSCOPY;DABIGATRAN;DIROFILARIA;DIROFILARIA REPENS;DNA MISMATCH REPAIR;DUODENITIS;ECULIZUMAB;ELTROMBOPAG;ENTEROBACTERIACEAE;FETAL HEAD;FETAL POSITION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GERMLINE MUTATION;GLYCATED HEMOGLOBIN;GLYCOGEN STORAGE DISEASE TYPE II;GOLIMUMAB;HAEMOPHILIA B;HISTONE METHYLTRANSFERASE;IMATINIB MESYLATE;INSULIN GLARGINE;KARYOTYPE;KETOACIDOSIS;KLEBSIELLA PNEUMONIA;LACTOBACILLUS PARACASEI;LIVE ATTENUATED INFLUENZA VACCINE;LOSS FUNCTION;MEROPENEM;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NILOTINIB;NIVOLUMAB;NON-SMALL CELL LUNG CANCER (NSCLC);OBESITY PARADOX;ORAL FOOD CHALLENGE;OSTEOPENIA;OSWESTRY DISABILITY INDEX;PAZOPANIB;PEDIATRIC EMERGENCY MEDICINE;PEDIOCOCCUS;PHILADELPHIA CHROMOSOME;POSACONAZOLE;PROBAND;PROPHYLACTIC SURGERY;RETINAL VASCULITIS;ROTAVIRUS VACCINE;RUXOLITINIB;SCLEROSTIN;SECUKINUMAB;SERVQUAL;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;STENOTROPHOMONAS MALTOPHILIA;TELEHEALTH;THROMBOPOIETIN;TIMI;TOTAL MESORECTAL EXCISION;UROTHELIAL CARCINOMA;VACCINATION SCHEDULE;VANCOMYCIN;VESICOURETERAL REFLUX","40;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;COVID-19;ITALY;FEMALE;MALE;CHILD;SARS-COV-2;ADULT;MIDDLE AGED;ADOLESCENT;AGED;DIABETES MELLITUS, TYPE 1;RETROSPECTIVE STUDIES;GLYCATED HEMOGLOBIN A;PROSPECTIVE STUDIES;HEART FAILURE;TREATMENT OUTCOME;CHILD, PRESCHOOL;COVID-19 VACCINES","104;87;55;44;35;35;25;24;23;20;17;15;14;13;12;10;9;9;8;8","CORONAVIRUS DISEASE 2019 RESEARCH;CORONAVIRUS DISEASE 2019;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;RENAL CELL CARCINOMA;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MANAGEMENT AND TREATMENT OF HEMOPHILIA;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EFFICACY AND RESISTANCE IN CML TREATMENT","12;11;9;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TYPE 1 DIABETES;DIABETES;VACCINES;CONTINUOUS GLUCOSE MONITORING;CLINICAL CHARACTERISTICS;TREATMENT;CLINICAL ENDPOINT;INTERQUARTILE RANGE;CROSS-SECTIONAL STUDY;DISCONTINUATION;INSULIN THERAPY;PROGRESSION-FREE SURVIVAL;REGIMEN;TELEHEALTH;TOLERABILITY;TYPE 2 DIABETES;CARDIAC ULTRASOUND;CORONA VIRUS","19;16;10;8;8;7;6;6;5;5;4;4;4;4;4;4;4;4;3;3","TYPE DIABETES;SARS-COV- INFECTION;CELL CARCINOMA;RENAL CELL;SOUTHERN ITALY;CYSTIC FIBROSIS;HEART DISEASE;ITALIAN SOCIETY;RANDOMIZED CLINICAL;CANCER PATIENTS;CLINICAL TRIAL;COHORT STUDY;CONGENITAL HEART;COVID- VACCINE;CROSS-SECTIONAL STUDY;EMERGENCY DEPARTMENT;HEALTH CARE;IMMUNE CHECKPOINT;INTERNATIONAL HOPE-COVID--REGISTRY;ACUTE LYMPHOBLASTIC;ALLERGIC DISEASES;ANTERIOR POSITIONS;APPROACH APPLIED;ARTIFICIAL INTELLIGENCE;AUTOMATIC DIFFERENTIATION;BLAST CRISIS;BNTB MRNA;BONE METASTASES;BOWEL DISEASE;CABOZANTINIB VERSUS","9;8;6;6;6;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","ADVISORY COMMITTEES;ENTITYS BOARD;SARS-COV- INFECTION;SPEAKERS BUREAU;BMI KGM;DISEASE ACTIVITY;INTENSIVE CARE;MEDIAN AGE;RISK FACTORS;COVID- PANDEMIC;MORTALITY RATE;UNIVERSITY HOSPITAL;CLINICAL PRACTICE;EMERGENCY DEPARTMENT;HR CI;STATISTICALLY SIGNIFICANT;CA GRANDA;CARE UNIT;COVID- PATIENTS;SEVERE COVID-;CATARACT SURGERY;CORONAVIRUS DISEASE;RESPIRATORY INSUFFICIENCY;ANGELO BIANCHI;BIANCHI BONOMI;BONOMI HAEMOPHILIA;CENTRE FONDAZIONE;CONSULTANCY HONORARIA;FONDAZIONE IRCCS;FOUNDATION MILAN","22;22;21;15;14;13;13;13;13;12;12;12;11;11;11;11;10;10;10;10;9;9;9;8;8;8;8;8;8;8",51,0.27,9.41,12,1.25,2.5,0,6,1,0,1,14.5,1,1,12,1,2,1,2.75,8,3,0,0,54,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,32,3.22,581.19,19.05,14,0.44,67.62,0,0,4,0,9,0,0,19,0,17,15,0,0,0,0,0,0,31,1,0,32,0,0,0,0,0,0,0,0,0,"Italy;United States;Japan;Denmark;Ireland","18;6;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3215 REPRODUCTIVE MEDICINE;34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;36 CREATIVE ARTS AND WRITING;3603 MUSIC;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","30;15;8;5;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;PREVENTION;HEMATOLOGY;PATIENT SAFETY;DIGESTIVE DISEASES;PEDIATRIC;PEDIATRIC CANCER;BIOENGINEERING;KIDNEY DISEASE;PAIN RESEARCH;AUTOIMMUNE DISEASE;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;ORPHAN DRUG;REGENERATIVE MEDICINE;STEM CELL RESEARCH;TRANSPLANTATION","31;16;11;11;10;8;7;6;6;5;4;4;4;3;3;3;3;3;3;3","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;INFECTION;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;BLOOD;MENTAL HEALTH;SKIN;STROKE","10;3;3;2;2;2;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;7.1 INDIVIDUAL CARE NEEDS","19;1;1;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;MYELOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;KIDNEY CANCER;LUNG CANCER;SARCOMA;GENITAL SYSTEM, FEMALE;HODGKIN'S DISEASE;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;OVARIAN CANCER;PANCREATIC CANCER;SMALL INTESTINE CANCER","5;3;2;2;2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.2 TECHNOLOGY AND/OR MARKER EVALUATION WITH RESPECT TO FUNDAMENTAL PARAMETERS OF METHOD;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","10;2;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;ZENODO","3;2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3401 ANALYTICAL CHEMISTRY;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","8;5;3;2;1;1;1;1;1","CLINICAL RESEARCH;PATIENT SAFETY;PSORIASIS;CANCER;HEMATOLOGY;INFECTIOUS DISEASES;PREVENTION;SEPSIS","3;2;2;1;1;1;1;1","CONGENITAL;INFECTION;SKIN;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM","2;2;2;1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","2;2;1;1","CLINICAL;BIOMEDICAL","4;1","CLINICAL MEDICINE AND SCIENCE","5","MELANOMA","1","3 GOOD HEALTH AND WELL BEING","1"
"AOUSSN_POLICLINICOBARI",2022,208,17.6634615384615,2.53846153846154,0.288461538461538,0.264423076923077,0.274038461538462,1.71986970684039,1.22448979591837,1.41025641025641,1.23913043478261,0.8125,3,56,42,27,18,0.27,0.2,0.13,0.09,5.86,0.656514245363028,5.44832041343668,0.264423076923077,0.894230769230769,0.48,0.445,0.399,0.456,"FRANCESCO LA TORRE;FABIO CARDINALE;CARLO D’AGOSTINO;FLORENZO IANNONE;ANTONIO VITALE;MARIA CRISTINA MAGGIO;MICOL FRASSI;MARIA CHIRONNA;GAAFAR RAGAB;BRUNO FREDIANI;GIUSEPPE LOPALCO;ABDURRAHMAN TUFAN;MARIA FELICIA FAIENZA;ALBERTO BALISTRERI;EWA WIĘSIK–SZEWCZYK;ROSA MARIA RODRIGUES PEREIRA;LUCA CANTARINI;MAURIZIO DELVECCHIO;JURGEN SOTA;CARLA GAGGIANO","14;13;12;11;10;10;10;10;9;9;9;9;9;9;9;9;9;9;9;9","LEONARDO MILELLA;CARLO D’AGOSTINO;D CARRETTA;GIOVANNI PISCOPO;MARCO RINALDI;DANIELA DIBELLO;MARIA FELICIA FAIENZA;MARIA CHIRONNA;ROSSELLA TROCCOLI;ALBINA TUMMOLO;CAMILLO PORTA;DANIELA LOCONSOLE;A FERRIERI;A DENTICO;PELLEGRINO MUSTO;VALENTINA DI CARLO;G EPICOCO;F CARRETTA;PAOLA GIORDANO;MICHELE COVIELLO","1.49;1.34;1.16;1.1;1;0.99;0.96;0.94;0.93;0.88;0.88;0.82;0.8;0.8;0.79;0.74;0.74;0.74;0.71;0.64","FRANCESCO LA TORRE;FABIO CARDINALE;CARLO D’AGOSTINO;FLORENZO IANNONE;MARIA FELICIA FAIENZA;MAURIZIO DELVECCHIO;CAMILLO PORTA;PELLEGRINO MUSTO;D CARRETTA;PAOLA GIORDANO;ALBINA TUMMOLO;ROSSELLA TROCCOLI;RITA FISCHETTO;A FERRIERI;A DENTICO;ANGELANTONIO VITUCCI;DANIELA DIBELLO;ELVIRA PICCINNO;G EPICOCO;F CARRETTA","14;13;12;11;9;9;8;8;8;8;7;6;6;6;6;6;5;5;5;5","LEONARDO MILELLA;CARLO D’AGOSTINO;D CARRETTA;GIOVANNI PISCOPO;MARCO RINALDI;DANIELA DIBELLO;MARIA FELICIA FAIENZA;ROSSELLA TROCCOLI;ALBINA TUMMOLO;CAMILLO PORTA;A FERRIERI;A DENTICO;PELLEGRINO MUSTO;G EPICOCO;F CARRETTA;PAOLA GIORDANO;MICHELE COVIELLO;RUGGIERO FRANCAVILLA;FERNANDA CRISTOFORI;ANNAMARIA DICINTIO","1.49;1.34;1.16;1.1;1;0.99;0.96;0.93;0.88;0.88;0.8;0.8;0.79;0.74;0.74;0.71;0.64;0.64;0.64;0.6","FABIO CARDINALE;MARIA CHIRONNA;FRANCESCO LA TORRE;DANIELA LOCONSOLE;FLORENZO IANNONE;ANTONIO VITALE;MARIA CRISTINA MAGGIO;ABDURRAHMAN TUFAN;ALBERTO BALISTRERI;BRUNO FREDIANI;CARLA GAGGIANO;CLAUDIA FABIANI;EWA WIĘSIK–SZEWCZYK;GAAFAR RAGAB;GIUSEPPE LOPALCO;JURGEN SOTA;LUCA CANTARINI;PIERO RUSCITTI;ROSA MARIA RODRIGUES PEREIRA;FRANCESCA CENTRONE","147;139;135;134;110;106;105;104;104;104;104;104;104;104;104;104;104;104;104;103","FABIO CARDINALE;FRANCESCO LA TORRE;MARIO DELIA;ANNA SALLUSTIO;CAMILLO PORTA;ANTONIO DALENO;ELVIRA PICCINNO;MAURIZIO DELVECCHIO;CARLO D’AGOSTINO;ANGELA GERNONE;RITA FISCHETTO;ROBERTA CARDINALI;SIMONETTA SIMONETTI;TANIA LORÈ;DANIELE CASULLI;LEONARDO MILELLA;MIMMA RIZZO;VIOLETTA MASTRORILLI;AZZURRA ORLANDI;CRISTINA SERIO","147;135;88;77;48;46;43;41;39;38;37;35;35;35;33;32;32;30;29;29","FABIO CARDINALE;FRANCESCO LA TORRE;CARLO D’AGOSTINO;CAMILLO PORTA;D CARRETTA;MAURIZIO DELVECCHIO;PELLEGRINO MUSTO;ALBINA TUMMOLO;A DENTICO;A FERRIERI;RITA FISCHETTO;ROSSELLA TROCCOLI;ANNA SALLUSTIO;ANGELANTONIO VITUCCI;DANIELA DIBELLO;ELVIRA PICCINNO;FERNANDA CRISTOFORI;MARIO DELIA;RUGGIERO FRANCAVILLA;ANNAMARIA DICINTIO","14;14;12;8;8;8;7;7;6;6;6;6;5;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;MATHEMATICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;BUSINESS;GEOLOGY;GEOGRAPHY","205;57;24;12;11;10;9;9;7;7;6;5;4;4;1","INTERNAL MEDICINE;SURGERY;PEDIATRICS;GENETICS;CARDIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PATHOLOGY;ONCOLOGY;INTENSIVE CARE MEDICINE;VIROLOGY;ENDOCRINOLOGY;PSYCHIATRY;GASTROENTEROLOGY;FAMILY MEDICINE;OPTICS;BIOCHEMISTRY;NURSING;ANESTHESIA;PHYSICAL THERAPY","159;47;41;32;30;29;29;28;22;19;19;17;17;16;14;14;13;11;10;10","DISEASE;POPULATION;GENE;CANCER;COHORT;OUTBREAK;HEART FAILURE;INCIDENCE (GEOMETRY);RECEPTOR;VACCINATION;ANTIBODY;CLINICAL TRIAL;CONFIDENCE INTERVAL;ADVERSE EFFECT;DIABETES MELLITUS;OBSERVATIONAL STUDY;RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;BLOOD PRESSURE;CONTEXT (ARCHAEOLOGY);LEUKEMIA;RENAL CELL CARCINOMA","59;27;19;17;16;13;12;12;11;11;10;9;9;8;8;8;8;7;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;EJECTION FRACTION;ELECTRONIC DATA CAPTURE;IMMUNOTHERAPY;PHENOTYPE;DISEASE REGISTRY;MUTATION;BREAST CANCER;CABOZANTINIB;CLINICAL ENDPOINT;MONOCLONAL ANTIBODY;OVARIAN CANCER;SEPTIC SHOCK;SEROLOGY;TYPE 1 DIABETES;ANAKINRA;ANTIBIOTIC RESISTANCE;CRONBACH'S ALPHA;DESENSITIZATION (MEDICINE);ENZYME REPLACEMENT THERAPY;HEART RATE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;INNATE IMMUNE SYSTEM;NEUTROPENIA;PSORIATIC ARTHRITIS;SUNITINIB;TITER;TYPE 2 DIABETES;VASCULAR RESISTANCE;VENOUS THROMBOSIS","30;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;MONOCLONAL;PEMBROLIZUMAB;SECUKINUMAB;AXITINIB;CARDIAC RESYNCHRONIZATION THERAPY;DNA METHYLATION;FEBRILE NEUTROPENIA;GENETIC HETEROGENEITY;GOLIMUMAB;IPILIMUMAB;MEASLES VACCINE;MISSENSE MUTATION;MUCOPOLYSACCHARIDOSIS TYPE I;PAZOPANIB;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;USTEKINUMAB;ACINETOBACTER BAUMANNII;ACUTE BRONCHIOLITIS;ACYL COA DEHYDROGENASE;ADAMTS13;ALLERGEN IMMUNOTHERAPY;ALTERNATIVE COMPLEMENT PATHWAY;ANGIOTENSIN II RECEPTOR TYPE 1;ANTIBIOTIC STEWARDSHIP;ANTIMICROBIAL STEWARDSHIP;ANTIRETROVIRAL THERAPY;ASPARTATE TRANSAMINASE;BASAL INSULIN;BENCE JONES PROTEIN;BLINATUMOMAB;BRADYCARDIA;BRCA MUTATION;CANAKINUMAB;CANNABINOID RECEPTOR;CARBOPLATIN;CATH LAB;CERTOLIZUMAB PEGOL;CHEMOSENSITIZER;CHIMERIC ANTIGEN RECEPTOR;CIRCULATING TUMOR CELL;CLADE;CLASSICAL COMPLEMENT PATHWAY;COMPLEMENT DEFICIENCY;COMPLEMENTATION;CONCUSSION;CONTINUOUS GLUCOSE MONITORING;COPY-NUMBER VARIATION;DEATH CERTIFICATE;DEBULKING;DOPAMINERGIC PATHWAYS;DORSOLATERAL PREFRONTAL CORTEX;DYSCRASIA;ELTROMBOPAG;ENTHESITIS;EPIRETINAL MEMBRANE;EPITHELIAL–MESENCHYMAL TRANSITION;ESMOLOL;EXOME SEQUENCING;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;FONDAPARINUX;FRAMESHIFT MUTATION;GERMLINE MUTATION;GROWTH HORMONE DEFICIENCY;HAEMOPHILIA B;HEART FAILURE WITH PRESERVED EJECTION FRACTION;HERPESVIRIDAE;HUMAN GROWTH HORMONE;HYPERPHENYLALANINEMIA;IBRUTINIB;IMMUNOGLOBULIN D;IN UTERO;INFORMATION GOVERNANCE;INSULIN DELIVERY;INSULIN PUMP;KRAS;LOSS FUNCTION;MACHINE PERFUSION;MACULAR HOLE;MEROPENEM;MUCOPOLYSACCHARIDOSIS I;MUCOPOLYSACCHARIDOSIS TYPE II;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NONTUBERCULOUS MYCOBACTERIA;OBETICHOLIC ACID;OSTEOPROTEGERIN;PARATHYROID HORMONE-RELATED PROTEIN;PHENYLKETONURIAS;PHOSPHOINOSITIDE 3-KINASE;PKD1;PLACENTA;PLAQUE REDUCTION NEUTRALIZATION TEST;PLASMA CELL DYSCRASIA;POLYCYSTIC OVARY;PONSETI METHOD;PROPHYLACTIC SURGERY;PYLOROMYOTOMY;RANKL;RIFABUTIN;RUXOLITINIB;SALMONELLA ENTERICA;SANGER SEQUENCING;SENTINEL LYMPH NODE;SENTINEL NODE;SEROTONERGIC;SEROUS CARCINOMA;SEX HORMONE-BINDING GLOBULIN;SOMATOSTATIN RECEPTOR 2;STEATOHEPATITIS;SUBLINGUAL IMMUNOTHERAPY;SYNBIOTICS;SYSTEMIC THERAPY;THROMBOPOIETIN;TILT TABLE TEST;TRANSIENT ELASTOGRAPHY;TROUGH LEVEL;VACCINE SAFETY;VACCINIA;VANCOMYCIN;VENETOCLAX;VON WILLEBRAND DISEASE","30;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;COVID-19;CHILD;FEMALE;MALE;RETROSPECTIVE STUDIES;SARS-COV-2;TREATMENT OUTCOME;DIABETES MELLITUS, TYPE 1;RENAL INSUFFICIENCY, CHRONIC;ADOLESCENT;ADULT;ITALY;CARDIOVASCULAR DISEASES;CARCINOMA, RENAL CELL;COVID-19 VACCINES;KIDNEY NEOPLASMS;MUCOPOLYSACCHARIDOSIS I;HEART FAILURE","115;92;43;30;17;16;16;15;13;12;12;11;11;11;9;8;8;8;8;7","CORONAVIRUS DISEASE 2019 RESEARCH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;RENAL CELL CARCINOMA;CORONAVIRUS DISEASE 2019;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ACUTE MYELOID LEUKEMIA;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA","11;7;7;5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","TREATMENT;PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;VACCINES;ELECTRONIC DATA CAPTURE;TYPE 1 DIABETES;CABOZANTINIB;CLINICAL ENDPOINT;DIABETES;DISEASE REGISTRY;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;LEAD (GEOLOGY);NEPHROLOGY;PATIENT REGISTRY;REFRACTORY (PLANETARY SCIENCE);CONCOMITANT;CORONA VIRUS;DISCONTINUATION;ECHOCARDIOGRAPHY;GOLD STANDARD (TEST)","13;11;8;7;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3","CELL CARCINOMA;INTERNATIONAL REGISTRY;RENAL CELL;AIDA INTERNATIONAL;SARS-COV- INFECTION;SOUTHERN ITALY;ARTERIAL HYPERTENSION;COVID- PANDEMIC;PSORIATIC ARTHRITIS;PULMONARY ARTERIAL;SEPTIC SHOCK;TYPE DIABETES;ADVANCED RENAL;AUTOINFLAMMATORY DISEASES;BIOLOGIC TREATMENTS;CLINICAL OUTCOME;ITALIAN SOCIETY;ITALY RESULTS;LEAD EXTRACTION;LONGITUDINAL STUDY;MONOCLONAL GAMMOPATHY;NEWBORN SCREENING;OBSERVATIONAL LONGITUDINAL;RETROSPECTIVE ANALYSIS;SINGLE CENTER;STILLS DISEASE;TRANSVENOUS LEAD;UNDETERMINED SIGNIFICANCE;VON WILLEBRAND;ACUTE LYMPHOBLASTIC","7;7;7;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","SARS-COV- INFECTION;MGUS PATIENTS;RISK FACTORS;ADVERSE EVENTS;SIGNIFICANT DIFFERENCES;INTERNATIONAL REGISTRY;PACLITAXEL MGM;ADULT PATIENTS;AUC PACLITAXEL;BEV MGKG;CARBOPLATIN AUC;HEART FAILURE;INTENSIVE CARE;MEDIAN AGE;CARE UNIT;VACCINATED MGUS;AIDA INTERNATIONAL;HR CI;PATIENTS TREATED;SIGNIFICANTLY LOWER;STILLS DISEASE;BNTB MRNA;COVID- PATIENTS;HRD-POSITIVE PATIENTS;INCREASED RISK;OBSERVATIONAL STUDY;OVARIAN CANCER;RUCAPARIB MG;AE COSTS;ALLIANCE AIDA","29;21;17;15;14;13;13;12;12;12;12;12;12;12;11;11;10;10;10;10;10;9;9;9;9;9;9;9;8;8",50,0.24,7.18,7,0,1,0,2.5,1,0,0,9,1,0,6.5,0,0,1,2.75,4,2,0,0,20.5,20.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,4.5,1834.22,6.25,8,0.44,110.5,0,0,0,0,8,0,3,7,0,13,5,0,0,0,0,0,0,18,0,0,17,0,0,1,0,0,0,0,0,0,"United States;Italy;Denmark;Australia;Finland;Spain","11;3;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;4206 PUBLIC HEALTH;5202 BIOLOGICAL PSYCHOLOGY","18;13;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PREVENTION;RARE DISEASES;LUNG;BIOENGINEERING;DIGESTIVE DISEASES;NEUROSCIENCES;NUTRITION;PEDIATRIC;ASSISTIVE TECHNOLOGY;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CANCER;COLO-RECTAL CANCER;DIABETES;EPILEPSY;KIDNEY DISEASE;NEURODEGENERATIVE","18;13;7;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","CANCER;METABOLIC AND ENDOCRINE;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;RESPIRATORY;STROKE","3;3;3;3;2;2;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;5.1 PHARMACEUTICALS;6.4 SURGERY","10;2;2;1;1;1;1;1","COLON AND RECTAL CANCER;BRAIN TUMOR;KIDNEY CANCER;LIVER CANCER;MYELOMA","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;2.3 INTERACTIONS OF GENES AND/OR GENETIC POLYMORPHISMS WITH EXOGENOUS AND/OR ENDOGENOUS FACTORS;3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","3;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"FRONTIERS;KARGER PUBLISHERS","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;52 PSYCHOLOGY;5201 APPLIED AND DEVELOPMENTAL PSYCHOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY","8;8;4;2;2;1","CLINICAL RESEARCH;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;NUTRITION;OBESITY;CANCER;BIOTECHNOLOGY;BRAIN CANCER;BRAIN DISORDERS;KIDNEY DISEASE;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER","5;5;4;4;4;2;1;1;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1","BRAIN TUMOR;KIDNEY CANCER","1;1",NA,NA
"AOUSSN_POLICLINICOBARI",2023,199,20.286432160804,2.35175879396985,0.221105527638191,0.231155778894472,0.256281407035176,1.57046979865772,1.25714285714286,1.35294117647059,1.24390243902439,0.693467336683417,2,59,33,21,21,0.3,0.17,0.11,0.11,3.41,0.777313634502843,4.98842592592593,0.281407035175879,0.889447236180904,0.432,0.431,0.36,0.414,"FRANCESCO LA TORRE;FLORENZO IANNONE;MARIA FELICIA FAIENZA;FABIO CARDINALE;PELLEGRINO MUSTO;GABRIELE SIMONINI;GIUSEPPE LOPALCO;MAURIZIO DELVECCHIO;GIOVANNI CONTI;ANGELA MAURO;MARIA CRISTINA MAGGIO;MARCO CATTALINI;IBRAHIM ALMAGHLOUTH;BRUNO FREDIANI;NICOLA CASCAVILLA;VALERIA CAGGIANO;ANTONIO VITALE;ABDURRAHMAN TUFAN;ALBERTO BALISTRERI;MIMMA RIZZO","15;8;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6","FRANCESCO LA TORRE;ANGELO CIGNARELLI;MARIA ELENA PAPAGNI;DESIRÉE CASELLI;UGO VAIRO;M. LOMBARDI;GIOVANNI MELIOTA;ALFREDO DI LEO;MARIA FELICIA FAIENZA;ROBERTO LOVERO;SILVIO TAFURI;FRANCESCA DI SERIO;BIAGIO MORETTI;ANDREA TADDIO;RITA DARIO;MARINA POPOLIZIO;VINCENZO DI LECCE;ALBERTO AMATO;PELLEGRINO MUSTO;MARCO CATTALINI","1.15;1;1;0.86;0.84;0.76;0.76;0.74;0.72;0.62;0.6;0.54;0.51;0.5;0.5;0.5;0.5;0.5;0.49;0.48","FRANCESCO LA TORRE;FLORENZO IANNONE;MARIA FELICIA FAIENZA;FABIO CARDINALE;PELLEGRINO MUSTO;MAURIZIO DELVECCHIO;MIMMA RIZZO;MARCO PETRUZZELLIS;ALESSANDRA RICCO;ALFREDO DI LEO;DESIRÉE CASELLI;ROBERTO LOVERO;FRANCESCA DI SERIO;UGO VAIRO;LORETO GESUALDO;ALESSANDRO BERTOLINO;FRANCESCO LOCONSOLE;CAMILLO PORTA;MARCO MATTEO CICCONE;RITA FISCHETTO","15;8;8;8;8;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4","FRANCESCO LA TORRE;ANGELO CIGNARELLI;MARIA ELENA PAPAGNI;DESIRÉE CASELLI;UGO VAIRO;M. LOMBARDI;GIOVANNI MELIOTA;ALFREDO DI LEO;MARIA FELICIA FAIENZA;ROBERTO LOVERO;SILVIO TAFURI;FRANCESCA DI SERIO;RITA DARIO;PELLEGRINO MUSTO;LORETO GESUALDO;GIUSEPPE LOSURDO;FABIO CARDINALE;A MAIORANO;MARCO MATTEO CICCONE;RUGGIERO FRANCAVILLA","1.15;1;1;0.86;0.84;0.76;0.76;0.74;0.72;0.62;0.6;0.54;0.5;0.49;0.48;0.47;0.46;0.46;0.44;0.43","FRANCESCO LA TORRE;MAURIZIO DELVECCHIO;TERESA SANTANTONIO;ENZA MOZZILLO;ALBERTO ENRICO MARAOLO;ALESSANDRA MULARONI;ALESSIO FARCOMENI;ALICE ANNALISA MEDAGLIA;ANDREA MARINO;ANNA CARRETTA;ANTONINA FRANCO;ANTONIO ALBANESE;ANTONIO CASCIO;BRUNO CACOPARDO;CALOGERO RICCARDO BUSCEMI;CARMELO IACOBELLO;CHRISTIAN SGROI;CLAUDIA GIOÈ;DONATELLA PALAZZO;FILIPPO PIERALLI","70;60;56;54;53;53;53;53;53;53;53;53;53;53;53;53;53;53;53;53","FRANCESCO LA TORRE;MAURIZIO DELVECCHIO;LIDIA DALFINO;ALESSANDRA RICCO;ELVIRA PICCINNO;RUGGIERO FRANCAVILLA;PELLEGRINO MUSTO;FABIO CARDINALE;FERNANDA CRISTOFORI;MIMMA RIZZO;ANGELANTONIO VITUCCI;ANTONIO MOSCHETTA;MARCO PETRUZZELLIS;CAMILLO PORTA;DESIRÉE CASELLI;DOMENICO ADDUCE;FRANCESCO LOCONSOLE;DELIO GAGLIARDI;FRANCESCA DI SERIO;MARTINO PEPE","70;60;53;48;47;45;37;31;30;28;23;23;23;21;21;21;20;19;14;14","FRANCESCO LA TORRE;FABIO CARDINALE;PELLEGRINO MUSTO;MAURIZIO DELVECCHIO;ALESSANDRA RICCO;MARCO PETRUZZELLIS;MIMMA RIZZO;FRANCESCA DI SERIO;UGO VAIRO;A MAIORANO;CAMILLO PORTA;DESIRÉE CASELLI;FRANCESCO LOCONSOLE;GIOVANNI MELIOTA;M. LOMBARDI;MARCO MATTEO CICCONE;MARIO DELIA;RITA FISCHETTO;ROBERTO LOVERO;RUGGIERO FRANCAVILLA","15;8;8;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;CHEMISTRY;MATHEMATICS;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;GEOLOGY;PHILOSOPHY;SOCIOLOGY;BUSINESS;GEOGRAPHY;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE","188;34;26;16;15;10;10;8;8;7;3;3;3;2;2;1;1","INTERNAL MEDICINE;SURGERY;PEDIATRICS;IMMUNOLOGY;PATHOLOGY;CARDIOLOGY;INTENSIVE CARE MEDICINE;GASTROENTEROLOGY;GENETICS;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;ONCOLOGY;PSYCHIATRY;BIOCHEMISTRY;DERMATOLOGY;NURSING;FAMILY MEDICINE;RADIOLOGY;OPTICS;PHYSICAL THERAPY","148;47;43;30;28;23;21;20;20;19;18;17;17;16;12;12;11;11;10;9","DISEASE;COHORT;RETROSPECTIVE COHORT STUDY;POPULATION;GENE;CANCER;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;COHORT STUDY;INCIDENCE (GEOMETRY);ADVERSE EFFECT;ALTERNATIVE MEDICINE;CHEMOTHERAPY;DIABETES MELLITUS;EPIDEMIOLOGY;RECEPTOR;CONFIDENCE INTERVAL;HEART FAILURE;IMMUNE SYSTEM;PLATELET;TRANSPLANTATION","46;27;23;19;15;11;10;10;9;9;8;8;8;8;8;8;7;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;PSORIATIC ARTHRITIS;2019-20 CORONAVIRUS OUTBREAK;ANAKINRA;EJECTION FRACTION;GENOTYPE;HAZARD RATIO;IMMUNIZATION;PLACEBO;UNIVARIATE ANALYSIS;COLORECTAL CANCER;CUMULATIVE INCIDENCE;GLYCEMIC;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOTHERAPY;INFLIXIMAB;RITUXIMAB;THROMBOLYSIS;TYPE 2 DIABETES","11;7;6;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);COLONOSCOPY;SECUKINUMAB;ADAMTS13;BOOSTER DOSE;CANAKINUMAB;DORSOLATERAL PREFRONTAL CORTEX;ELTROMBOPAG;IBRUTINIB;IMMUNE CHECKPOINT;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LEGIONNAIRES' DISEASE;MILAN CRITERIA;MODIFIED RANKIN SCALE;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;ACID SPHINGOMYELINASE;ACINETOBACTER BAUMANNII;ACUTE LYMPHOCYTIC LEUKEMIA;AFLIBERCEPT;ALLELE FREQUENCY;ANAPLASTIC LYMPHOMA KINASE;ANTHRACYCLINE;ANTIBIOTIC STEWARDSHIP;ANTIMICROBIAL STEWARDSHIP;AORTIC VALVULOPLASTY;BENDAMUSTINE;BLINATUMOMAB;BRADYCARDIA;BRAIN METASTASIS;CELL CYCLE CHECKPOINT;CENTRAL PRECOCIOUS PUBERTY;CHEMOIMMUNOTHERAPY;CHILD ABUSE;CILIOPATHY;CONTACT URTICARIA;CONTINUOUS GLUCOSE MONITORING;COR TRIATRIATUM;CYCLIN-DEPENDENT KINASE;DEFIBROTIDE;DIFFUSING CAPACITY;DOUBLE BLIND;DYSKINESIA;ENTHESITIS;ESTROGEN RECEPTOR;EXTRAVERSION AND INTROVERSION;FIBROBLAST GROWTH FACTOR RECEPTOR 2;FIBROBLAST GROWTH FACTOR RECEPTOR 3;FRAMESHIFT MUTATION;GENE MUTATION;GENETIC HETEROGENEITY;GENOMICS;GLUCAGON-LIKE PEPTIDE 1 RECEPTOR;GLYCATED HEMOGLOBIN;GLYCEMIC INDEX;GOLIMUMAB;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;HBSAG;HEPATIC VENO-OCCLUSIVE DISEASE;HUMAN GROWTH HORMONE;HYPOPHOSPHATASIA;IDIOPATHIC NEPHROTIC SYNDROME;IDIOPATHIC SHORT STATURE;IGHV@;IMMUNOGLOBULIN A;INTERMEDIATE UVEITIS;IVABRADINE;JANUS KINASE INHIBITOR;KARYOTYPE;KLEBSIELLA PNEUMONIAE;KNEE PAIN;LACTOBACILLUS REUTERI;LIRAGLUTIDE;MACHINE PERFUSION;METASTATIC BREAST CANCER;MICROANGIOPATHIC HEMOLYTIC ANEMIA;MISSENSE MUTATION;MOLECULAR EPIDEMIOLOGY;MONOCLONAL;NILOTINIB;OBINUTUZUMAB;OLIGOARTHRITIS;OSTEOCALCIN;OSTEOPROTEGERIN;PARS PLANA;PHOSPHATIDYLSERINE;POLYCYSTIC OVARY;POSACONAZOLE;PRIMARY CILIARY DYSKINESIA;RANIBIZUMAB;RETINAL VASCULITIS;ROS1;STAT PROTEIN;SYNAPTIC PRUNING;TETRAPLEGIA;TNF INHIBITOR;UREA CYCLE;UROTHELIAL CANCER;UROTHELIAL CARCINOMA;VACCINE-PREVENTABLE DISEASES;VENETOCLAX;VINORELBINE;VON WILLEBRAND DISEASE","11;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;CHILD;COVID-19;ITALY;FEMALE;MALE;RETROSPECTIVE STUDIES;ADULT;TREATMENT OUTCOME;ADOLESCENT;AGED;CHILD, PRESCHOOL;SARS-COV-2;STROKE;THROMBOCYTOPENIA;ANTI-BACTERIAL AGENTS;BRONCHIOLITIS;COVID-19 VACCINES;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA","112;87;25;24;22;18;18;18;15;14;11;9;8;8;8;8;7;7;7;7","DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;ACUTE MYELOID LEUKEMIA;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;MANAGEMENT OF BRAIN METASTASES IN CANCER PATIENTS;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EMERGENCY DEPARTMENT CROWDING;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS","5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CLINICAL ENDPOINT;HEMATOLOGY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CONCOMITANT;TREATMENT;2019-20 CORONAVIRUS OUTBREAK;CROSS-SECTIONAL STUDY;DEEP VEIN THROMBOSIS;DISCONTINUATION;MULTISYSTEM INFLAMMATORY SYNDROME;PANDEMIC;PHLEBOTOMY;PSORIASIS;STROKE (ENGINE);TRANSFUSION THERAPY;UNIVARIATE ANALYSIS;BRAIN METASTASES;CUMULATIVE INCIDENCE;DELPHI METHOD;ECHOCARDIOGRAPHY","7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3","SOUTHERN ITALY;AIDA NETWORK;CELL CARCINOMA;STILLS DISEASE;CELIAC DISEASE;CLINICAL PRACTICE;INTERNATIONAL AIDA;ITALIAN NATIONAL;ITALIAN SOCIETY;MULTICENTER STUDY;RENAL CELL;RETROSPECTIVE ANALYSIS;RETROSPECTIVE STUDY;SARS-COV- INFECTION;TYPE DIABETES;ACUTE MYELOID;BRAIN METASTASES;CHECKPOINT INHIBITORS;CHRONIC LYMPHOCYTIC;CLINICAL FEATURES;COHORT STUDY;IMMUNE CHECKPOINT;INFLAMMATORY SYNDROME;ITALIAN REGISTRY;LYMPHOCYTIC LEUKEMIA;MODERATE-TO-SEVERE PSORIASIS;MULTIPLE MYELOMA;MULTISYSTEM INFLAMMATORY;MUSCULAR ATROPHY;MYELOID LEUKEMIA","6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PATIENTS TREATED;STILLS DISEASE;STABLE IMPROVED;WORSENED STABLE;ADVERSE EVENTS;HR CI;MEDIAN AGE;PEDIATRIC PATIENTS;MULTIVARIATE ANALYSIS;SARS-COV- INFECTION;CLINICAL FEATURES;PATIENTS RECEIVED;RETENTION RATE;RHGH THERAPY;SIGNIFICANT DIFFERENCES;ADVISORY ROLE;INTENSIVE CARE;MEDIAN IQR;MM PATIENTS;RETROSPECTIVE STUDY;RISK FACTORS;SKIN INCISION;VISUAL ACUITY;ADULT PATIENTS;CLINICAL PRACTICE;DISEASE ACTIVITY;HEART FAILURE;AGED MONTHS;BIOLOGIC AGENT;CARE UNIT","20;17;15;15;14;13;13;12;11;11;10;10;10;10;10;9;9;9;9;9;9;9;9;8;8;8;8;7;7;7",37,0.19,5.08,6,1,1,0,2.5,0,1,0,7,1,0,6.75,1,1,1,3.5,9.25,6.25,0,0,10,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,1.5,1109.57,2.87,0,0,66.62,0,0,0,0,1,0,0,7,0,3,5,0,0,0,0,0,0,7,1,0,8,0,0,0,0,0,0,0,0,0,"Italy;Denmark;Japan;United States","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3215 REPRODUCTIVE MEDICINE;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","7;5;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NUTRITION;BRAIN DISORDERS;DIABETES;NEUROSCIENCES;OBESITY;PREVENTION;AUTOIMMUNE DISEASE;CANCER;CARDIOVASCULAR;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;EPILEPSY;HEART DISEASE;HEMATOLOGY;INFECTIOUS DISEASES;LUNG;NEURODEGENERATIVE","7;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;METABOLIC AND ENDOCRINE;CANCER;INFECTION;MUSCULOSKELETAL;NEUROLOGICAL","2;2;1;1;1;1","6.1 PHARMACEUTICALS;3.3 NUTRITION AND CHEMOPREVENTION;6.4 SURGERY","2;1;1","MYELOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"FRONTIERS;ZENODO;SPRINGER NATURE","2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3213 PAEDIATRICS","8;3;2;2;1;1;1","CARDIOVASCULAR;CLINICAL RESEARCH;HEART DISEASE;BIOMEDICAL IMAGING;DIABETES;LUNG;PREVENTION;RARE DISEASES","3;3;3;2;1;1;1;1","CARDIOVASCULAR;ORAL AND GASTROINTESTINAL","2;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;6.1 PHARMACEUTICALS","2;1;1;1","CLINICAL;POPULATION & SOCIETY","3;1","CLINICAL MEDICINE AND SCIENCE","5",NA,NA,NA,NA
"AOUSSN_POLICLINICOBARI",2024,167,21.562874251497,2.38323353293413,0.245508982035928,0.227544910179641,0.269461077844311,1.5546875,1.13888888888889,1.1875,1.21621621621622,0.634730538922156,1,59,32,26,18,0.35,0.19,0.16,0.11,0.61,0.639087107023666,4.06942889137738,0.317365269461078,0.898203592814371,0.422,0.416,0.4,0.455,"FRANCESCO LA TORRE;MIMMA RIZZO;CARLO D’AGOSTINO;FABIO CARDINALE;RUGGIERO FRANCAVILLA;GAAFAR RAGAB;GIUSEPPE LOPALCO;ANTONIO VITALE;SAMAR THARWAT;GIOVANNI CONTI;FRANCESCO MASSARI;MARIA CRISTINA MAGGIO;PETROS P. SFIKAKIS;ANDREA HINOJOSA‐AZAOLA;VALERIA CAGGIANO;R. C. KARDAŞ;ABDURRAHMAN TUFAN;SILVANA GUERRIERO;GIANDOMENICO ROVIELLO;JOSÉ HERNÁNDEZ‐RODRÍGUEZ","12;9;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6","CARLO D’AGOSTINO;EMANUELE ROSSI;RUGGIERO FRANCAVILLA;A FERRIERI;IDA PASTORE;D CARRETTA;FABIO CARDINALE;FERNANDA CRISTOFORI;MIMMA RIZZO;L BENEDETTO;VINCENZO BRESCIA;FRANCESCO LA TORRE;FRANCESCA DI SERIO;MARIA CHIRONNA;GIOVANNI MELIOTA;ALBINA TUMMOLO;ROSA CARELLA;DONATELLA DE GIOVANNI;C COLUCCI;DANIELA LOCONSOLE","1.09;1;0.78;0.73;0.73;0.73;0.67;0.6;0.56;0.53;0.5;0.48;0.45;0.45;0.44;0.43;0.43;0.43;0.42;0.39","FRANCESCO LA TORRE;MIMMA RIZZO;CARLO D’AGOSTINO;FABIO CARDINALE;RUGGIERO FRANCAVILLA;GIUSEPPE LOPALCO;FRANCESCO MASSARI;FERNANDA CRISTOFORI;CAMILLO PORTA;FRANCESCA DI SERIO;A FERRIERI;MAURIZIO DELVECCHIO;IDA PASTORE;VINCENZO BRESCIA;GENNARO MARTINES;D CARRETTA;GIOVANNI MELIOTA;ALESSANDRO BERTOLINO;LORENZO GIOVANNICO;CHIARA MORELLI","12;9;8;8;8;7;7;6;5;5;4;4;4;4;4;4;4;3;3;3","CARLO D’AGOSTINO;EMANUELE ROSSI;RUGGIERO FRANCAVILLA;A FERRIERI;IDA PASTORE;D CARRETTA;FABIO CARDINALE;FERNANDA CRISTOFORI;MIMMA RIZZO;L BENEDETTO;VINCENZO BRESCIA;FRANCESCO LA TORRE;FRANCESCA DI SERIO;GIOVANNI MELIOTA;ALBINA TUMMOLO;ROSA CARELLA;DONATELLA DE GIOVANNI;C COLUCCI;VANESSA NADIA DARGENIO;MARCO MARIA DICORATO","1.09;1;0.78;0.73;0.73;0.73;0.67;0.6;0.56;0.53;0.5;0.48;0.45;0.44;0.43;0.43;0.43;0.42;0.39;0.36","DESIRÉE CASELLI;RUGGIERO FRANCAVILLA;MAURIZIO ARICÒ;MAURIZIO DELVECCHIO;NICOLA LAFORGIA;CHIARA FERRECCHI;CLAUDIA COLOMBA;CLAUDIO CAFAGNO;DANIELA DIBELLO;DANIELA TROTTA;ELIO CASTAGNOLA;ERNESTO ROSSI;INES CARLONI;MARCELLO MARIANI;MARIA CRISTINA MAGGIO;ALEXANDER M. MENZIES;ALICE INDINI;ANA ARANCE;ANDREA SCARAMUZZA;ANNA MARIA DI GIACOMO","9;9;8;8;8;7;7;7;7;7;7;7;7;7;7;6;6;6;6;6","RUGGIERO FRANCAVILLA;DESIRÉE CASELLI;CLAUDIO CAFAGNO;DANIELA DIBELLO;ELVIRA PICCINNO;FERNANDA CRISTOFORI;MARCO TUCCI;MARIA CHIARA SERGI;MAURIZIO DELVECCHIO;ELENA SBLENDORIO;FABIO CARDINALE;FRANCESCO LA TORRE;MIMMA RIZZO;ANNA SALLUSTIO;CARLA MASTRORILLI;DANIELE CASULLI;DILETTA DOMENICA TORRES;FRANCESCA CENTRONE;ANNA DE TULLIO;CELESTE RAGUSEO","9;8;7;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;3;3","FRANCESCO LA TORRE;MIMMA RIZZO;RUGGIERO FRANCAVILLA;FABIO CARDINALE;FERNANDA CRISTOFORI;FRANCESCA DI SERIO;GIOVANNI MELIOTA;VINCENZO BRESCIA;CARLA MASTRORILLI;FRANCESCA CENTRONE;SIMONETTA SIMONETTI;ALBINA TUMMOLO;DOMENICO SERGIO ZIMATORE;DONATELLA DE GIOVANNI;MARCO MATTEO CICCONE;ROSA CARELLA;UGO VAIRO;A MAIORANO;ANNA SALLUSTIO;ANTONELLA VIMERCATI","13;9;8;7;6;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;SOCIOLOGY;MATHEMATICS;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;GEOGRAPHY;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY","155;43;14;13;11;11;11;10;9;9;7;3;3;3;2;2;2;1","INTERNAL MEDICINE;SURGERY;GENETICS;CARDIOLOGY;INTENSIVE CARE MEDICINE;PEDIATRICS;IMMUNOLOGY;PATHOLOGY;ONCOLOGY;MICROBIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;PALEONTOLOGY;PSYCHIATRY;RADIOLOGY;PHYSICAL THERAPY;BIOCHEMISTRY;FAMILY MEDICINE;GASTROENTEROLOGY;LAW;NURSING","108;30;27;26;26;25;18;18;14;11;10;10;10;10;10;9;8;8;8;7;7","DISEASE;CANCER;GENE;RANDOMIZED CONTROLLED TRIAL;OBSERVATIONAL STUDY;DIABETES MELLITUS;RETROSPECTIVE COHORT STUDY;COHORT;ANTIBIOTICS;CHEMOTHERAPY;HEALTH CARE;HEART FAILURE;ADVERSE EFFECT;BACTERIA;CLINICAL TRIAL;MYOCARDITIS;POPULATION;PREGNANCY;PULMONARY HYPERTENSION;ASTHMA;CONFIDENCE INTERVAL;CONTEXT (ARCHAEOLOGY);GUT FLORA;INCIDENCE (GEOMETRY);OBESITY;OUTBREAK;STROKE (ENGINE)","29;20;14;14;9;8;8;7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","BLADDER CANCER;IMMUNOTHERAPY;COLORECTAL CANCER;GENOTYPE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MULTICENTER STUDY;BEHCET'S DISEASE;FAMILIAL MEDITERRANEAN FEVER;MUTATION;TYPE 2 DIABETES;VASCULITIS;ALLELE;BREAST CANCER;CARDIAC AMYLOIDOSIS;CARDIAC MAGNETIC RESONANCE;CARDIOMYOPATHY;CARDIOTOXICITY;CLINICAL ENDPOINT;COCHRANE LIBRARY;DEPOSITION (GEOLOGY);DNA SEQUENCING;GENE EXPRESSION;GENOME;GESTATIONAL AGE;GLYCEMIC;HAZARD RATIO;INFLAMMATORY BOWEL DISEASE;LEGIONELLA;LIVER TRANSPLANTATION;NEPHROPATHY;NEURORADIOLOGY;PHENOTYPE;PHENYLALANINE;PROGENITOR CELL;PROTOCOL (SCIENCE);RADIOFREQUENCY ABLATION;RELATIVE RISK;SPHEROID;UNIVARIATE ANALYSIS;WEIGHT LOSS","5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","UROTHELIAL CARCINOMA;CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;EXOME SEQUENCING;GASTRIC BYPASS;PEMBROLIZUMAB;PHENYLKETONURIAS;RETINAL VASCULITIS;SANGER SEQUENCING;WHOLE GENOME SEQUENCING;ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS;ASPARAGINASE;ASPARAGINE SYNTHETASE;BRAIN METASTASIS;BRONCHIAL HYPERRESPONSIVENESS;CYANOACRYLATE;DEMETHYLASE;DIABETES MANAGEMENT;DIABETES TREATMENT;DOUBLE BLIND;ECHOVIRUS;ENDOVASCULAR ANEURYSM REPAIR;ENTEROVIRUS INFECTIONS;EPITHELIAL–MESENCHYMAL TRANSITION;FETAL HEAD;FUSOBACTERIUM;FUSOBACTERIUM NUCLEATUM;GLUCOSE HOMEOSTASIS;HEALTH WORKER;HIATAL HERNIA;IMPAIRED GLUCOSE TOLERANCE;INDUCED PLURIPOTENT STEM CELL;INSULIN PUMP;IPILIMUMAB;IRINOTECAN;IVACAFTOR;KLEBSIELLA PNEUMONIAE;KRAS;LENVATINIB;LIRAGLUTIDE;MESALAZINE;MILAN CRITERIA;MODEL FOR END-STAGE LIVER DISEASE;MORAXELLA CATARRHALIS;MULTILOCUS SEQUENCE TYPING;MULTIPLEX POLYMERASE CHAIN REACTION;NORMAL WEIGHT;OSTEOCALCIN;PRASUGREL;PROGENITOR;RENAL STEM CELL;RNA SPLICING;SEED DORMANCY;SINGLE-NUCLEOTIDE POLYMORPHISM;SYSTEMIC THERAPY;SYSTEMIC VASCULITIS;TAKOTSUBO SYNDROME;TICAGRELOR;TRANSCRIPTOME;UROTHELIAL CANCER;VANCOMYCIN;VENTROLATERAL PREFRONTAL CORTEX","5;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;CHILD;ITALY;ADULT;MIDDLE AGED;ADOLESCENT;RETROSPECTIVE STUDIES;AGED;TREATMENT OUTCOME;CHILD, PRESCHOOL;INFANT, NEWBORN;PROSPECTIVE STUDIES;INFANT;YOUNG ADULT;AGED, 80 AND OVER;COVID-19;PROGNOSIS","92;75;39;39;26;23;22;18;14;13;11;11;9;9;8;7;7;6;6;6","METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;RENAL CELL CARCINOMA;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;ASTHMA;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS, TREATMENT, AND EPIDEMIOLOGY OF NONTUBERCULOUS MYCOBACTERIAL DISEASES;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE","6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","METASTATIC UROTHELIAL CARCINOMA;PHENYLKETONURIA;TREATMENT;MYOCARDITIS;PULMONARY HYPERTENSION;STROKE (ENGINE);CENTER (CATEGORY THEORY);CONCOMITANT;CROSS-SECTIONAL STUDY;DIAGNOSIS;GLUTEN SENSITIVITY;IGA NEPHROPATHY;INFARCTION TREATMENT;INFLAMMATION;INTERQUARTILE RANGE;MODALITIES;POSITION PAPER;RENAL CELL CARCINOMA;RISK STRATIFICATION;SINGLE CENTER","5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","AIDA NETWORK;ITALIAN SOCIETY;UROTHELIAL CARCINOMA;INTERNATIONAL AIDA;OBSERVATIONAL STUDY;POSITION PAPER;ADVANCED UROTHELIAL;BEHÇETS DISEASE;CARDIAC AMYLOIDOSIS;CELL CARCINOMA;CLINICAL TRIAL;DISEASE REGISTRY;FAMILIAL MEDITERRANEAN;MEDITERRANEAN FEVER;PULMONARY HYPERTENSION;RENAL CELL;SOUTHERN ITALY;ADVANCED RENAL;AMINO ACID;ARTERIAL HYPERTENSION;BARIATRIC SURGERY;BONE METABOLISM;BOWEL DISEASE;CANCER PATIENTS;CARDIAC ARREST;CELLS ISOLATED;CLINICAL OUTCOME;COHORT STUDY;COLORECTAL CANCER;CORD INJURY","6;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","ABSTRACT INTRODUCTION;ANTIBIOTIC THERAPY;DISEASE ACTIVITY;HEART FAILURE;STATISTICALLY SIGNIFICANT;VENTRICULAR PREEXCITATION;PATIENTS TREATED;ATRIAL TACHYCARDIA;BEHÇETS DISEASE;GR MB;MEDIAN AGE;PATIENTS AFFECTED;PATIENTS UNDERGOING;PROTEIN INTAKE;PULMONARY ARTERIAL;RR CI;SSTAMPGT NGML;Β CI;ARPC-DERIVED SPHEROIDS;CARDIOVASCULAR RISK;CELIAC DISEASE;CLINICAL TRIALS;FMF PATIENTS;ISCHEMIC STROKE;PATIENTS RECEIVED;POCKET INFECTION;POSTOPERATIVE COMPLICATIONS;PULMONARY HYPERTENSION;RISK FACTORS;SIGNIFICANT DIFFERENCES","12;9;9;8;8;8;7;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,50,0.41,0,0,27,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PATIENT SAFETY;RARE DISEASES","1;1;1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1","MYELOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
